Characterization of the vascular control of hindlimb metabolism by Dora, Kim A(Andrea)
CHARACTERIZATION OF THE VASCULAR CONTROL OF 
HINDLIMB METABOLISM 
by 
c'L 
Kim ADora BSc (Hons) 
Submitted in fulfilment of the requirements 
for the degree of Doctor of Philosophy 
Department of Biochemistry 
University of Tasmania (July, 1993) 
CONTENTS 
Contents 	 Page 
LIST OF CONTENTS: 
LIST OF TABLES: 	 vii 
LIST OF FIGURES: viii 
PREFACE: 	 xiIi 
ACKNOWLEDGMENTS: 	 xviIi 
STATEMENT: 	 xix 
ABBREVIATIONS: 	 XX 
ABSTRACT: 	 xxi 
CHAPTER 1 Thesis introduction. 1 
1.1 Control of blood flow in skeletal muscle. 1 
1.1.1 Vasoactive agents. 1 
1.1.1.1 Involvement in thermoregulation. 4 
1.1.1.2 Release postprandially. 4 
1.1.1.3 Release during exercise. 5 
1.1.1.4 Action during hypoxia. 6 
1.1.1.5 Contribution to disease states. 6 
1.2 Measurement of skeletal muscle metabolism. 9 
1.2.1 Composition of rat hindlimb. 10 
1.2.1.1 Skeletal muscle fibres. 10 
1.2.1.1.1 Mechanism of skeletal muscle contraction. 10 
1.2.1.1.2 Energetics of skeletal muscle contraction. 11 
1.2.1.2 Vascular system. 11 
1.2.1.2.1 Mechanism of vascular smooth muscle contraction. 12 
1.2.1.2.2 Energetics of vascular smooth muscle contraction. 13 
1.2.1.2.3 Mechanism of vascular smooth muscle dilatation. 14 
1.2.2 Resting rat hindlimb as a model of skeletal muscle. 14 
1.2.2.1 In situ studies. 14 
1.2.2.2 Isolated hindlimb perfused with constant pressure. 15 
1.2.2.3 Isolated hindlimb perfused with constant flow. 15 
1.2.2.3.1 Erythrocyte-perfused 15 
•ii 
Contents Page 
I. 2. 2. 3.2 Erythrocyte-free. 16 
1.3 Effects of norepinephrine in constant-flow 
perfused hindlimb. 16 
1.3.1 Sites of NE-induced effects. 19 
1. 3.2 Thermogenic effects of NE. 19 
1. 3.2. 1 Skeletal muscle thermogenesis. 21 
1.3. 2. 2 Heterogeneity offlow. 22 
1.3.2.3 Heterogeneity °plow to highly metabolically active 
regions. 23 
1.3.2.4 Vascular thermogenesis. 24 
1.3.3 Non-thermogenic effects of NE. 25 
1.4 Effects of serotonin in constant-flow perfused 
hindlimb. 25 
1.4.1 Sites of 5-HT-induced effects. 27 
1.5 The present study. 27 
CHAPTER 2 Vascular effects of NE and 5-HT. 28 
2.1 Introduction. 28 
2.1.1 Vasoconstrictor-mediated increases in skeletal 
muscle metabolism. 28 
2.1.2 Vasoconstrictor-mediated decreases in skeletal 
muscle metabolism. 29 
2.2 Materials and methods. 30 
2.2.1 Perfusion techniques. 30 
2.2.1.1 Animal care. 30 
2.2.1.2 Surgical procedures. 30 
2.2.1.2.1 Perfused rat hindlimb. 30 
2.2.1.2.2 Perfused rat mesenteric artery arcade. 33 
2.2.1.3 Perfusion medium. 35 
2.2.1.4 Perfusion apparatus. 35 
2.2.1.5 Chemicals and drugs. 38 
Contents Page 
2.2.1.6 Oxygen uptake calculations. 39 
2.2.1.7 Dose-response curves. 39 
2.2.1.8 Statistical analysis. 39 
2.2.2 Metabolite assay techniques. 40 
2.3 Results. 40 
2.3.1 Effects of NE in the perfilsed hindlimb. 41 
2. 3. 2 Effects of 5-HT in the perfused hindlimb. 48 
2.3.3 Effects of reversible hindlimb occlusion at the knee. 50 
2. 3. 4 Effects of 5-HT in the perfused mesenteric artery 
arcade. 50 
2.4 Discussion. 56 
CHAPTER 3 Metabolic characteristics of 
vasoconstriction. 61 
3.1 Introduction. 61 
3.2 Materials and methods. 62 
3.2.1 Perfused hindlimbs. 62 
3.2.2 Statistical analysis. 62 
3.3 Results. 62 
3.3.1 Effects of vasoconstrictors. 62 
3.3.2 Oxygen-dependence. 65 
3.3.2.1 Dose-dependent effects of NE. 65 
3.3.3 Carbohydrate-dependence. 69 
3.4 Discussion. 72 
CHAPTER 4 Sub-classification of a l-AR- and 5-HT- 
receptor stimulation. 76 
4.1 Introduction. 76 
4.2 Materials and methods. 78 
4.2.1 Perfused hindlimbs. 78 
4.2.1.1 Modification of extracellular [Ca2- ]. 78 
iv 
Contents Page 
4.2.2 Statistical analysis. 79 
4.3 Results. 79 
4.3.1 NE-mediated effects. 81 
4.3.1.1 Perfusion medium Ca2+ perturbations. 81 
4.3.1.2 Effects of a l-AR antagonists on the response to NE 
in the presence of extracellular Ca2+. 81 
4. 3. I. 3 Effects of al-AR antagonists on the response to NE 
in the absence of extracellular Ca2+. 84 
4.3.2 5-HT-mediated effects. 84 
4.3.2.1 Perfusion medium Ca2+ perturbations. 84 
4.3.3 Additivity of NE- and 5-HT-mediated effects. 84 
4.4 Discussion. 90 
CHAPTER 5 Effect of vasoconstrictors on insulin- 
mediated glucose uptake. 	 97 
5.1 Introduction. 97 
5.2 Materials and methods. 99 
5.2.1 Perfused hindlimbs. 99 
5.2.1.1 Experiments involving 5-HT 99 
5.2.1.2 Experiments involving NE. 100 
5.2.2 Incubated muscles. 100 
5.2.3 Statistical analysis. 101 
5.3 Results. 101 
5.3.1 Experiments involving 5-HT at 32°C. 103 
5.3.1.1 Effects of insulin in perfused hindlimbs. 103 
5.3.1.2 Effects of 5-HT in perfiused hindlimbs. 108 
5.3.1.3 Effects of insulin plus 5-HT in perfused hindlimbs. 108 
5.3.1.4 Effects of insulin, 5-HT, and insulin plus 5-HT in 
incubated muscles. 109 
5.3.2 Experiments involving NE at 37°C. 109 
5. 3. 2. 1 Effects of insulin in perfused hindlimbs. 112 
Contents Page 
5.3.2.2 Effects of low-dose NE in perfused hindlimbs. 112 
5. 3. 2. 3 Effects of insulin plus low-dose NE in perfused 
hindlimbs. 112 
5.3.2.4 Effects of high-dose NE in perfused hindlimbs. 115 
5.3.2.5 Effects of insulin plus high-dose NE in perfused 
hindlimbs. 115 
5.4 Discussion. 119 
CHAPTER 6 Effect of 5-HT during skeletal muscle 
contraction. 125 
6.1 Introduction. 125 
6.2 Materials and methods. 126 
6.2.1 Perfused hindlimbs. 126 
6.2.1.1 Egthrocyte-free perfusions. 128 
6.2.1.1.1 Effect of prior infusion of 5-HT on skeletal muscle 
contraction. 128 
6.2.1.1.2 Effect of 5-HT during skeletal muscle contraction. 129 
6.2.1.2 Egthrocyte perfusions. 129 
6. 2.2 Incubated muscles. 130 
6. 2. 3 Statistical analysis. 132 
6.3 Results. 132 
6.3.1 Egthrocyte-free perfusions. 132 
6.3.1.1 Effect of prior infusion of 5-HT on skeletal muscle 
contraction. 133 
6.3. 1.2 Effect of 5-HT during skeletal muscle contraction. 133 
6. 3.2 Erythrocyte perfusions. 136 
6. 3.2. 1 Effect of 5-HT during skeletal muscle contraction. 136 
6. 3. 3 Incubated muscles. 141 
6.4 Discussion. 141 
vi 
Contents 	 Page 
CHAPTER 7 Vasoconstrictor-mediated alterations in 
flow distribution. 	 146 
7.1 	Introduction. 	 146 
7.2 	Materials and methods. 	 147 
7.2.1 	Perfused hindlimbs. 	 147 
7.2.2 	Evans blue dye efflux kinetics. 	 148 
7.2.3 	Entrapment of fluorescein-labelled dextral!. 	 149 
7.2.4 	Microsphere injection. 	 150 
7.2.5 	Statistical analysis. 151 
7.3 	Results. 	 151 
7.3.1 	Evans blue dye efflux kinetics. 	 151 
7.3.2 	Entrapment of fluorescein-labelled dextran. 	 153 
7.3.3 	Microsphere injection. 	 158 
7.4 	Discussion. 	 158 
CHAPTER 8 Thesis discussion. 	 164 
8.1 	Summary of findings. 	 164 
8.2 	Implications of findings. 	 166 
8.3 	Future considerations. 	 169 
REFERENCES: 	 170 
vii 
LIST OF TABLES 
Table 	 Page 
CHAPTER 1 
1.1 	Metabolite concentrations in rat Endlimb skeletal muscle. 	 17 
1.2 	Rates of metabolism in hindlimb skeletal muscle. 	 18 
1.3 	Effect of NE on V02 and perfusion pressure in constant-flow 
perfused rat hindlimb. 	 20 
1.4 	Effect of 5-HT on perfusion pressure in constant-flow perfused 
rat hindlimb. 	 26 
CHAPTER 3 
3.1 	Effects of hypoxia, cyanide, and azide on hindlimb V0 2 and 
perfusion pressure under basal conditions. 	 63 
3.2 	Effects of NE and 5-HT on hindlimb V0 2 and perfusion pressure 
during hypoxia and in the presence of cyanide or azide. 	 64 
CHAPTER 4 
4.1 	Effect of perfusion medium Ca2+ perturbations on basal hindlimb 
conditions. 	 80 
4.2 	Effect of perfusion medium Ca2+ perturbations on the hindlimb 
response to 5-HT. 	 85 
4.3 	Summary of evidence for sub-classification of AR- and 5-HT- 
receptor stimulation in constant-flow perfused rat hindlimb. 	96 
CHAPTER 5 
5.1 	Relationship between rat size, perfusion temperature and flow 
rate on basal hindlimb perfusion conditions. 	 102 
5.2 	Effect of insulin on perfused hindlimb glucose uptake. 	 120 
CHAPTER 6 
6.1 	Effect of 5-HT on VO2 by perfused hindlimb during skeletal 
muscle contraction. 	 139 
6.2 	Basal and contraction-stimulated V02 in erythrocyte-perfused rat 
hindlimbs. 	 140 
LIST OF FIGURES 
Figure 	 Page 
CHAPTER 1 
1.1 	Modified Landsberg hypothesis. 	 7 
CHAPTER 2 
2.1 	Vessels ligated during surgical preparation of the isolated rat 
hindlimb. 	 32 
2.2 	Vessels ligated during surgical preparation of the isolated rat 
mesenteric artery arcade. 	 34 
2.3 	Rat hindlimb perfusion apparatus. 	 36 
2.4 	Mesenteric artery arcade perfusion apparatus. 	 37 
2.5  Effects of representative low- and high-dose NE and 5-HT 
concentrations on hindlimb venous P02 and perfusion 
pressure. 42 
2.6  Time course for the effects of NE, 5-HT and reversible occlusion 
at the knee on hindlimb V0 2, perfusion pressure and lactate 
release. 43 
2.7 	Dose-response curves for NE and 5-HT on changes in hindlimb 
V02, perfusion pressure and lactate release. 	 44 
2.8 	Effect of a-AR antagonists on the response to low-dose NE on 
hindlimb V02 and perfusion pressure. 	 45 
2.9 	Effect of a-AR antagonists on the response to high-dose NE on 
hindlimb V02 and perfusion pressure. 	 46 
2.10  Effect of a l - and 13-AR antagonists on the NE dose-response 
curve on changes in hindlimb V0 2, perfusion pressure and 
lactate release. 47 
2.11  Dose-response curves for 0-agonists on hindlimb lactate release 
expressed as a proportion of the maximum response by each 
agonist. 49 
2.12 	Effect of a 5-HT2-antagonist on the 5-HT dose-response curve 
on changes in hindlimb V02 and perfusion pressure. 	 51 
ix 
Figure 	 Page 
2.13 	Effect of a representative dose of 5-HT in the presence of both a 
5-HT2-antagonist and angiotensin II on hindlimb venous P02 
and perfusion pressure. 	 52 
2.14  Dose response curve for 5-HT in the presence of a 5-HT 2- 
antagonist and angiotensin II on hindlimb V0 2 and perfusion 
pressure. 53 
2.15  Time course of 5-HT-mediated effects on venous P0 2 and 
perfusion pressure in isolated perfused mesenteric artery 
arcade. 54 
2.16  Dose-response curves for 5-HT on changes in V02, perfusion 
pressure and lactate release in isolated perfused mesenteric 
artery arcade. 55 
CHAPTER 3 
3.1 	Effects of hypoxia, cyanide, and azide on NE- and 5-HT- 
mediated changes in hindlimb venous P02 and perfusion 
pressure. 	 66 
3.2 	Effect of hypoxia, cyanide and azide on dose-response curve for 
NE on hindlimb perfusion pressure. 	 67 
3.3 	Dose-response curves for prazosin against NE on hindlimb 
perfusion pressure under hypoxic conditions. 	 68 
3.4  Effect of glucose-free perfusion medium on the hindlimb response 
to a representative dose of 5-HT in the absence and presence 
of cyanide. 70 
3.5 	Carbohydrate-dependence of the hindlimb response to NE and 
5-HT. 	 71 
CHAPTER 4 
4.1 	Receptor-mediated events leading to vasoconstriction in vascular 
smooth muscle. 	 77 
4.2 	Effect of varying the extracellular [Ca 21 concentration on the 
response to NE on hindlimb V0 2 and perfusion pressure. 	 82 
Figure 	 Page 
4.3 	Effect of at-AR antagonists on the dose-response curves for NE 
on hindlimb V02 and perfusion pressure in the presence of 
extracellular Ca2+. 	 83 
4.4 Effect of a i-AR antagonists on the dose-response curves for NE 
on hindlimb V02 and perfusion pressure in the absence of 
extracellular Ca2+. 86 
4.5 	Dose-dependent effects of NE on changes in hindlimb V0 2 
uptake versus changes in perfusion pressure. 	 87 
4.6 	Effect of removing extracellular Ca 2+ on the response to 5-HT on 
hindlimb V02 and perfusion pressure. 	 88 
4.7 	Additivity of maximal NE and 5-HT responses on hindlimb V0 2 
and perfusion pressure in the absence of extracellular Ca2±. 	89 
CHAPTER 5 
5.1 	Effects of perfusion temperature, flow rate and rat size on the 
dose-dependent V02 and perfusion pressure effects of 5-HT 
in hindlimbs. 	 104 
5.2 	Effects of insulin, and 5-HT in the absence and presence of 
insulin, on hindlimb V02 and perfusion pressure. 	 105 
5.3 	Effects of insulin, and 5-HT in the absence and presence of 
insulin, on hindlimb lactate release and glucose uptake. 	 106 
5.4 Average steady-state effects of insulin, and 5-HT in the presence 
and absence of insulin, on hindlimb V02, perfusion pressure, 
lactate release and glucose uptake. 107 
5.5 Effects of 5-HT, insulin and 5-HT plus insulin on glucose uptake 
by isolated incubated soleus and extensor digitorum longus 
muscles. 110 
5.6 Effects of perfusion temperature, flow rate and rat size on the 
dose-dependent V02 and perfusion pressure effects of NE in 
hindlimbs. 111 
5.7 Effects of insulin, and low-dose NE in the presence and absence 
of insulin and AR antagonists, on hindlimb V02 and perfusion 
pressure. 113 
xi 
Figure 	 Page 
5.8 	Effects of insulin, and low-dose NE in the presence and absence 
of insulin and AR antagonists, on hindlimb lactate release and 
glucose uptake. 	 114 
5.9  Effects of insulin, and high-dose NE in the presence and absence 
of insulin and AR antagonists, on hindlimb V0 2 and perfusion 
pressure. 116 
5.10  Effects of insulin, and high-dose NE in the presence and absence 
of insulin and AR antagonists, on hindlimb lactate release and 
glucose uptake. 117 
5.11  Average steady-state effects of insulin, and NE in the presence 
and absence of insulin and AR antagonists, on hindlimb V02, 
perfusion pressure, lactate release and glucose uptake. 118 
CHAPTER 6 
6.1 	Apparatus used to electrically stimulate and measure tension 
development in the GPS muscle group. 	 127 
6.2 	Isolated muscle incubation apparatus. 	 131 
6.3  Effect of 5-HT on V0 2, lactate release, perfusion pressure and 
tension development before and during skeletal muscle 
contraction. 134 
6.4 	Effect of 5-HT on V02, lactate release, perfusion pressure and 
tension development during skeletal muscle contraction. 	 135 
6.5 	Effect of 5-HT on lactate release, perfusion pressure and tension 
development during skeletal muscle contraction. 	 137 
6.6 	Effect of 5-HT on muscle tension development by electrically- 
stimulated isolated soleus and EDL muscles. 	 142 
CHAPTER 7 
7.1 	Dye washout profiles and difference curves in the constant-flow 
perfused rat hindlimb. 	 152 
7.2 	Perfusion protocol for determining the entrapment of FITC- 
dextran during infusion of NE or 5-HT. 	 155 
7.3 	Time course of the washout of NE- and 5-HT-mediated and total 
entrapped spaces in perfused hindlimb. 	 156 
Figure 	 Page 
7.4 	Effect of time on the apparent volume entrapped by NE and 
5-HT in perfused hindlimb. 	 157 
7.5 	Effect of 5-HT on the washout of injected microspheres in 
perfused hindlimb I. 	 159 
7.6 	Effect of 5-HT on the washout of injected microspheres in 
perfused hindlimb H. 	 160 
CHAPTER 8 
8.1 	Schematic diagram of the branching sequence in the micro- 
vascular network of skeletal muscle. 	 167 
8.2 	The link between hypertension and insulin-resistance: a model. 	168 
PREFACE 
The majority of the experimental work presented in this thesis was carried 
out in the period from February 1990 to January 1993. Work performed by other 
members of this department has been presented and acknowledged where relevant. In 
this regard, contributions were made by Dr Stephen Rattigan in the insulin-mediated 
glucose uptake studies (Chapter 5), Dr Steve Edwards in the microsphere studies 
(Chapter 7), and Mr John Newman in the fluorescent marker entrapment studies 
(Chapter 7). 
Some of the data presented here has been published or presented at scientific 
meetings and the relevant publications are listed below. 
Publications directly arising from this thesis: 
1. Dora, K.A., Colquhoun, E.Q., Hettiarachchi, M., Rattigan, S. and Clark, M.G. 
(1991) The apparent absence of serotonin-mediated vascular thermogenesis in 
perfused rat hindlimb may result from vascular shunting. Life Sci. 48: 1555- 
1564. 
2. Dora, K.A., Richards, S.M., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. 
(1992) Serotonin and norepinephrine-mediated vasoconstriction in the perfused 
rat hindlimb have different oxygen requirements. Am. J. Physiol. 262: H698- 
H703. 
Currently unpublished papers directly arising from this thesis: 
3. Rattigan, S., Dora, K.A., Colquhoun, E.Q. and Clark, M.G. (accepted subject 
to revision) Serotonin-mediated acute insulin resistance in the perfused rat 
hindlimb but not in incubated muscle: a role for the vascular system. Life Sci. 
4. Dora, K.A., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. (submitted) 
Serotonin impairs aerobic muscle contraction in perfused rat hindlimb. J. App!. 
Physiol. 
Additional publications: 
5. Richards, S.M., Dora, K.A., Hettiarachchi, M., Rattigan, S. and Colquhoun, 
E.Q. and Clark, M.G. (1992) A close association between vasoconstrictor-
mediated uracil and lactate release by the perfused rat hindlimb. Gen. 
Pharmacol. 23: 65-69. 
xiv 
6. Hettiarachchi, M., Richards, S.M., Dora, K.A., Rattigan, S., Colquhoun, E.Q., 
and Clark, M.G. (1992) A role for vascular smooth muscle in vasoconstrictor-
mediated release of lactate from the perfused rat hindlimb. J. App!. PhysioL 73: 
2544-2551. 
7. Eldershaw, T.P.J., Colquhoun, E.Q., Dora, K.A., Peng, Z-C., and Clark, M.G. 
(1992) Pungent principles of ginger (Zingiber officinale) are thermogenic in the 
perfused rat hindlimb. Int. J. Obesity 16: 755-763. 
8. Richards, S.M., Dora, K., Rattigan, S., Colquhoun, E.Q., and Clark M.G. 
(1993) Role of extracellular UTP in the release of uracil from vasoconstricted 
hindlimb. Am. J. Physiol. 264: H233-H237. 
9. Matthias, A., Richards, S.M., Dora, K.A., Clark, M.G., and Colquhoun, E.Q. 
(accepted subject to revision) Characterization of perfused periaortic brown 
adipose tissue from the rat. Can. J. PhysioL PharmacoL 
10. Eldershaw, T.P.D., Colquhoun, E.Q., Bennet, K.L., Dora, K.A., and Clark, 
M.G.(submitted) Resiniferatoxin and piperine: vanilloid stimulators of oxygen 
uptake in the perfused rat hindlimb. Planta Med. 
11. Richards, S.M., Clark, M.G., Steen, J.T., Dora, K.A., Rattigan, S., and 
Colquhoun, E.Q. (submitted) Release of purines and pyrimidines from perfused 
rat hindlimb, perfused mesenteric arcade and incubated de-endotheliated aorta. 
J. Vasc. Res. 
12. Clark, M. G., Colquhoun, E.Q., Dora, K.A., Rattigan, S., Eldershaw T.P.D., 
Hall J.L. and Ye J-M. (submitted) Resting muscle: a source of thermogenesis 
controlled by vasomodulators. In: Temperature Regulation, edited by A.S. 
Milton. UK: Birkhauser. 
Papers presented at scientific meetings: 
1. Dora, K.A., Colquhoun, E.Q. & Clark, M.G. (1989) Investigations into modes 
of action for the spice principle capsaicin in the perfused rat hindlimb. Proc. 
Aust. Biochem. Soc. 21: SP12. 
2. Clark, M.G., Richards, S.M., Dora, K.A., Hettiarachchi, M. & Colquhoun, E.Q. 
(1990) High rates of oxygen consumption and uracil release by constricting 
vascular tissue. J. Molec. Cell Cardiol. 
XV 
3. Richards, S.M., Dora, K.A., Colquhoun, E.Q. & Clark, M.G. (1990) The 
vasodilatory action and metabolism of UTP in the perfused rat hindlimb. J. 
Molec. Cell Cardiol. 
4. Colquhoun, E.Q., Hettiarachchi, M., Ye, J-M., Peng, Z., Dora, K.A., Rattigan, 
S. and Clark, M.G. (1990) Vascular involvement in resting muscle 
thermogenesis: a new site of action for thermogenic drugs. Eur. J. Pharmacol. 
183: 677. 
5. Clark, M.G., Richards, S.M., Dora, K.A., Rattigan, S., Hettiarachchi, M., Ye, J-
M., Appleby, G.J. & Colquhoun, E.Q. (1990) Vasoconstrictor-mediated release 
of uracil and the vasodilatory action of UTP in the perffised rat hindlimb. Eur. J. 
Pharmacol. 183: 810-811. 
6. Dora, K.A., Eldershaw, T.P.D., Clark, M.G. & Colquhoun, E.Q. (1991) A 
vanilloid receptor on vascular smooth muscle? Proc. Aust. Soc. Biochem. Mol. 
Biol. 23: P34. 
7. Colquhoun, E.Q., Edwards, S.J., Montgomery, I.M., Peng, Z-C., Eldershaw, 
T.P.D., Dora, K.A., Hettiarachchi, M., Rattigan, S. and Clark, M.G. (1991) 
Thermogenic properties of hot spices. Proc. Dietitians Assoc. Aust. 10: 101. 
8. Colquhoun, E.Q., Dora, K.A., Peng, Z-C. and Clark, M.G. (1991) Vascular 
thermogenesis and vascular shunting. J. Molec. Cell Cardiol. 
9. Dora, K.A., Richards, S.M., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. 
(1991) Oxygen dependence of noradrenaline and serotonin-induced 
vasoconstriction in perfused rat hindlimb. Proc. Aust. Soc. Med Res. 30: 15 
(oral presentation given) 
10. Rattigan, S., Dora, K.A., Colquhoun, E.Q. and Clark, M.G. (1991) Serotonin-
induced vascular shunting in the perfused rat hindlimb leads to insulin resistance. 
Proc. Aust Soc. Med Res. 30: P12. 
11. Rattigan, S., Dora, K.A., Colquhoun, E.Q. and Clark, M.G. (1992) Serotonin-
induced vasoconstriction associated with marked insulin resistance in the 
perfused hindlimb. J. Hypertension 10 (Suppl 4): S51. 
12. Dora, K.A., Richards, S.M., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. 
(1992) Vascular control of hindlimb fuel metabolism. FASEB Summer Research 
Conference - Regulation of Energy Balance. 
xvi 
13. Dora, K.A., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. (1992) 
Characterization of serotonin-induced shunting in perfused rat hindlimb. Proc. 
2nd Int. Symp. Serotonin p71. 
14. Rattigan, S., Dora, K.A., Colquhoun, E.Q. and Clark, M.G. (1992) Impairment 
of skeletal muscle function during vasoconstriction by serotonin in rat hindlimb. 
Proc. 2nd Int. Symp. Serotonin p71. 
15. Hall, J.L., Dora, K.A., Rattigan, S., Clark, M.G. and Colquhoun, E.Q. (1992) 
Sympathetic nerve stimulation mediates a complex pattern of oxygen 
consumption through the alpha-1 adrenoceptor in the perfused rat hindlimb. 
Proc. Aust. Soc. Biochem. MoL Biol. 36: POS-2-9. 
16. Rattigan, S., Dora, K.A., Colquhoun, E.Q. and Clark M.G. (1992) Acute 
insulin-resistance in the perfused rat hindlimb mediated by catecholatnines. Proc. 
Aust. Soc. Biochem. MoL Biol. 36: POS -2- 10. 
17. Dora, K.A., Rattigan, S., Edwards, S.J., Clark M.G. and Colquhoun E.Q. 
(1992) Oxygen consumption associated with vasoconstriction in muscle can be 
either stimulated or inhibited by separate atypical alpha-l-adrenergic receptors. 
Proc. Aust. Soc. Biochem. MoL Biol. 36: COL-3 -4. 
18. Rattigan, S., Dora, K.A., Richards, S.M., Hettiarachchi, M., Edwards, S.J., 
Newman, J.M., Clark, M.G. and Colquhoun, E.Q. (1992) Rat hindlimb 
perfusion: A model for studying the vasculature and its influence on skeletal 
muscle metabolism. Proc. Aust. Soc. Biochem. MoL BioL 36: SYM-9- 1. 
19. Clark, M.G., Matthias, A., Dora, K.A., Rattigan, S., Eldershaw, T.P.D., Hall, 
J.L. and Colquhoun, E.Q. (1993) Vascular control of muscle metabolism: 
possible novel thermogenic mechanisms regulated by vasomodulators. Proc. 
Aust. Soc. Biochem. MoL Biol. (WA branch). 
20. Clark, M. G., Colquhoun, E.Q., Dora, K.A., Rattigan, S., Eldershaw T.P.D., 
Hall J.L. and Ye J-M. (1993) Vascular system involvement in resting muscle 
thermogenesis. IUPS Symp. Temp. Regulation, Aberdeen. 
21. Clark, M.G., Colquhoun, E.Q., Richards, S.M., Hettiarachchi, M., Dora, K.A., 
Rattigan, S., Ye, J-M., and Steen, J.T. (1993) Metabolic indicators of an 
energetically active and potentially thermogenic vascular tissue. IUPS Symp. 
Temp. Regulation, Aberdeen. 
xvi i 
22. Dora, K.A., Rattigan, S., Ye, J-M., Eldershaw, T.P.D., Hall, J.L., Colquhoun, 
E.Q. and Clark, M.G. (1993) Vascular control of rat hindlimb nutrient delivery, 
uptake and release. IUPS (1993), 25. 
22. Clark, M.G., Rattigan, S., Dora, K.A., Newman, J. and Colquhoun, E.Q. (1993) 
Vascular control of insulin-mediated glucose uptake in muscle. Proc. Aust Soc. 
Biochem. MoL BioL, 25 
23. Colquhoun, E.Q., Bennett, K.L., Eldershaw, T.P.D., Hall, J.L., Dora, K.A. and 
Clark, M.G. (1993) Two different vanilloid (VNI and VN 2) receptors stimulate 
or inhibit oxygen consumption in perfused rat hindlimb. Proc. Aust. Soc. 
Biochem. MoL Biol., 25 
24. Dora, K.A., Hall, J.L., Ye, J-M., Eldershaw, T.P.D., Rattigan, S., Clark, M.G. 
and Colquhoun, E.Q. (1993) Alpha-adrenoceptor control of thermogenesis in 
muscle. Aust. Soc. Study Obesity. 
25. Colquhoun, E.Q., Clark, M.G., Rattigan, S., Dora, K.A., Eldershaw, T.P.D., 
Ye, J-M., Edwards, S.J., Peng, Z-C. and Hall, J.L. (1993) Possible new 
pharmacological approaches to the management of obesity. Aust. Soc. Study 
Obesity. 
26. Dora, K.A., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. (1993) A discrete 
alpha-adrenergic vascular effect of noradrenaline to inhibit insulin-mediated 
glucose uptake. Aust. Diabetes Soc. 
27. Rattigan, S., Dora, K.A., Colquhoun, E.Q. and Clark, M.G. (1993) Vascular 
shunting in the perfused rat hindlimb leads to acute insulin resistance. Aust. 
Diabetes Soc. 
28. Dora, K.A., Rattigan, S., Colquhoun, E.Q. and Clark, M.G. (1993) 
Noradrenaline-mediated insulin resistance in skeletal muscle a consequence of 
haemodynamic effects. XV Int. Congress Nutrition (Satellite). 
29. Clark, M. G., Colquhoun, E.Q., Hall, J.L., Dora, K.A. and Rattigan, S. (1993) 
A haemodynamic basis in muscle for insulin-resistance and obesity. XV Int. 
Congress Nutrition (Satellite). 
xvii i 
ACKNOWLEDGMENTS 
This thesis would not have been possible without the help of my colleagues, 
friends and family. 
Firstly I would like to thank my supervisors Assoc Prof Eric Colquhoun and 
Prof Michael Clark. Their willingness to encourage and develop research ideas was 
invaluable towards achieving the final outcome. The freedom to pursue goals that 
were of particular interest to me was an ideal environment to work in and I am 
grateful for this possibility. I would also like to thank them for their advice and help in 
attending local and international meetings and in visiting other laboratories. This 
formed an important part of my scientific development and I recommend others to do 
the same. 
Dr Stephen Rattigan has helped me in every respect and his patience 
deserves a medal. We have worked well together and thankfully the liaison will 
continue. 
Other direct contributors to my thesis include Dr Steve Edwards and Mr 
John Newman (See Preface). Their work forms an integral part of this thesis and I 
thank them for allowing me to include their data and for our fruitful discussions. I 
also appreciate the technical assistance by Mr Michael Glancy and Ms Sandi Warr. 
I also thank Mr John Jordan for his patience and help in my times of (usually 
urgent) need. His technical knowledge and skills were well appreciated. Thanks also 
to Ms Lynn Wilson for helping with the typing of references. 
An advantage of receiving freedom in my experimental design was the ability 
to perform collaborative work with other members of the group. I thank Dr Steve 
Richards for his help with my own work and for the opportunity to perform 
collaborative work. Thanks also to Mr Tristram Eldershaw whose research interests 
are now tending to be complementary to much of the work in this thesis, Dr 
Manthinda Hettiarachchi, and Ms Anita Matthias. 
I would like to thank all the members of our regular "tasting" group 
(especially the ones not mentioned yet: Kate, Ross, Jenny and John) for enabling me 
to overcome those more difficult weeks. 
Finally, to my parents whose love and encouragement was greatly 
appreciated. 
xix 
STATEMENT 
This thesis contains no material which has been used for the award of any 
other higher degree or graduate diploma in any tertiary institution without written 
permission and, to the best of my knowledge and belief, the thesis contains no material 
previously published or written by another person, except where due reference is made 
in the text of the thesis. 
Kim Dora 
XX 
ABBREVIATIONS 
5-HT 	5-Hydroxytryptamine, serotonin 
5-MU 	5-Methyl urapidil 
ADP 	Adenosine diphosphate 
AR Adrenoceptor 
ATP 	Adenosine triphosphate 
AVA 	Arteriovenous anastomoses 
BSA 	Bovine serum albumin 
cAMP 	Adenosine 3',5'-cyclic phosphate 
CEC 	Chloroethylclonidine 
cGMP 	Guanosine 3',5'-cyclic phosphate 
CrP 	Creatine phosphate 
DAG 	1,2-Diacylglycerol 
EDL 	Extensor digitorum longus 
EDRF 	Endothelium-derived relaxing factor 
EGTA 	Ethyleneglycol-bis-(b-aminoethyl ether) N,N,N',N-tetraacetic acid 
FITC 	Fluorescein isothiocyanate 
IP3 Inositol 1,4,5-triphosphate 
NAD 	Nicotine adenine dinucleotide 
NE Norepinephrine, noradrenaline 
NIDDM 	Non-insulin-dependent diabetes mellitus 
P02 	Oxygen partial pressure 
RBC 	Red blood cell 
SHR 	Spontaneously hypertensive rat 
SR Sarcoplasmic reticulum 
UTP 	Uridine triphosphate 
V02 	Oxygen uptake 
ABSTRACT 
Characterization of the vascular control of hindlimb metabolism 
The constant-flow perfused rat hindlimb was used as a model to characterize 
norepinephrine (NE, noradrenaline)- and serotonin (5-HT)-mediated vasoconstriction 
and their associated effects on metabolism. Rat hindlimbs of various sizes were 
perfused using medium with or without erythrocytes at temperatures varying between 
25 and 37°C. Varying these perfusion parameters altered the quantitative, but not 
qualitative, effects of the hormones. 
In the hindlimb, infusion of NE stimulated both a l - and 13-adrenoceptors 
(AR). The overall effect was the rapid onset of a sustained increase in perfusion 
pressure which was only slightly increased upon 13-AR blockade. Energy for NE-
stimulated vasoconstriction was supplied via aerobic means, involving oxidative 
formation of ATP. In addition, vasoconstriction appeared to be dependent on 
extracellular Ca2+, suggesting an a iA-AR-stimulated Ca2+ influx through plasma 
membrane channels. 
In association with vasoconstriction, NE dose-dependently increased 
hindlimb oxygen uptake (V0 2) and lactate release via stimulation of a l -AR. During 
prolonged NE infusion, lactate release included a minor contribution by 13-AR-
stimulated glycogenolysis. NE impaired insulin-mediated glucose uptake via 
stimulation off3-ARs. 
Infusion of 5-HT dose-dependently caused sustained increases in hindlimb 
perfusion pressure by stimulation of 5-HT2A- and 5-HT1-like receptors. Upon 
blockade of these receptors, a vasodilatory component was unmasked, presumably via 
stimulation of orphan 5-HT-receptors. Vasoconstriction by 5-HT and supra-
physiological high-doses of NE, the latter acting through a subgroup of a l -AR, could 
be supported through either aerobic and/or anaerobic metabolism and was not 
extracellular Ca2+-dependent. In Ca2±-free conditions, NE stimulated direct inhibition 
of V02 in association with markedly attenuated rises in perfusion pressure, consistent 
with stimulation of a 1B-ARs. 
In association with vasoconstriction, both 5-HT and high-dose NE decreased 
hindlimb V02 . 5-HT inhibited, whereas high-dose NE had no effect, on basal lactate 
release. Both agonists impaired hindlimb insulin-mediated glucose uptake, the NE 
impairment involving stimulation of both ai- and 0-ARs. In addition, infusion of 
5-HT impaired sciatic nerve-stimulated striated muscle aerobic contraction in 
perfused, but not incubated, preparations. 
In contrast to the observations in the hindlimb, both 5-HT and NE increased 
V02 and lactate release in association with vasoconstriction in the isolated, constant-
flow perfused mesenteric artery arcade. 
These results, in conjunction with literature reports, suggest NE and 5-HT 
control hindlimb metabolism by site-selective vasoconstriction. Lower doses of NE 
stimulated a l -AR probably located on arterioles within the microcirculation, increased 
vascular smooth muscle metabolism, and may also have redistributed flow to highly 
metabolically active regions. Conversely, 5-HT 2-receptors and a separate subgroup of 
a i-AR are proposed to be located at discrete vascular sites on larger blood vessels 
that, when stimulated, selectively redistributed blood-flow (functional vascular 
shunting), resulting in reduction of oxygen and glucose delivery to metabolically active 
hindlimb tissues. 
Thus the control of blood flow and distribution by endogenous vasoactive 
agents alters tissue metabolism. Further characterization of these effects and the 
relevance to in vivo situations are discussed and may give important insights into the 
causes, treatment and links between some aspects of obesity, hypertension and type II 
diabetes. 
CHAPTER 1 
Thesis introduction 
1.1 	Control of blood flow in skeletal muscle. 
The expenditure of energy may be related to a state of rest or to different 
degrees of physical exertion. Resting energy expenditure (which is usually measured 
under standardized conditions) is a complex function of the unavoidable thermal loss 
associated with cellular metabolism and physiological functions sustained at repose. 
The skeletal muscle mass comprises approximately 40% of total body mass in man 
(Dickerson & Widdowson, 1960), and accounts for over 25% of the total oxygen 
uptake (V02) in resting humans (Brozek & Grande, 1955), and up to 90 percent 
during intense exercise (Lehninger, 1982). Alterations in skeletal muscle metabolism 
contribute to the problems associated with a number of disorders including obesity 
(Zurlo et al., 1990) and diabetes (Klip & Marette, 1992). 
Blood flow in skeletal muscle serves to supply nutrients to the muscle fibres 
and to remove metabolites; it influences tissue growth and atrophy, and affects the 
response of muscle in disease. In the 1920s Krogh (cited in Krogh, 1959) reported 
the flow through an organ was variable due to local contractions and dilatations, and 
he considered this an important contribution to maintaining "uniformity of the 
circulation". Indeed, this observation arguably led to the large body of research 
investigating the central, neural and local vasoactive agents controlling tissue nutrient 
supply in accordance with demand. 
1.1.1 	Vasoactive agents. 
The circulation has an intricate system for regulation of arterial pressure. 
Briefly, normal mean arterial pressure is maintained by both rapid onset nervous and 
hormonal mechanisms and by slow onset kidney function and blood volume regulation 
mechanisms. The central nervous system controls blood pressure and blood flow, by 
regulating vascular smooth muscle tone, and cardiac rate and contractility. 
Increases in sympathetic nervous system activity, induced by situations 
including feeding, cold and hypoxia (Appenzeller, 1990), are modulated by arterial 
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baroreceptor and chemoreceptor reflexes (Spyer, 1990). The exquisite control that 
the sympathetic nervous system exerts is achieved by the interaction of variable 
innervation and numerous differences in transmission characteristics and effector cell 
sensitivity. The major sympathetic neurotransmitter released at the effector organs is 
norepinephrine (NE), which stimulates a host of responses including vasoconstriction 
through post-synaptic a l- and a2-adrenoceptors (AR). All blood vessels are 
innervated by sympathetic fibres (Mulvany & Aalkjxr, 1990). The number of 
adrenergic nerve terminals and receptors increases with decreasing vessel size, with 
the highest density surrounding the small arteries and arterioles (Fuxe & Sedvall, 
1965; Nilsson et aL, 1986; Hirst 8c Edwards, 1989). Other co-transmitters such as 
ATP and neuropeptide Y may induce vasoconstriction independently, but generally 
amplify the effects of NE (Pernow et al., 1986; Burnstocic, 1990). Circulating 
serotonin (5-HT) has been shown to amplify sympathetic and NE-mediated 
vasoconstriction within vessels of hindlimbs (Medgett, 1987; Van Nueten & Janssens, 
1988; Szabo et al., 1991), and may be taken up and stored in sympathetic nerve 
endings (reviewed by Urabe et al., 1991). 
NE enters plasma principally by overflow of released neurotransmitter to the 
circulation (reviewed by Esler et aL, 1990), and resting skeletal muscle contributes 
approx. 20% of plasma NE (Esler et al., 1984). 5-HT released by central or periph-
eral nerves and by chromaffin cells also overflows to the plasma. In many instances 
plasma levels of NE and 5-HT are low due to the rapid uptake by circulating platelets 
and endothelial cells, particularly in the pulmonary artery (Bhat & Block 1990). Thus 
the circulating free concentration of NE (reviewed by Esler et al., 1990) and 5-HT 
(Vanhoutte & Cohen, 1983) are usually very low. In addition to uptake, platelets 
store and release bioatnines such as 5-HT, histamine, epinephrine and NE (Da Prada 
et aL, 1981). The amounts of 5-HT released from aggregating platelets are sufficient 
to contract the blood vessel wall in vitro (reviewed by Vanhoutte & Cohen, 1983). 
In addition to vasoconstriction (via stimulation of 5-HT2 receptor subtypes), 
5-HT also stimulates vasodilatation and a host of other responses by stimulation of 
various receptor subtypes (Humphrey etal., 1993). 1 . Thus 5-HT can lead to complex 
1. 	5-HT receptor nomenclature has recently been modified from the previously 
accepted Bradley et al. nomenclature described in 1986 (in Humphrey et al., 1993). 
Changes relevant to this thesis are 5-HT2A for 5-HT2; 5-HT2C for 5-HT lc; 
like for the non 5-HT LA-, 5HT 1B-, or 5-HT 1D-receptor negatively coupled to 
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changes in the cardiovascular system which may comprise bradycardia or tachycardia, 
and hypotension or hypertension. The eventual response depends, among other 
factors, upon the species, the vascular bed under study, and the dose employed 
(reviewed by Saxena & Villalon, 1990). 5-HT can vasodilate blood vessels either 
directly by stimulation of 5-HT I-receptor subtypes, or indirectly by inhibiting NE 
release from sympathetic nerve terminals, and releasing EDRF (Mylecharane, 1990). 
An area receiving current attention is the control of arteriovenous-anastomoses 
(AVAs) blood flow in certain vascular beds. In the human forearm, porcine hindleg 
and carotid artery, 5-HT appears to improve nutrient blood flow by vasoconstriction 
through 5-HT 1 -like receptors and a resulting reduction of flow through AVAs (Blauw 
et al., 1991; den Boer et al., 1991). One spin-off has been that 5-HT 1 -like receptor 
stimulation improved cerebral flow and could treat migraine (Ferrari & Saxena, 
1993). 
Other important humoral factors that affect circulatory function include the 
potent vasoconstrictors angiotensin II and vasopressin (reviewed by Berecek & 
Swords, 1990). Renin released from the kidneys is converted to angiotensin II by 
angiotensin converting enzyme located in blood vessels. Angiotensin II stimulates 
AT I -receptors located in most blood vessels. Vasopressin is released from the 
posterior pituitary gland to the blood. Normally plasma levels are low, but may rise 
during haemorrhage. Vasopressin stimulates V I -receptors to stimulate 
vasoconstriction and V2-receptors in the kidney to retain water. 
In addition to the actions of neuronally released or circulating vasoactive 
agents, vascular smooth muscle may constrict or dilate in response to raised or 
lowered intravascular pressure, respectively, termed the myogenic response, leading 
to autoregulation of flow (initially proposed by Bayliss, 1902). These phenomena 
have also been reported within resting skeletal muscle (Stainsby & Renkin, 1961; 
Grande et al., 1977). More recently it has been shown that locally released 
vasodilators (endothelium-derived relaxing factors, EDRFs) provide an opposing 
feedback mechanism to confer overall stability (Griffith et al., 1987; Bevan & Joyce, 
1990; Smiegko & Johnson, 1993). 
adenylate cyclase; and orphan 5-HT-receptor for the receptor mediating direct 
vasodilatory effects through 5-HT. This current recommended terminology will be 
used throughout for consistency, regardless of terminology used by the authors of 
articles cited. 
4 
	
1.1.1.1 	Involvement in thennoregulation. 
The maintenance of body temperature in health and disease is one of the 
fundamental physiological functions of the homeotherm (reviewed by Cassel & 
Casselman, 1990). During thermoregulation, the multiple levels of reception and 
control in conjunction with the segmental arrangements of the sympathetic nervous 
system permit both general and highly specific responses (Riedel & IriIci, 1979). 
Hsieh et al. (1957) demonstrated that in mice exposed to cold, sympathetic 
nervous system activity, through NE, increased body temperature without shivering. 
This has now been demonstrated in many species, including humans. Plasma levels of 
NE increase in proportion to degrees of cold exposure, due to discriminant release 
from organs or tissues, including skeletal muscle (reviewed by Landsberg & Young, 
1983). The release of catecholamines from the adrenal medulla also plays a role in 
cold-acclimation (reviewed by Landsberg & Young, 1983). 
In humans, skin sympathetic nerve activity is involved primarily in 
thermoregulation, and decreases with increases in body temperature (Wallin & Fagius, 
1988). The "cold-pressor test" (Fagius et al., 1989) and cold-exposure (Moore et al., 
1972) induce rises in blood pressure, each presumably due to increased muscle 
sympathetic nerve activity (Fagius et al., 1989). 
1.1.1.2 	Release postprandially. 
It is widely accepted that caloric restriction suppresses, while increased 
caloric intake stimulates, the sympathetic nervous system, thereby altering 
cardiovascular function, including blood flow distribution (reviewed by Landsberg & 
Young, 1983). After ingestion of protein, fat or carbohydrate an increased V0 2 has 
been observed in the postprandial period (reviewed by Landsberg & Young, 1983). 
Fagius and his co-workers have used microneurography to measure impulses 
by sympathetic nerves in human extremity nerves (Wallin & Fagius, 1988). Using this 
technique they have found that insulin-induced hypoglycaemia (Fagius et al., 1986) 
and infusion of 2-deoxy-D-glucose (Fagius & Berne, 1989) increased skeletal muscle 
sympathetic nerve activity to resistance vessels. These effects were consequences of 
central nervous system glucopaenia, and not the previously suggested baroreceptor-
induced counteraction of cardiovascular changes (reviewed by Mano, 1990). In 
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addition to increased sympathetic nervous system activity, infusion of glucose (Welle 
et al., 1981; Levin, 1991), but not protein (VVelle et al., 1981) into rats raised plasma 
NE levels. However, NE did not appear to affect glucose levels when infused into 
dogs (except at very high NE levels, possibly due to hepatic glucose production, 
Connolly et al., 1991), suggesting NE per se does not have a role in glucose disposal 
and has an alternative role when released upon glucose infusion. NE release from 
skeletal muscle sympathetic nerve endings would alter and perhaps control blood 
flow, and may also increase metabolism in this tissue by vasoconstriction-associated 
consumption of energy (Colquhoun & Clark, 1991). 
In genetically obese Zucker rats, which exhibit defective thermogenic 
capacity and hyperinsulinaemia, NE biosynthesis is reduced (particularly in brown 
adipose tissue) leading to lower free NE levels upon sympathetic nervous system 
activation (Levin etal., 1983). 
1.1.1.3 	Release during exercise. 
Increased metabolic demand associated with skeletal muscle work in vivo 
causes an increase in flow, and thereby oxygen, nutrient and metabolite passage, in 
proportion to the intensity of exercise. The communication among endothelial and 
smooth muscle cells normally causes vasodilatation and thereby hyperaemia to the 
exercising muscle by a combination of flow-dependent and endothelial cell-mediated 
relaxation (reviewed in Segal, 1992). 
There is a direct relationship between muscle blood flow and slow-twitch 
oxidative fibre populations (Laughlin & Armstrong, 1982), with CL-AR stimulation 
limiting flow to fast-twitch glycolytic fibres (Laughlin & Armstrong, 1987). Exercise-
mediated NE spillover from sympathetic nerves has been reported in humans (Hasking 
et al., 1988) and dogs (Peronnet et al., 1988). Exercise-stimulated sympathetic 
nervous system activity acts predominantly to redistribute cardiac output away from 
inactive areas. However, as exercise intensity increases, the maximal flow to 
contracting muscle can be limited by sympathetic vasoconstriction (Joyner et al., 
1990, 1992). 
Several studies have shown that changes in blood flow can alter the force 
exerted by a muscle contracting intermittently during an extended period. This has 
been demonstrated in normal man (Barcroft & Millen, 1939), in man with cardiac 
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impairment (Donald et al., 1957) and in the isolated cat gastrocnemius-soleus 
(Hirvonen & Sonnenschein, 1962; Wright & Sonnenschein 1965). 
	
1.1.1.4 	Action during hypoxia. 
Regional hypoxia has been shown to stimulate the release of the vasodilators 
prostaglandin 12 (Busse et al., 1984) and EDRF (Pohl & Busse, 1989). Under anoxic 
conditions, EDRF is no longer produced (De Mey & Vanhoutte, 1983) and an 
endothelium-derived constricting factor is released (Rubanyi & Vanhoutte, 1985). 
During systemic hypoxia, flow is diverted away from nutritive capillaries without 
compromising tissue need (Harrison et al., 1990b) by altering the locus of myogenic 
tone to larger blood vessels (Bertuglia et aL, 1991), predominantly by increased 
sympathetic nerve activity (Mian & Marshall, 1991a). 
In general, larger vessels are usually able to maintain constriction during 
hypoxic conditions (Shibata & Briggs, 1967; Altura & Altura, 1976; De Mey & 
Vanhoutte, 1983). Conversely, small blood vessels tend to dilate in response to low 
oxygen tensions (Carrier et aL, 1964; Duling, 1972; Harris etal., 1976). 
1.1.1.5 	Contribution to disease states. 
Changes in the flow to organs or tissues have profound implications for 
nutrient and hormone delivery as well as product removal. Disorders such as 
hypertension, obesity and Type II, non-insulin-dependent diabetes mellitus (NIDDM) 
are usually associated with increased sympathetic nervous system activity (reviewed 
by Daly & Landsberg, 1991), vascular disease (reviewed by Ruderman et al., 1992) 
and altered responsiveness to vasoactive agents (reviewed by Struyker-Boudier et al., 
1990). Interestingly, low capillary density in skeletal muscle has been correlated with 
increased fat deposition and insulin-resistance (Lillioja et al., 1987). In addition, 
modifications exist in the hindlimb skeletal muscle vasculature of spontaneously 
hypertensive rats (SHR) that reduce the capillary exchange capacity and limit flow 
delivery (Sexton et al., 1990). 
There is growing clinical (reviewed by Julius et al., 1992) and experimental 
(Hwang et al., 1987; Mondon & Reaven, 1988; Finch et al., 1990) evidence that 
hypertension and NIDDM are often associated with each other, and the occurrence of 
one may lead to the symptoms of another. Insulin resistance and hyperinsulinaemia 
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are commonly associated with hypertension in the obese, particularly upper body 
"abdominal" obesity (Landsberg, 1990). These associations have led Landsberg and 
co-workers to propose that the insulin resistance of obesity, and its consequent 
hyperinsulinaemia, stimulates the sympathetic nervous system, which then drives 
thermogenic mechanisms, thereby increasing metabolic rate and limiting further 
weight gain. The hyperinsulinaemia and sympathetic stimulation, via effects imposed 
on the kidney, heart and blood vessels, result in hypertension (reviewed in Landsberg 
& Krieger, 1989). This hypothesis was extended by the proposal that diet-induced 
increases in sympathetic activity to muscle vasculature (Fagius & Berne, 1989) may 
contribute to the whole body increase in metabolic rate by consuming energy during 
vasoconstriction (Clark et al., 1991; Figure 1.1). 
However it is not clear whether the link between hypertension and insulin 
resistance is indicative of a causal relationship as proposed by Landsberg and Krieger 
(1989). The relationship between cause and effect remains unclear for humans as well 
as animal models (Buchanan et aL, 1992; Bursztyn et aL, 1992; Mitrakau et al., 
1992). Indeed, there is accumulating clinical evidence demonstrating the importance 
of blood flow control to skeletal muscle in insulin-resistant patients with hypertension 
(reviewed by Julius et aL, 1992). Evidence supporting a haemodynamic basis for the 
insulin resistance observed in patients with elevated mean arterial pressure (and 
presumably hypertension) is provided by Baron et al. (1993, and references therein) 
who showed that flow was reduced to skeletal muscle, thereby impairing the delivery 
of insulin and glucose and creating a state of insulin resistance. Microvascular 
rarefaction observed in the microcirculation of skeletal muscle in SHRs (Prewitt et al., 
1982; le Noble et al., 1990) and human essential hypertension (Henrich et al., 1988) 
contributes to the rise in blood pressure and may further decrease the delivery of 
nutrients and hormones to the muscle. Recent evidence (Saltzman et aL, 1992) 
suggests that within skeletal muscle of SHRs, adrenergic nerve plexus density 
increases to the majority of vessels, possibly contributing to elevated arteriolar tone. 
In addition to alterations in sympathetic nervous system activity, certain 
disease states are associated with changes in levels of circulating vasoactive agents. 
Increased plasma levels of 5-HT have been observed in patients with hypertension 
(reviewed by Vanhoutte, 1982), NIDDM (Barradas et al., 1988) and other diseases 
including atherosclerosis (reviewed by Barradas & Milchailidis, 1992). 
In hypertension, decreases in blood vessel internal (hypertrophy) and external 
(remodelling) diameters impair maximal vasodilatation (reviewed by Heistad et al., 
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Figure 1.1 	Modified Landsberg hypothesis. 
This modification depicts the proposed relationship between obesity, 
insulin, sympathetic nervous system (SNS) activity, blood pressure and 
vascular thermogenesis. Blood pressure is shown as a positive stimulus 
for increased vascular thermogenesis which is a component of the total 
thermogenic response along with metabolic thermogenesis involving intra-
and inter-tissue events and with brown adipose tissue (BAT) 
thermogenesis (if appropriate). 
Modified from Landsberg (1986) and Clark etal. (1991). 
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1991), and premature aging of the blood vessel wall augments the response to agents 
such as 5-HT (reviewed by Vanhoutte & Cohen, 1983). There appears to be 
conflicting evidence for a direct role of 5-HT in hypertension (reviewed by van 
Zwieten et al., 1992), although vascular responsiveness to agents including 5-HT (and 
NE) are often augmented in diseased animals (reviewed by van Nueten & Janssens, 
1988), including the hindlimb of spontaneously hypertensive rats (Cheng & Shibata, 
1980). 
Atherosclerosis is characterized by intimal proliferation, although lesions are 
displaced outwards (remodelling) until compensatory mechanisms fail and 
encroachment on the lumen begins. Impairment of EDRF release, and potentiation of 
vasoconstrictor responses to 5-HT are associated with this disease (reviewed by 
Heistad etal., 1991). 
1.2 	Measurement of skeletal muscle metabolism. 
Since early this century, hindquarters of various large animal models have 
been used to study the control mechanisms of metabolism in skeletal muscle 
(reviewed by Ruderman et al., 1971; Stainsby & Lambert, 1979). Around 1960, 
experiments on the hindquarter of the rat were reported by various investigators 
(reviewed by Ruderman et al., 1971). The calorigenic action of NE was first 
demonstrated in the leg muscles of dogs by Issekutz et al. (1950). Since then, 
perfilsed hindlimbs have been utilized to demonstrate the effects of amongst other 
things, insulin and cc— and f3—adrenoceptor stimulation on V02, glucose uptake, 
lactate release and exercise performance (Ruderman et al., 1971, 1977; Grubb & 
Folk, 1976, 1977; Chiasson et al., 1981; Richter et al., 1982a; Cote et al., 1985; 
Schadewaldt et al., 1985; Colquhoun et al. 1988, 1990; Ye et al., 1990b; 
Hettiarachchi et al., 1992). The results from normal, warm-acclimated rats have been 
compared to hypo- or hyper-thyroid, cold-acclimated, exercise-trained, diabetic and 
hypertensive rats. 
The effects of agents, including insulin and adrenergic agonists, on 
metabolism in isolated incubated skeletal muscles have also been determined (Challiss 
et al., 1986; Wallberg-Henriksson et al., 1988; Dimitriadis et al., 1991; Hettiarachchi 
etal., 1992). However, it was shown that metabolic rate did not increase in incubated 
muscles upon addition of catecholamines (Hannon et al., 1963; Eaton & Vaughan, 
1964), suggesting the importance of a functional vascular system when assessing the 
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metabolic actions of vasoconstrictors. 
1.2.1 	Composition of rat hindlimb. 
In the rat, the hindquarter contributes almost 20% of body mass (Ruderman 
et al., 1971). Thus alterations in skeletal muscle blood flow and metabolism have the 
potential to affect whole body maintenance of blood pressure and metabolism. The 
hindlimb of 170-230 g rats is predominantly composed of skeletal muscle (77%) with 
minor components including bone (10%) and skin (12%), and the mass of muscle is 
proportional to the total body weight of the rat (8.3%) (Ruderman etal., 1971). 
1.2.1.1 	Skeletal muscle fibres. 
Skeletal muscle fibres have different oxidative capacity, thus changes in 
blood flow may alter the nutrient usage of the muscles. Of the rat hindlimb muscle 
fibres, less than 10% are slow-twitch oxidative, approximately 40% are fast-twitch 
oxidative/glycolytic, and the remainder are fast-twitch glycolytic (Laughlin & 
Armstrong, 1983). It is generally, but not always (Maxwell et al., 1980), accepted 
that capillary and mitochondrial density decrease in parallel with oxidative capacity, 
thereby decreasing the diffusion distance for delivered oxygen (Gauthier, 1971; 
Eriksson & Myrhage, 1972). Although fast-twitch glycolytic and slow-twitch 
oxidative fibres tend to have similar glycogen stores (Richter & Galbo, 1986), fast-
twitch glycolytic fibres fatigue rapidly (Segal et al., 1986), and glycogen stores are 
markedly depleted during contractions (Richter & Galbo, 1986), suggesting a 
dependence on anaerobic metabolism. 
1.2.1.1.1 	Mechanism of skeletal muscle contraction. 
Skeletal muscle fibres are innervated by large myelinated nerve fibres. 
Action potentials spread towards the end of each muscle fibre, allowing coordinated 
contraction, and signal the release of Ca 2+ from the sarcoplasmic reticulum (reviewed 
by Guyton, 1986), possibly via the generation of inositol triphosphate (1P 3 , reviewed 
by Hidalgo & Jaimovich, 1989). Simplistically, muscle contraction is based on the 
interaction of two proteins, myosin and actin, in the presence of ATP. Actomyosin 
has a high Mg2+-ATPase activity that is inhibited by troponin. Ca2+ removes the 
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inhibitory effect of troponin (Ebashi, 1971). ATPase activity causes the ADP levels 
to rise which in turn is the signal to intermediary metabolism for the observed 
increased through-put of substrates for the generation of ATP. ATP supplies the 
energy to actuate the "walk-along" mechanism by which the cross-bridges pull the 
actin filaments, for Ca2+ pumping from the sarcoplasm into the sarcoplasmic 
reticulum, and for pumping Na+ and K+ through the muscle fibre membrane to 
maintain an appropriate ionic environment for the propagation of action potentials. 
1.2.1.1.2 	Energetics of skeletal muscle contraction. 
Skeletal muscle phosphocreatine stores can supply energy for the first few 
seconds of contraction, but for maintained contraction either aerobic or anaerobic 
generation of ATP is required. Glycolytic ATP formation is approx. 2.5 times more 
rapid than by oxidative metabolism, but generally supplies less energy in total 
(Guyton, 1986). Insulin (James et al., 1988) and exercise (Douen et aL, 1990) have 
both been shown to translocate the unique GLUT 4 glucose transporters to skeletal 
myocyte cell membranes from distinct internal stores (Douen et al., 1990; Marette et 
al., 1992) by an as yet not fully determined mechanism. Elevation of cAMP (eg. with 
13-adrenergic agonists) activates triglyceride lipase and, subsequently, lipolysis. 
Exercise-stimulated fatty acid oxidation by an unknown mechanism generates the 
main source of ATP during contraction. 
1.2.1.2 	Vascular System. 
The vascular bed in skeletal muscle is considered to be haemodynamically 
one of the most important circuits in the systemic circulation (Lindbom & Arfors, 
1984). The function of vascular resistance in this tissue is fundamental for the blood 
pressure homeostasis. Local processes within the muscle tissue adjust the flow and 
exchange according to tissue metabolic needs by coordinating the responses of 
resistance and exchange vessels in the muscle (reviewed by Bevan, 1987, and 
Mulvany & Aalkjxr, 1990). 
Direct intravital observation of the vascular bed of resting skeletal muscle in 
situ demonstrated that small arterioles generally exhibit pronounced vasomotion 
(Tangelder et al., 1984). It was proposed that these oscillatory changes in blood flow 
were not associated with sympathetic nerve activity, but an interaction between K+- 
12 
channels and potential-dependent Ca2+-channels (reviewed by Mulvany & Aalkjmr, 
1990). Vasomotion activity has been shown to be greatest at the terminal arterioles 
(Meyer et al., 1987) and decreased upon addition of vasodilators or reduction of 
arterial pressure in muscle due to aortic occlusion (Meyer et al., 1988; Slaaf et al., 
1989). However, in the latter studies oxygen delivery to muscle may have been 
markedly reduced. 
It has been suggested that in situations of decreased flow velocity or elevated 
metabolic rate, smooth muscle partial pressure of oxygen (P0 2) decreases resulting in 
vasodilatation and an increase in blood flow (Duling & Berne, 1970; reviewed by 
Duling & Klitzman, 1980). Despite earlier suggestions, it has recently been found 
that oxygen did not have a direct effect on arterioles (Boegehold & Johnson, 1988). 
Jackson (1987) suggested oxygen reactivity was mediated by either a tissue sensor or 
by a sensor within the distal portions of the microvasculature. This idea has gained 
support due to ability of terminal arterioles and capillaries to conduct responses along 
the arterial network to the proximal arterioles that control the distribution and 
magnitude of flow by either vasodilatation or constriction (Jackson, 1987; Segal, 
1991). The mechanism of this cell-to-cell conduction is currently being investigated, 
with recent evidence highlighting the importance of smooth muscle and endothelial 
cell coupling via gap junctions (Segal & Bay, 1992). 
Peripheral vasomotor tone is a complex interrelationship between neural and 
hormonal vasoactive compounds. Thus in situations where tone begins to 
compromise tissue function, the local metabolic vasodilatory processes can override 
the tone. Conversely, it is also possible that tone regulates the flow to the tissue and 
may prevent unnecessary usage of fuels, for example, in the resting state flow through 
brown adipose tissue of rats is low due to increased tone on the arteries supplying the 
abundant capillary plexus (Nnodim & Lever, 1988). However in the absence of futile 
cycles or uncoupling, it must be argued that increases in delivery of fuels to 
uncompromised resting tissue would not increase metabolic rate. 
1.2.1.2.1 	Mechanism of vascular smooth muscle contraction. 
The mechanism of vascular smooth muscle contraction is similar to that of 
skeletal muscle in that activation of the myosin ATPase, and thus contraction, is 
dependent on increases in cytosolic Ca 2+ (reviewed by Somlyo & Somlyo, 1992). 
However, myosin light chain phosphorylation and attachment of cross-bridges to actin 
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does not fully describe cellular processes in smooth muscle contraction. Murphy 
(1988) proposed a latch state to account for observed maintenance of force with 
reduced myosin light chain phosphorylation and maximal shortening velocity 
(reviewed by Stull et al., 1991). Excitation-contraction coupling may be either 
electromechanical, involving depolarization of the membrane potential by agents 
including K+, or pharmacomechanical, involving drug-induced contractions without 
depolarization (reviewed by Somlyo & Somlyo, 1992). Electromechanical coupling 
may use both Ca2+ influx and release from the sarcoplasmic reticulum, and in general 
is more sensitive to Ca2+ entry blockers or removal of extracellular Ca 2+ (Somlyo & 
Somlyo, 1992). Pharmacomechanical coupling involves ligand-gated Ca 2+ influx, 
intracellular Ca2+ release by IP3, and modulation of the Ca2+ sensitivity of the 
contractile regulatory apparatus; and is usually accompanied by electromechanical 
coupling (reviewed by Somlyo & Somlyo, 1992). 
1.2.1.2.2 	Energetics of vascular smooth muscle contraction. 
Energy for contraction of smooth muscle is predominantly generated by 
mitochondrial oxidative phosphorylation, and is compartmentalized, at least in some 
vessels, from glycolytically derived ATP utilized for membrane Na+ transport (Lynch 
& Paul, 1983). In incubated rabbit aorta rings, fatty acid oxidation accounted for 
almost all the basal V0 2, and a large proportion of the fatty acids were derived from 
endogenous tissue stores (Odessey & Chace, 1982). There appears to be a marked 
heterogeneity in fuel-dependence during smooth muscle contraction, which appears to 
be related to both blood vessel size and anatomical location (discussed in detail in 
Chapter 3). 
The amount of phosphagen in vascular smooth muscle is small in comparison 
to skeletal muscle (Paul, 1977), and there appears to be a large proportion of UTP 
(Clark et al., 1990). This suggests purine (and pyrimidine) triphosphate utilization 
and its metabolic resynthesis is tightly coupled, particularly in a temporal sense (Paul, 
1977). During vasoconstriction, but not skeletal muscle contraction, large increases 
in the release of purines and pyrimidines have been observed (Clark et al., 1990; 
Richards et al., 1992, 1993, submitted 1993). The breakdown products of ATP and 
UTP appear to be released from working tissue and subsequently rapidly degraded by 
endothelial ectonucleotidases to uric acid and uracil (Richards et al., 1993). Thus it 
appears that in addition to ATP, UTP may be a major fuel utilized during 
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vasoconstriction (Daemers-Lambert, 1964; Clark et aL, 1990; Richards et al., 
submitted 1993). 
1.2.1.2.3 	Mechanism of vascular smooth muscle dilatation. 
Hyperpolarization of the surface membrane of smooth muscle causes 
relaxation by reducing cytoplasmic Ca2+ by closing voltage-gated Ca2+ channels and 
by promoting Ca2+ uptake into the sarcoplasmic reticulum (Clapp & Gurney, 1991). 
The inhibitory action of drugs can also include pharmacomechanical components that 
are not dependent on changes in the surface membrane potential (Somlyo & Somlyo, 
1992). For example, vasodilatation via stimulation of 13—adrenoceptors occurs 
primarily due to activation of adenylate cyclase, thereby forming cAMP, which can 
reduce intracellular [Ca2+J by decreasing Ca2+-release from the sarcoplasmic 
reticulum (McDaniel et al., 1991). In addition to a reduction in intracellular [Ca2 ], 
stimulation of guanylate cyclase and formation of cGMP by agents such as 
nitrovasodilators also separate the generation of tension from myosin phosphorylation 
by an unknown mechanism (McDaniel et al., 1992). 
1.2.2 	Resting rat hindlimb as a model of skeletal muscle. 
1.2.2.1 	In situ studies. 
Jansky and Hart (1963) were the first to evaluate rat hindquarter V02 . 
These authors showed that cold-acclimating rats and infusion of NE increased basal 
V02. The response to NE occurred in the absence of a change in flow to the muscle, 
and was attributed to an increased V0 2 by skeletal muscle (Janslcy & Hart, 1963). 
These authors evaluated the extent of muscle perfiised in the rat hindquarter by 
injecting India ink via the femoral artery and fixing the leg in formaldehyde. Using a 
visual scale of 0-4, 4 indicating total blackening, it was found that 63% of muscle 
were 4 and most of the remaining muscle were between 2 and 3 (Jansky & Hart, 
1963). Unfortunately, the authors did not repeat the procedure in the presence of NE. 
A technique often utilized is the autoperfusion of hindlimbs (usually with 
constant flow) with blood from the carotid artery pumped into the femoral artery. In 
this procedure, circulating vasoactive agents are not removed, yet nicotinic and 
muscarinic acetylcholine receptors and 13—ARs are usually blocked. In autoperfused 
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preparations it is generally considered that NE stimulates a l- and a2-ARs 
(Timmermans & Van Zwieten, 1980; Medgett & Ruffolo, 1987; Faber, 1988; Nielsen 
et al., 1990). Adrenergic constriction of small, precapillary arterioles was due to 
stimulation of a2-ARs, whereas constriction of large arterioles and venules was due to 
stimulation of a i - and a2-ARs (Faber 1988, Ohyanagi et al., 1991). Interestingly, 
vasoconstriction mediated by stimulation of a 2-ARs, and to a lesser extent a 1 -ARs, 
was inhibited by endothelium-derived relaxing factor (EDRF) (Ohyanagi et al., 1992). 
Earlier findings had proposed endothelial a 2-ARs directly stimulated EDRF release 
(Angus etal., 1986). 
1.2.2.2 	Isolated hindlimb perfused with constant pressure. 
Few studies have perfused isolated rat hindlimbs with constant pressure. In 
one study, hindlimbs were perfused at 20°C with a modified Tyrode solution 
containing 5% bovine serum albumin (van Meel etal., 1983). Stimulation of both ar 
and a2-ARs decreased flow, and stimulation of a2-ARs, but not a l -ARs, was 
sensitive to Ca2+-entry blockers (van Meel et al., 1983). No effects on V02 were 
measured. 
1.2.2.3 	Isolated hindlimb perfused with constant flow. 
Isolated rat hindquarter preparations have been perfused with various media, 
rat sizes, flow rates and temperatures. Variables in media include the presence of 
erythrocytes and/or albumin. 
1.2.2.3.1 	Erythrocyte -perfused. 
Experiments using erythrocyte-perfused hindlimbs were usually performed at 
37°C. Erythrocytes from varying species, including human (Ruderman et al., 1971, 
1980), porcine (Grubb & Folk, 1976, 1977), and bovine (Karlsson etal., 1975; Lewis 
et al., 1977), have been washed and added to buffered (usually modified Krebs-
Henseleit) perfusion medium. Most perfusion mediums also contained either serum 
albumin or dextran (usually 4%). 
Ruderman et al. (1971) made a systematic effort to compare the activities of 
the isolated rat hindquarter (hindlimb) preparation with the hindquarter in situ. These 
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workers perfused rat hindquarters at 37°C with medium containing Krebs-Henseleit 
buffer, 4% bovine serum albumin and aged washed human erythrocytes. They 
compared muscle oxygen, glucose and ketone body uptake, lactate and K+ release, 
and the tissue concentrations of creatine phosphate and the adenine nucleotides (Table 
1.1). In addition, muscle appearance under the electron microscope was determined 
and the responses to infusion of insulin and electrical stimulation of the hindquarter 
were compared between in situ and in vivo preparations. The results suggested the 
behaviour of the perfused hindquarter closely resembled that of the hindquarter of the 
intact rat. Other studies by Ruderman and co-workers in later years (Ruderman et al., 
1977; Ruderman & Berger, 1974; Ruderman & Goodman, 1973, 1974) provided 
further evidence to support their earlier findings (Ruderman et al., 1971) suggesting 
the isolated perfused rat hindquarter preparation was suitable for metabolic studies. 
1.2.2.3.2 	Erythrocyte-free. 
In the absence of added erythrocytes, various media have been employed to 
perfuse rat hindlimbs. The viability of perfusing with a modified Krebs-Henseleit 
buffer in the presence of 4% BSA at 37°C (Strohfeldt et al., 1974), 2% BSA at 25°C 
(Colquhoun et al., 1990) or absence of albumin at 32°C (Shiota & Sugano, 1986) was 
assessed by comparing tissue concentrations of high energy phosphates and glycogen 
in perfused and unperfused muscle (Tables 1.1 & 1.2). It was found that omitting 
erythrocytes, or decreasing [BSA] and temperature had no significant effect on tissue 
metabolites in comparison to levels observed in vivo or using erythrocyte-perfused 
hindlimbs. 
The vasoconstrictor effects of hormones have also been determined by 
perfusing hindlimbs with Krebs-Ringer medium containing 4% dextran (Cheng & 
Shibata, 1980), and modified Tyrode solution also containing 4% dextran (Verheyen 
etal., 1991), or 3% artificial colloid (Ficoll) (Ahlund et al., 1977). 
1.3 	Effects of norepinephrine in constant-flow perfused hindlimb. 
NE is thought to stimulate a— and 13—adrenoceptors (AR) in rat hindlimb 
(Grubb & Folk, 1977; Richter et al., 1982a; Cote et al., 1985; Colquhoun et al., 
1990; Hettiarachchi et al., 1992). Stimulation of 13—ARs is generally associated with 
vasodilatation (Colquhoun et al., 1990; Hettiarachchi et al., 1992) and increased 
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Wet wt  
Medium 	Dry wt 	 Metabolite (lAmol.g wet wt -1 ) 	Ref. 
ATP ADP CrP Glycogen 
In Vivo 
N.D. 5.0 ± 0.2 0.75 ± 0.01 15.6 ± 0.8 N.D. A 
N.D. 6.4 ± 0.2 N.D. 18.5 ± 0.6 33.8 ± 2.0 B 
4.4 ± 0.1 6.2 ± 0.2 0.80 ± 0.05 16.4 ± 0.9 27.4± 1.3 C 
4.1 ± 0.0 0.73 ± 0.03 16.6 ± 1.7 N.D. 
Perfused 
(I) N.D. 5.2 ± 0.3 0.95 ± 0.09 15.1 ± 0.6 N.D. A 
(II) N.D. 7.9± 0.4 N.D. 20.1 ± 1.5 36.0± 2.9 B 
(IIIa) 4.7 ± 0.1 5.4 ± 0.1 0.62 ± 0.04 14.6 ± 0.2 30.8 ± 2.6 C 
(lilt)) 5.5 ± 0.3 4.9 ± 0.2 0.69 ± 0.09 12.2 ± 0.2 22.5 ± 1.4 C 
6.1 ± 0.1 3.9 ± 0.3 0.38 ± 0.03 11.0 ± 0.3 25.9 ± 0.6 C 
(N) 5.8 3.1 ± 0.2 0.45 ± 0.03 14.1 ± 0.8 N.D. 
Table 1.1 	Metabolite concentrations in rat hindlimb skeletal muscle. 
Hindlimbs from anaesthetized rats of varying size were either freeze-
clamped (in vivo) or perfused at a constant flow-rate with modified Krebs-
Henseleit perfusion medium gassed with 95% 0 2-5% CO 2 and containing 
either 4% bovine serum albumin (BSA) with (I) or without (II) 
erythrocytes (RBC) at 37°C, 2% BSA without erythrocytes at 25°C (III), 
or without erythrocytes or BSA at 32°C (Iv): A, from Ruderman et al. 
(1971); B, from Strohfeldt et al. (1974); C, from Colquhoun et al. (1990) 
after 50 min perfusion (a) or 180 min perfusion in the absence (b) or 
presence (c) of vasopressin; D, from Shiota and Sugano (1986); *, 
assuming wet wt/dry wt = 4.4 (C). N.D., not determined. Values are 
means ± SE. 
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Ref. Temp 
(°C) 
Flow 
Rate 
Oxygen 
Uptake 
Lactate 
Release 
Pyruvate 
Release 
Glucose 
Uptake 
Glycerol 
Release 
(4mo1.11-1 .gri) 
A 37 0.30(-9 21.6 ± 1.6 5.4 ± 1.2 N.D. 1.0 ± 0.6 0.5 ± 0.04 
B 37 1.31(-) 30.6 ± 0.4 7.0 ± 0.9 N.D. 7.8 ± 0.4 0.3 ± 0.02 
C 25 0.27 6.4 ± 0.2 6.4 ± 4.8 0.6 ± 0.2 N.D. N.D. 
D 32 0.88 10.5 21.1 3.5 2.1 N.D. 
Table 1.2 	Rates of metabolism in hindlimb skeletal muscle. 
Hindlimbs from rats of varying size were perfused at a constant flow-rate 
with modified Krebs-Henseleit perfusion medium gassed with 95% 02-5% 
CO2 and containing either 4% bovine serum albumin (BSA) with (+) or 
without (-) erythrocytes at 37°C, 2% BSA without erythrocytes at 25°C, 
or without BSA or erythrocytes at 32°C: A, from Ruderman et al. (1971); 
B, from Strohfeldt et al. (1974); C, from Colquhoun et aL (1990); D, from 
Shiota and Sugano (1986); N.D., not determined. Values are means, and 
when available, ± SE. 
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glycogenolysis (Richter et al., 1982a), whereas a—AR stimulation leads to 
vasoconstriction (Grubb & Folk, 1977; Cote et al., 1985; Colquhoun et al., 1990; 
Hettiarachchi et al., 1992). In erythrocyte-free, constant-flow preparations the 
vasoconstrictor response to NE was blocked by the a l-AR antagonist prazosin 
(Grubb & Folk, 1977), thereby leaving in doubt the occurrence of a 2-AR stimulation. 
The apparent absence of an a2-AR response may be due to a lack of sufficient basal 
tone using in vitro perfusion techniques (McGrath et al., 1990). 
	
1.3.1 	Sites of NE-induced effects. 
Subtypes of a—ARs have been shown to be located on both arterial and 
venous smooth muscle within the microcirculation of skeletal muscle (Faber, 1988). 
Results from various reports suggest stimulation by lower doses of NE caused 
vasoconstriction of smaller arterioles. Direct observation (Gray, 1971), analysis of 
the number of adrenergic nerve terminals and receptors surrounding different sized 
vessels (Hirst & Edwards, 1989), and dependence on extracellular Ca 2+ during 
vasoconstriction (Sutter et al., 1977), all support the constriction of small arterioles 
by low doses of NE in skeletal muscle. Similarly, D—ARs also appear to be located on 
smaller, rather than larger vessels (Lundvall & Hillman, 1978; Lundvall et al., 1982). 
The increased responsiveness to NE of arterioles within fast-twitch glycolytic muscle 
(Gray, 1971) suggests flow may increase to slow-oxidative muscle upon infusion of 
low doses of NE. 
In contrast, higher doses of NE begin to stimulate a i -ARs located on larger 
vessels (Gray, 1971; Faber, 1988) which are capable of extracellular Ca 2+- 
independent vasoconstriction (Sutter et al., 1977). 
1.3.2 	Thermogenic effects of NE. 
Since the work of Mejsnar and Jansky (1971) and Ruderman et al. (1971) 
the constant-flow perfused rat hindlimb has been used as a model to investigate NE-
induced changes in V02 . In this system, NE has repeatedly been demonstrated to 
dose-dependently increase basal V02 by a maximum of 50-100% in associated with 
increases in perfusion pressure during constant-flow perfusion using physiological 
medium with red blood cells at 37°C (Table 1.3; Mejsnar & Jansky, 1971; Grubb & 
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Flow 
Ref. 	Rate 	[NE] 	Oxygen Uptake 	Perfusion Pressure 
(nM) (mmHg) 
Basal Change Basal Change 
A 0.08 300 17.3 ± 1.8 15 25 15 
3000 -2 90 
B 0.48 * 24.0± 1.0 13 59.2 ± 2.0 40 
C 0.21 10 24.6 ± 1.5 4 43.5 ± 1.7 5 
63 8 20 
D 0.27 200 12.0 ± 0.4 7 50 60 
2000 -2 100 
E 0.27 50 6.4± 0.2 3.1 ± 0.1 29.0± 1.0 15 
F 1.03 50 13 0.2 90 80 
Table 1.3 	Effect of NE on V02 and perfusion pressure in constant-flow 
perfused rat hindlimb. 
Hindlimbs from rats of varying size were perfiised at a constant flow-rate 
with modified Krebs-Henseleit perfusion medium gassed with 95% 0 2-5% 
CO2 and containing either 4% bovine serum albumin (BSA) and 
erythrocytes (RBC) at 37°C (A, B), 2% BSA without erythrocytes at 25°C 
(C-E), or without BSA and erythrocytes (F): A, from Grubb and Folk 
(1976), maximum and minimum effects on V02; B, from Richter et al. 
(1982a), *, 24 nM epinephrine + 10 JAM (+)-propranolol; C, from 
Hettiarachchi, 1992; D, from Cote et al. (1985), maximum and minimum 
effects on V02; E, from Colquhoun et a/. (1988), maximal effect on V02; 
F, from Shiota and Masumi (1988); V02, oxygen uptake. Values are 
means, and when available, ± SE. 
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Folk, 1976; Richter et al., 1982a), or without red blood cells at 25°C (Cote et al., 
1985). 2 - 
Work at the Department of Biochemistry, University of Tasmania had found 
that vasoconstrictors such as vasopressin and angiotensin II as well as NE increased 
hindlimb V02 and lactate release in association with increases in perfiision pressure in 
a dose dependent manner (Colquhoun et al., 1988; Hettiarachchi et al., 1992). These 
effects occurred over physiological dose ranges and were rapidly reversible upon 
agonist removal. The explanation for vasoconstrictor-induced thermogenesis is not 
fully elucidated, although a series of proposals has been developed by either analogy 
to, or direct evidence from, the literature (reviewed by Colquhoun & Clark, 1991). 
1.3.2.1 	Skeletal muscle thermogenesis. 
It was initially considered that NE directly stimulated skeletal muscle 
thermogenesis. It is widely accepted that stimulation of 0—adrenoceptors (13—AR) led 
to increased muscle glycogenolysis (Richter et al., 1982a) which was observed in both 
perfused and incubated muscle preparations (Hettiarachchi et al., 1992). However, in 
the presence of propranolol, NE-induced V02 was not inhibited suggesting an cc—AR 
mechanism (Colquhoun et al., 1990). However, the small populations of a l -AR 
detected in skeletal muscle preparations were thought to be due to vascular smooth 
muscle a—AR contaminants (Martin et al., 1990). This evidence in conjunction with 
the inhibition of NE-induced but not contraction-induced thermogenic effects by 
vasodilators, including nitroprusside, and the additivity of vasoconstrictor- and 
contraction-induced increased V0 2 led to the proposal that NE did not directly 
stimulate skeletal muscle metabolism (Colquhoun et al., 1988, 1990; Hettiarachchi et 
al., 1992). In addition, perifused skeletal muscle preparations were found to have 
2. 	However, in experiments where BSA was omitted from the medium, the 
hindlimb response to NE (50 nM) in warm-, but not cold-, acclimated rats on V02 
was almost totally absent despite rises in perfusion pressure (Table 1.3; Shiota & 
Masumi, 1988). When work of Shiota and Masumi (1988) was duplicated in this 
laboratory, despite gross oedema, the V02 and perfusion pressure responses to NE 
(50 nM) were observed, and found to be consistent with observations with albumin 
added to the perfusion medium (Hettiarachchi, 1992). 
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only minor thermogenic responses to NE (Dubois-Ferriere & Chinet, 1981; 
Hettiarachchi et al., 1992) and angiotensin H (Hettiarachchi et al., 1992), although a 
13-adrenergic response to increase lactate release was observed suggesting adequate 
diffusion of hormones (Hettiarachchi et al., 1992). 
1.3.2.2 	Heterogeneity of flow. 
It has been consistently observed, but not always reported, that infusion of 
doses of NE which increased V02 led to the washout of a small number of 
erythrocytes (Clark et al. 1990), less than 10% of the total cleared from the hindlimb. 
There may be various explanations for this washout, including the perfusion of 
previously unperfused or underperfused regions. The washout was observed when 
one or two hindlimbs were perfused, and the presence of torso, tail and abdominal 
tourniquets suggested a heterogeneity of microvascular flow at the level of the 
capillaries rather than flow to other tissues (unpublished observation). 
The possibility that addition of vasoconstrictors controls access of the 
perfusate to large areas of skeletal muscle (an additional 65% based on the NE-
mediated increase in V02) capable of increased metabolism would require that the 
hindlimb was partially hypoxic in the basal perfiised state. Hypoxia has detrimental 
effects on the adenine nucleotide pool in perfused skeletal muscle, but no changes in 
adenine nucleotides, phosphocreatine, glucose-6-phosphate, glycogen, or lactate were 
observed after 3 h perfusion in the absence or presence of vasopressin (Table 1.1, 
Colquhoun et al., 1990). In addition, only small quantities of hypoxanthine were 
produced by this system (Clark et al., 1990). The response to vasoconstrictors on 
V02, perfusion pressure and release of purine and pyrimidine products was sustained 
and quantitatively reproducible independently of the period between infusions 
(Richards et al., 1992, submitted 1993). This observation was in direct contrast to 
the washout of purines and pyrimidines upon reperfusion of ischaemic regions, where 
release levels were proportional to the time of stopped flow (Richards et al., 
submitted 1993). 
Other evidence refuting the presence of hypoxic or ischaemic regions comes 
from perfusions performed at higher flow rates. When flow rates were increased by 
more than 4-fold, thereby reducing the possibility of hypoxic regions, infusion of NE 
was still observed to stimulate marked increases V0 2 and pressure. In addition, 
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infusion of the vasodilator nitroprusside decreased basal V02 from control (Ye et aL, 
1990b). 
1.3.2.3 	Heterogeneity of flow to highly metabolically active regions. 
Another possibility for increased V0 2 and lactate release with 
vasoconstrictor agonists is that the vasoconstrictors increase the rate of one or more 
forms of futile cycling or ion pumping in the hindlimb, with the consequent increases 
in ATP hydrolysis leading to increased metabolism. This would necessitate either 
receptors for the agonists directly coupled to these events, or the specific redirection 
of flow to otherwise quiescent regions which were substrate limited and/or lacked a 
signal. This latter possibility is consistent with the findings of both Honig et al. 
(1982) where functional capillary density in resting skeletal muscle was both actively 
and passively controlled by arterioles, and the classical work by Verzar (1912) and 
more recently Chinet and Mejsnar (1989) where flow, and thereby oxygen availability, 
was related to V02 by cells. It must be noted that decreasing oxygen delivery to 
skeletal muscle did not always affect V02 (Stainsby & Otis, 1964). However, if the 
relationship does hold, either oxygen of an alteration in ATP demand may regulate 
muscle metabolism, a so called "metabolic switch" (reviewed by Arthur et al., 1992). 
In the insect, flight muscle substrate cycling is suppressed during 
contractions (Clark et al., 1973), thus by analogy, substrate cycling could be expected 
to be inhibited during skeletal muscle contraction. This does not appear so, as 
contraction- and angiotensin II-induced V0 2 were additive (Colquhoun et al., 1990). 
Similar data were found by others with the infusion of epinephrine plus propranolol 
during contractions in the erythrocyte-perfused hindlimb (Richter et al., 1982a). 
However in both studies only 30% of the perfused hindlimb mass was contracting 
(Rennie & Holloszy, 1977). 
Alternatively, vasoconstrictors may redistribute flow to specialized heat-
producing cells, analogous to the modified eye muscle of the billfish (Block, 1987). 
In this tissue, Ca2+ cycling by the sarcoplasmic reticulum (SR) was proposed to 
generate heat (Block, 1987). Ca2+ cycling has also been implicated in skeletal muscle 
heat production during malignant hyperthermia (Gronert, 1986) and hyperthyroidism 
(van Hardeveld & Clausen, 1984). However a direct link between vasoconstriction 
and futile Ca2+ cycling has not been established. There is nevertheless continual 
pumping of Ca2+ from the cytosol into the SR and out of the cell in association with 
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vasoconstriction, and, if analogous to skeletal muscle, may contribute a large 
proportion of energy turnover during contraction (reviewed by Clausen et al., 1991; 
Chinet etal., 1992). 
Another possibility (which may not depend on heterogeneous flow) is an 
endothelial cell shear-stress-dependent control of metabolism. Recent findings in 
perfused guinea pig hearts have shown that a rise in flow rate increased the shear-
stress on the endothelial lining of blood vessels (glycocalyx) thereby stimulating 
glycolytic flux (Suarez & Rubio, 1991). These authors proposed a from of metabolic 
coupling between capillary endothelial cells and myocardial cells (Suarez & Rubio, 
1991) which may also occur in skeletal muscle. 
1.3.2.4 	Vascular thermogenesis. 
Recent work in this laboratory provided evidence that the vascular system 
controlled 902 in the perfused rat hindlimb. This evidence also raised the possibility 
that smooth muscle rather than skeletal muscle metabolism was responsible for the 
increase in 902 during vasoconstriction, with considerable thermogenesis occurring 
during constriction and maintenance of tension, giving rise to the notion of vascular 
thermogenesis or "hot pipes" (Colquhoun etal., 1988, 1990; Ye et al., 1990a, 1990b; 
Hettiarachchi etal., 1992; reviewed by Colquhoun & Clark, 1991). 
This proposal has inherent investigational problems due to difficulties in 
separating skeletal and smooth muscle metabolism. The argument relies on the 
assumption that small arterioles have much higher metabolic rates than the well 
described low rates of metabolism in larger vessels such as the aorta (Paul, 1980). In 
the light of the apparently small volume of vascular tissue within the hindlimb 
(approx. 3.4%, Paul, 1980), and Murphy's latch-bridge hypothesis (1988), 
vasoconstrictors that mediate increases in 902 may stimulate the relatively large 
number of small arterioles which undergo a form of vasomotion 3 and thereby 
stimulate a net large increase in sustained V0 2 . More direct evidence supporting the 
possibility of vascular thermogenesis comes from agonist-mediated large rises in 90 2 
in association with vasoconstriction in the isolated perfused rat mesenteric artery 
arcade (Ye etal., 1990a). 
3. 	Despite the reported decrease in vasomotion with reduced arterial perfusion 
pressure (Slaaf et al., 1989), the phenomenon of vasomotion has not been 
investigated in a constant-flow perfusion system that lacks high basal tone yet has 
adequate oxygen delivery. 
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1.3.3 	Non-thermogenic effects of NE. 
Infusion of high concentrations of NE into the hindlimb has been shown to 
result in dose-dependent decreases of maximum V0 2 to levels below basal, despite 
further rises in perfusion pressure (Grubb & Folk, 1976; Cote et al., 1985). These 
high concentrations of NE would not be expected to be circulating due to rapid 
breakdown by monoamine oxidase and catecholamine-o-methyl transferase located 
within vessels. However, high local concentrations of NE may be found within the 
synaptic cleft and thus it is possible that a major flow-controlling mechanism involves 
sympathetic vasoconstrictor nerves (Iversen & Nicolaysen, 1990). From perfusion 
experiments using the isolated dog hindleg and gastrocnemius muscle, Pappenheimer 
(1941) proposed that reduced V0 2 was the result of sympathetic nerves acting on 
blood vessels to divert blood flow from capillaries to arteriov-enous anastomoses. 
Duran and Renkin (1976) investigated this phenomenon in some detail, and although 
their conclusion differed from Pappenheimer's, they found that high frequency 
supramwdmal stimulation of the lumbar trunk led to an inhibition of V02 with a rise in 
resistance, but low frequency stimulation increased V02 as well as resistance (Duran 
& Renlcin, 1976). Intermediate frequency stimulation was often associated with an 
initial fall followed by an increase in V02 and relatively constant resistance (Duran & 
Renkin, 1976). This pattern of response has been reproduced in this laboratory and 
was markedly attenuated by a l -AR antagonists (unpublished observations). 
1.4 	Effects of serotonin in constant-flow perfused hindlimb. 
The vasoconstrictor effects of 5-HT have been reported previously in 
perfused rat hindlimb (Table 1.4; Ahlund et al., 1977; Cheng & Shibata, 1980; 
Verheyen et al., 1991), but no associated measurements of V02 were recorded. 
Increases in perfusion pressure were totally blocked by ketanserin (5-HT 2A-
antagonist) or LY 53,857 (general 5-HT 2-antagonist), indicating 5-HT-mediated 
vasoconstriction occurred via stimulation of 5-HT 2-receptors in the dog hindlimb 
(Blackshear et al., 1985), rat aorta (Cohen et al., 1983) and to a general extent in 
most blood vessels including rabbit femoral and tibial arteries (van Nueten, 1985). 
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Ref. 	Temp 	Flow Rate 	[5-HT] 
(T) 	(ml.min-1 .1eg-1 ) (jLM) 
Perfusion Pressure 
(mmHg) 
  
Basal 	 A 
A(I) 	37 	1 	 1.0 	 40 	 60 
A(II) 	37 	1.5 	 0.0025 	26 ± 2 	80 
B 	35 	1.0 	 0.25 	15 	 130 
C 	38 	5.0 	 1.0 	 30 	 200 
Table 1.4 	Effects of 5-HT on perfusion pressure in constant-flow perfused 
rat hindlimb. 
Hindlimbs from rats of varying size were perfused at a constant flow-rate 
using perfusion medium gassed with 95% 0 2-5% CO 2 containing either 
dextran (4%): A, from Cheng and Shibata (1980), auto-blood-perfused (I) 
and Krebs-Ringer-perfused (II); B, from Verheyen et a/. (1991), Tyrode-
perfused; or 3% artificial colloid (Ficoll): C, from Ahlund et aL (1977) 
Tyrode-perfused. Values are means, and when available, ± SE of maximal 
5-HT-mediated effects. 
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1.4.1 	Sites of 5-HT-induced effects. 
5-HT is generally reported to vasoconstrict larger arteries, and not small 
arteries or arterioles (Hollenberg, 1985; Blackshear et aL, 1985; Tuncer et al., 1992). 
In skeletal muscle, Harris and co-workers have demonstrated 5-HT-mediated LY 
53,857-sensitive constriction of large arterioles and LY 53,857-insensitive dilatation 
of small arterioles, suggesting the presence of 5-HT 2- and orphan 5-HT-receptors 
respectively (Wilmoth et aL, 1984; Alsip & Harris, 1991). 
1.5 	The present study. 
The importance of the vascular system in the control and contribution to 
metabolism within skeletal muscle was investigated in the constant-flow perfused rat 
hindlimb. 
The vasoconstrictor and vasodilatory effects mediated by NE and 5-HT were 
characterized by use of selective receptor antagonists and the marked reduction of 
oxygen, carbohydrate or Ca2+ from the inflow perfusion medium. The agonist-
induced effects on tissue metabolism were also investigated by measuring arterio-
venous differences in oxygen partial pressure and glucose levels, and the venous 
concentration of lactate. Final studies investigated agonist-mediated flow 
heterogeneity. 
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CHAPTER 2 
Vascular effects of NE and 5-HT. 
2.1 	Introduction. 
2.1.1 	Vasoconstrictor-mediated increases in skeletal muscle metabolism. 
Jansky and Hart (1963) demonstrated that skeletal muscle had an important 
role in norepinephrine (NE)-induced thermogenesis in vivo. Further investigation 
showed the increases in skeletal muscle oxygen uptake (V0 2) could be observed and 
quantified using constant-flow perfusion techniques (Mejsnar and Jansky, 1971). 
Since then, the constant-flow perfused rat hindlimb has been used as a model to 
investigate NE-induced oxygen uptake in skeletal muscle. In this system, NE has 
repeatedly been demonstrated to markedly increase basal oxygen uptake and lactate 
release during constant perfusion with erythrocytes at 37°C (Grubb and Folk, 1976; 
Richter et al., 1982a), or without erythrocytes at 25°C (Cote et al., 1985; Colquhoun 
et al., 1988, 1990; Ye et al., 1990b; Hettiarachchi et al., 1992). These effects were 
shown to be due to stimulation of a-adrenoceptors (AR) (Grubb and Folk, 1977; Cote 
et al., 1985; Colquhoun et al., 1990; Hettiarachchi et al., 1992), probably a i -AR 
(Grubb and Folk, 1977). 
Recent work in this laboratory provided evidence that the vascular system 
controlled V02 in the perfused rat hindlimb. Vasoconstrictors such as vasopressin and 
angiotensin II as well as NE increased hindlimb V02 and lactate release in association 
with perfusion pressure in a dose dependent manner (Colquhoun et al., 1988; 
Hettiarachchi et al., 1992). These effects were inhibited by the vasodilators 
nitroprusside, nifedipine and isoproterenol, indicating the involvement of the vascular 
system (Colquhoun et aL, 1988, 1990; Ye et al., 1990b; Hettiarachchi et al., 1992). 
This argument was strengthened by further work (Ye et al., 1990b; Colquhoun et al., 
1990) where (a) flow-induced increases in V0 2 and pressure were blocked by 
nitroprusside; (b) at all flow rates NE further increased the effects on V0 2 and 
perfusion pressure; and (c) skeletal muscle contraction-induced V0 2 was additive to 
V02 uptake produced by vasoconstriction. In addition vasoconstrictors were able to 
increase V02 and lactate release in a less complex vascular system, the perfused 
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mesenteric artery arcade (Ye et al., 1990a). The above evidence raised the possibility 
that smooth muscle metabolism rather than skeletal muscle metabolism was 
responsible for the increase in metabolism during vasoconstriction, giving rise to the 
notion of vascular thermogenesis or "hot pipes" (reviewed in Colquhoun and Clark, 
1991). 
In addition to vasocontrictor effects, NE has both a vasodilatory action in 
vascular smooth muscle and glycogenolytic action in skeletal muscle, due to 
stimulation of 0-ARs. 0-AR stimulation of smooth muscle stimulates cyclic AMP-
dependent phosphorylation and enhancement of Na+/K+ transport (Scheid et al., 
1979). In general, blood vessels contain predominantly 13 2-ARs (Fujimoto et al., 
1988), although some vessels exhibit 0 1 -AR-induced vasodilatation (Purdy et al., 
1988). The 0-AR density appears homogeneous on resistance arterioles within rat 
hindquarter, independent of surrounding skeletal muscle fibre type (Martin et al., 
1989). Colquhoun et al (1990) demonstrated the combination of the 0-antagonist 
propranolol (1 ptM) and NE resulted in greater increases in perfusion pressure and 
V02 than NE alone, for doses of NE greater than 25 nM. Stimulation of 0-ARs with 
isoproterenol (50 nM) in the absence or presence of vasoconstrictors led to decreases 
in perfusion pressure and V0 2 (Colquhoun et al., 1990; Hettiarachchi et al., 1992). 
The 0-ARs in skeletal muscle have been shown to increase lactate release due to 
stimulation of glycogenolysis (Dimitriadis et al, 1991). 02-ARs appear predominant, 
but evidence exists for I31- and 03-ARs in skeletal muscle (Kim et al., 1991; Molenaar 
et al., 1991). The receptor density increases with type I, slow-oxidative fibre content 
and vascular density (Martin et al., 1989; Kim et al., 1991). Consistent with earlier 
reports (Richter et al., 1982a), isoproterenol stimulated increases in skeletal muscle 
lactate release in perfused and unperfused muscle (Hettiarachchi et al., 1992). 
2.1.2 	Vasoconstrictor-mediated decreases in skeletal muscle metabolism. 
Infusion of vasoconstrictors into constant-flow perfused hindlimbs did not 
always lead to increases in metabolism. It was observed that upon infusion of higher 
doses of NE, perfusion pressure continued to rise, yet V02 began to decrease 
towards, and even below, basal levels despite constant-flow perfusion (Grubb and 
Folk, 1976; Cote et al., 1985). 
In 	preliminary 	experiments 	in 	this 	laboratory, 	serotonin 
(5-hydroxytryptarnine, 5-HT) was found to stimulate decreases in V0 2 in association 
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with rises in perfusion pressure. The reason for this decrease in metabolism was 
unclear, as there have been no reports of 5-11T directly affecting skeletal muscle 
metabolism. In general, 5-HT is reported to cause vasoconstriction within skeletal 
muscle via stimulation of 5-HT2 (5-HT2A  and/or  5-HT2C)  receptors on larger 
arteries, but not on smaller arteries or arterioles (Hollenberg, 1985; Blackshear et aL, 
1985; Alsip & Harris, 1991). 5-HT-mediated vasodilatation of smaller blood vessels 
in skeletal muscle has also been unmasked, and was thought to be via stimulation of 
orphan 5-HT-receptors (Alsip & Harris, 1991). 
It was considered of interest to further characterize these apparently 
anomalous findings with NE and 5-HT in the perfused hindlimb. In the present study, 
the actions of 5-HT and NE in both the isolated, perfused rat hindlimb and mesenteric 
arterial arcade were compared. Agonist-mediated effects on perfusion pressure, V0 2 
and lactate release were determined, and the receptors stimulated were assessed by 
use of selective adrenergic and 5-HT antagonists. 
2.2 	Materials and methods. 
2.2.1 	Perfusion techniques. 
2.2.1.1 	Animal care. 
Male hooded Wistar rats were used in all experiments. Five to eight rats 
were housed per cage under temperature-controlled conditions (12 h:12 h light/dark 
cycle). Rats were provided with a commercial diet (21.4% protein, 4.6% lipid, 68% 
carbohydrate and 6% crude fibre with added vitamins and minerals from Gibson's 
Hobart) and water ad libitum. 
2.2.1.2 	Surgical procedures. 
2.2.1.2.1 	Perfused rat hindlimb. 
Surgery was performed as described by (Colquhoun et al., 1988), which was 
a modified version of that used by Ruderman et al. (1971). The detailed operative 
procedure was as follows (and Figure 2.1): 
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Rats were anaesthetized with an intraperitoneal injection of aqueous 
pentobarbital sodium (6 mg/100 g body weight). After a midline abdominal incision, 
the skin was reflected and the superior epigastric vessels were ligated (for anatomical 
nomenclature see Greene, 1968). The abdominal wall was then incised from the pubic 
symphysis to the xiphoid process. Ligatures were placed around the left superficial 
epigastric vessel (1.), the internal spermatic vessels (2.) and other vessels supplying 
the testes, the neck of the bladder (3.) and the seminal vesicles (4.). The testes and 
seminal vesicles were removed. Two ligatures were placed around the descending 
colon {proximal to the inferior mesenteric artery, (5.)) and excised in between. The 
colon and large intestine were separated from the connective tissue to the level of the 
renal vessels (6.), and a ligature was placed around the duodenum taking care to tie 
off the superior mesenteric vessels (7.). The intestine was excised below the duodenal 
ligature and the entire gastro-intestinal tract was removed. Ligatures were placed 
around the iliolumbar vessels (8.), ureter (9.), tail near the anus (10.) and tarsus of the 
left foot (11.). In experiments when only one leg was perfused, flow was restricted to 
the left limb by ligation of the contralateral common iliac artery (12.). 
Next, two pairs of loose ligatures were placed around the aorta and the vena 
cava. The first pair (13.) was located immediately below the renal vessels, and the 
second pair (14.) above the iliolumbar vessels. Heparin (1000 units per ml) (0.1 
mU100 g body wt) was injected into the vena cava at the junction between 
the right renal vein and the vena cava and allowed to circulate. The vena cava (15.) 
was tied off (13.), and cannulated by passing a Terumo 18G needle with 16G catheter 
through the vessel wall (X). The catheter tip was positioned 3 mm above the aortic 
bifurcation and tied in place. The aorta (16.) was tied off (13.) and a small incision 
(X) allowed insertion of a Terumo 18G catheter filled with 0.9% NaCl. The catheter 
was pushed gently until the tip was at the same level as the venous catheter, and then 
secured. 
The preparation was then transferred to the perfusion apparatus, and the 
arterial cannula was connected to the oxygenated perfusion medium inflow line. In the 
majority of experiments perfusate was pumped into the rat at a constant flow-rate of 
4.1 ± 0.1 ml.min -1 . The outflow line was connected to the venous cannula (Figure 
2.3). Approximately 2 min elapsed from the time the vena cava was ligated and the 
circulation was re-established. A further ligature was placed around the abdomen of 
the rat at the level of the L3, L4 vertebrae to restrict flow to the upper torso. The 
animal was then sacrificed with an over-dose of pentobarbital sodium injected into the 
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15. Vena Cava 
16. Aorta 
6. Renal Vessels 
7. Superior mesenteric artery 
13. First ligature pair 
14. Second ligature pair 
X Points of incision 
8. Iliolumbar vessels 
2. Internal spermatic vessels 
9. Ureter 
12. Common iliac vessels 
5. Inferior mesenteric vessels 
1. Superficial epigastric 
External iliac vessels 
Hypogastric vessels 
4. Seminal vesicles 
3. Bladder 
12. Foot 
11. Tail 
Figure 2.1 	Vessels ligated during surgical preparation of the isolated rat 
hindlimb. 
The perfusion method was modified from Ruderman et al. (1971) according to 
Section 2.2.1.2.1. Numbers and names of the vessels are referred to in the text. 
Modified from Greene (1968) and Ruderman et al. (1971). 
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heart. The entire operative procedure required 20-25 min. 
2.2.1.2.2 	Perfused rat mesenteric artery arcade. 
Perfusion of the superior mesenteric artery arcade was based on that by Ye et 
(1990b) with some major modifications. Animal care, and the perfusion medium 
and apparatus are described in Sections 2.2.1.1 and 2.2.1.3, respectively. BSA (2%) 
was added to the modified Krebs-Henseleit bicarbonate buffer, and perfusions were 
conducted at 25°C. The detailed operative procedure was as follows (Figure 2.2): 
Rats (200-250g) were anaesthetized with an intraperitoneal injection of 
aqueous pentobarbital sodium (6 mg/100 g body weight). After a midline abdominal 
incision, the skin was reflected and the superior epigastric vessels were ligated (for 
anatomical nomenclature see Greene, 1968). The abdominal wall was then incised 
from the pubic symphysis to the xiphoid process. Two ligatures were placed around 
the descending colon (proximal to the inferior mesenteric artery, see Figure 2.2) and 
excised in between. The colon and large intestine were separated from the connective 
tissue to the level of the renal vessels. 
Next, two loose ligatures were placed around the aorta, the first above the 
superior mesenteric artery branch-point and second at the level of the left renal vein. 
A loose ligature was also placed around the superior mesenteric artery 2 mm from 
aortic branch-point. Heparin (100 U/100 g body wt) was injected into the vena cava 
below the right iliolumbar vein branch point, and allowed to circulate for 1 min. The 
first aortic ligature was tied off, and a small incision (X) allowed the retrograde 
insertion of a Terumo 18G catheter (inserted through a rubber stopper) filled with 
0.9% NaCl. The catheter was pushed up until the tip was at the superior mesenteric 
artery branch-point then was gently manoeuvred approx. 4 mm into this vessel. The 
lower aortic and mesenteric ligatures were then secured. 
The arterial cannula was connected to the oxygenated perfusion medium 
inflow line, and flow commenced through the arcade at 1.5 ml.min -I. Approximately 
1 min elapsed from the time the aorta was ligated and the circulation was re-
established. The intestine was then carefully cut away from the arcade 
microcirculation, thereby preventing capillary flow and venous return. The artery 
arcade was removed from the rat, bathed in perfusion medium to remove any residual 
red blood cells, and then transferred into the perfusion chamber. The chamber 
consisted of a glass tube tapered at the end (ID 16 mm, total volume 6 ml). The 
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Figure 2.2 	Vessels ligated during the surgical preparation of the isolated rat 
mesenteric artery arcade. 
The perfusion method and surgical preparation was modified from Ye et al. 
(1990a) according to Section 2.2.1.2.2. The cannulated arterial arcade was 
placed in a fluid-filled chamber (inset) to prevent oxygen loss to the atmosphere. 
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stopper on the carmula sealed the chamber, allowing upward perfusion, and filling of 
the chamber with perfusion medium. The outflow line was connected to the tapered 
end of the chamber. The animal was then sacrificed with an over-dose of 
pentobarbital sodium. The entire operative procedure required 20-25 min. 0.2 ml of 
Evans Blue dye was infused proximal to the arterial cannula to determine whether the 
entire network was being perfused before commencement of experiments, and on 
completion of experiments to allow determination of perfused mass. Unperfused 
tissue(predominantly lymph and fat deposits) was carefully dissected away, the 
preparation was then blotted and wet weight measured. 
	
2.2.1.3 	Perfusion medium. 
The standard perfusion medium was prepared according to Cote et al. 
(1985). 2% (w/v) bovine serum albumin (BSA) was added to Krebs-Henseleit 
bicarbonate buffer (118 m NaC1, 4.74 mM KC1, 1.19 mM KH 2PO4, 1.18 rnM 
MgSO4, 25 mM NaHCO 3) including 1.27 niM CaCl2 and 8.3 mM glucose. BSA was 
dialysed 5 times against distilled water before spectophotometric (540 nm) 
determination of protein content (Biuret Assay, Clark, 1964). The final solution was 
filtered (0.45 j.tm) before use. 
In experiments performed at higher temperatures, 4% BSA was added to the 
Krebs-Henseleit medium (Chapter 5) in addition to fresh, washed bovine erythrocytes 
(Chapter 6). 
2.2.1.4 	Perfusion apparatus. 
Perfusions were conducted in a thermostatically-controlled chamber (Figures 
2.3 & 2.4). Unless specified otherwise, the perfusion temperature was 25°C. This 
reduced basal oxygen uptake by hindlimb and mesenteric artery tissues and improved 
02-solubility, thereby allowing adequate 02 delivery by a non-erythrocyte medium as 
described by Cote et al. (1985). The perfusion medium reservoir was gassed with 
95% 02-5% CO2 maintained at 4°C to enable full oxygenation. Gassed perfusate was 
pumped at a constant-flow rate by a peristaltic pump (Masterflex, Cole Palmer, USA) 
from the reservoir through the apparatus. Before reaching the hindlimb (or mesenteric 
artery arcade), the medium passed through a water-jacketed glass heat exchange coil, 
and an oxygenator. The oxygenator consisted of a glass jar containing 3 meters of 
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TEMPERATURE-CONTROLLED CABINET 
Figure 2.3 	Rat hindlimb perfusion apparatus. 
Carbogen-gassed perfusion medium was pumped at a constant-flow rate by a 
peristaltic pump from the reservoir through the apparatus. Before reaching the 
hindlimb, the medium passed through a water-jacketed glass heat exchange coil, 
and a carbogen-gassed silastic tubing oxygenator. Perfusion pressure was 
continuously monitored in a sidearm mixing chamber/bubble trap proximal to the 
aorta. Continuous measurement of venous effluent oxygen content was 
achieved by an in-line 0.5-ml Clark-type oxygen electrode contained in a 
temperature-controlled water-jacket. Venous effluent was periodically sampled 
for measurement of lactate and glucose concentrations. Carbogen, 95% 0 2-5% 
CO2. 
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Figure 2.4 	Rat mesenteric artery arcade perfusion apparatus. 
Carbogen-gassed perfusion medium was pumped at a constant-flow rate by a 
peristaltic pump from the reservoir through the apparatus. Before reaching the 
mesenteric artery arcade, the medium passed through a water-jacketed glass 
heat exchange coil, and a carbogen-gassed silastic tubing oxygenator. Perfusion 
pressure was continuously monitored in a sidearm mixing chamber/bubble trap 
proximal to the artery. Continuous measurement of venous effluent oxygen 
content was achieved by an in-line 0.5-ml Clark-type oxygen electrode contained 
in a temperature-controlled water-jacket. Venous effluent was periodically 
sampled for measurement of lactate concentrations. Carbogen, 95% 0 2-5% 
CO2. 
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silastic tubing (ID 1.47 nun/OD 1.91 mm, Dow Corning, USA) which was continually 
gassed with 95% 02-5% CO2. This ensured constant arterial P0 2 levels. 
Perfusion pressure was continuously monitored in a sidearm proximal to the 
aorta. Changes in perfusion pressure reflected changes in vascular resistance. 
Continuous measurement of venous effluent oxygen content was achieved by 
an in-line 0.5-ml Clark-type oxygen electrode contained in a temperature-controlled 
water-jacket (usually 25°C). 
Arterial P02 at the perfusion flow rate was measured before and after 
completion of experiments. Calibration of the oxygen electrode was made routinely 
by using temperature-equilibrated 100% 0 2, air, and N2 before and after each 
experiment. The electrode response was assumed to be linear in the range of P0 2 
200-700 mmHg, with only an error of <10% in calculating oxygen uptake when 
compared to the slight curve obtained using various mixtures of 0 2-N2 . 
Freshly prepared solutions of agonists and antagonists were infused 
continuously (LKB Brommer, 2232 Microprepex S) into the perfusion line proximal 
to a small, stirred bubble trap and the arterial cannula. An infusion rate of <2% of the 
flow rate ensured the vehicle had no apparent effect on venous P0 2 or perfusion 
pressure. 
2.2.1.5 	Chemicals and drugs. 
(-)-Norepinephrine bitartrate, 5-hydroxytryptamine creatinine sulfate, 
prazosin HCI, (±)-propranolol HC1, (-)-isoproterenol HC1, arginine vasopressin, 
human angiotensin II, ethyleneglycol-bis-(b-aminoethyl ether) N,N,N,N'-tetraacetic 
acid (EGTA) and hydrazinium hydrate from Sigma, USA; ketanserin tartrate, LY 
53,857 maleate, 5-methyl urapidil, chloroethylclonidine 2HCI, and VVB-4101 HC1 
from Research Biochemicals Inc., USA; porcine insulin (Actrapid MC, 100 units/m1) 
was obtained from Novo Industri A/S; 2-deoxy-D[1- 3H]glucose and [U- 14C] sucro se 
were obtained from Amersham Australia Pty Ltd.; BSA (fraction V), pentobarbital 
sodium, lactate dehydrogenase and nicotinatnide adenine dinucleotide from 
Boehringer Mannheim, Australia. Heparin was from David Bull, Australia. Filtration 
apparatus (model RG5) from Amicon and millipore filters (0.45 jAm) from Millipore 
Corp., USA. All other chemicals were of analytical grade from Ajax, Australia. 95% 
02-5% CO2 (carbogen) and 95% N2-5% CO2 gas mixtures from CIG, Australia. 
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2.2.1.6 	Oxygen uptake calculations. 
Oxygen uptake rates (V02) for hindlimbs perfused with erythrocyte-free 
medium were calculated by multiplying the arteriovenous difference (A-V) in oxygen 
content by the flow rate of the perfusate per gram of hindlimb skeletal muscle (SKM). 
V02 in pmoles.11-1 .g-1 was calculated as follows: 
V02 
(pmoles.h-1 .g-1 ) 
= 	(A-V) x 0.03388* x 60 x flow rate (ml.min -1 )  
SKM masst x 22.44 
pi of oxygen dissolved per 100 1..t1 of perfusate medium per mmHg P0 2 at 25°C 
(Bunsen coefficient) from Christoforides et al. (1969). 
Assumed to be one twelfth the rat body mass per hindlimb (Ruderman et al., 
1971). 
At standard temperature and pressure the volume of 1 lAmol is 22.4 IA 
Calculation of V02 by the perfused mesenteric artery arcade preparation was 
performed in a manner similar to that for the hindlimb. The perfused mass was 
determined upon completion of each experiments (approx. 1 g) and used in the 
calculation. It was estimated that vascular tissue comprised approx. 6% of the 
perfused tissue (Ye etal., 1990a). 
	
2.2.1.7 	Dose-response curves. 
When generating dose-response curves for agonists, venous P02 and 
perfusion pressure values were taken after 15 min of agonist infusion when steady-
state values were achieved. In some experiments, perfusate samples were collected 
for lactate analysis. In general, perfusate samples were pooled for the 15 min of drug 
infusion to give a mean value of lactate concentration, except for time courses when 1 
ml samples were collected at the times indicated. 
2.2.1.8 	Statistical analysis. 
Data are shown as the means % standard errors. Curves were fitted using the 
Sigma Plot program (Version 4.0, Jandel Scientific). 
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The statistical significance of differences between groups of data was 
assessed by the either the paired or unpaired 2-tailed Student's t test or one way 
analysis of variance and least significant difference analysis (Snedecor & Cochran, 
1980). 
2.2.2 	Metabolite assay techniques. 
In some experiments venous effluent was assayed for lactate concentration. 
Perfusate samples were usually taken when steady state was reached as judged by 
pressure and V0 2 . Samples were collected into eppendorf tubes and kept at -20°C. 
Immediately prior to performing the assay, 0.1 ml of 2 M perchloric acid was added to 
0.5 ml of perfusate sample, mixed and centrifuged in an Eppendorf microfuge for 5 
min at 2°C. An aliquot (30 i.t1) of 2.5 M K2CO3 was added to 0.4 ml of supernatant, 
mixed and centrifuged for 5 min as above. The neutralized supernatant was then used 
for the lactate assays. 
The method used was that of Gutmann and Wahlefeld (1974). Absorbance 
before and after lactate dehydrogenase addition was measured spectrophotometrically 
at 340 nm. The net change in absorbance (AE) was used to calculate the 
concentration of lactate in the sample as follows: 
[lactate] = 	AE 	x 1000 x 	ml (cell vol.) 	x 	ml (total vol.)  
(mM) 6220* 	ml (neutralized vol.) 	ml (perftisate vol.) 
Extinction coefficient 
2.3 	Results. 
In this series of experiments the steady state mean perfusate arterial and 
venous P02 values for the rat hindlimb were 683.4 ± 4.4 mmHg and 399.9 ± 6.7 
mmHg, respectively (n = 68). These values were obtained after an initial 30 min 
equilibration period. The basal V02 by hindlimb muscle was calculated as previously 
described (Section 2.2.1.6) and, using the above values, was found to be 6.5 ± 0.1 
(n = 68). Steady state basal lactate production was 7.4 ± 0.5 
1 (n = 23) and basal perfusion pressure was 22.3 ± 0.4 mmHg (n = 68). The steady 
state basal values for V02, perfusion pressure and lactate release remained constant 
for the duration of control experiments (vehicle only) and were similar to those 
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reported previously from this laboratory (Colquhoun et al., 1988, 1990; Clark et al., 
1990; Richards et aL, 1992, 1993; Hettiarachchi et al., 1992). 
2.3.1 	Effects of NE in the perfused hindlimb. 
Upon NE infusion in the range 1-250 nM, V0 2 , lactate release and perfusion 
pressure increased dose-dependently (Figure 2.7). A dose of 50 nM NE was chosen 
to represent a stimulatory effect on V02 (Figures 2.5 & 2.6). This dose decreased 
venous P02 by 167.9 20.7 mmHg, equivalent to an (almost maximal) increase in 
V02 of 4.1 ± 0.5 lAmol.h -1 .g-1 , associated with an increase in perfusion pressure 
above basal of 28.6 ± 0.7 mmHg (n = 5). In addition, NE rapidly stimulated a 
transient, 4-fold increase in hindlimb lactate release, which reached steady state 20 
min after infusion to a value 12.9 ± 1.6 above basal (Figure 2.6, n = 3). 
It was noted that upon infusion of NE, the presence of a small quantity of 
erythrocytes transiently appeared in the perfusate. 
NE, at 50 nM, appeared to stimulate predominantly a i -ARs, as prazosin was 
approximately 100-fold more potent in blocking the NE-induced response than the 
a2-AR-antagonist, yohimbine (Figure 2.8). 0.1 I.LM prazosin almost totally opposed 
the 50 riM NE-mediated effects. This dose of NE had low affinity for the 13-AR 
(Figure 2.10). 
At doses tested beyond 0.25 1AM NE, perfusion pressure continued to 
increase, but steady state V02 and lactate release decreased dose dependently towards 
basal levels (Figure 2.7). After an initial, transient stimulation of V02 (Figure 2.5), 
2.5 JAM NE significantly inhibited V02 to levels 0.5 ± 0.2 pmol.h-1 .8-1 below basal, 
with a corresponding pressure increase of 206.0 ± 6.2 nunHg (n = 16, Figure 2.7). 
This higher dose of NE appeared to stimulate both al- and 13-ARs. Lower doses of 
prazosin selectively blocked the vasoconstriction associated with the inhibitory 
component of V02 (Figures 2.5 & 2.9). A dose of 0.5 p.M prazosin was required to 
oppose the 2.5 1.1M NE-mediated effects on perfusion pressure and V0 2 (Figure 2.9). 
Similar to the low-dose NE effects, a 100-fold higher dose of yohimbine was required 
to block the vasoconstriction-associated effects, although the antagonist dose-range 
was narrower (Figure 2.9). Propranolol increased high-dose NE-mediated perfusion 
pressure and V02 (Figure 2.10), although not significantly. Interestingly, ketanserin 
also selectively blocked the inhibition of V02 and the part of perfusion pressure 
increase (Figure 2.9), presumably due to antagonism of a l -AR, not 5-HT2A- 
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Figure 2.5 	Effects of representative low- and high-dose NE and 5-HT 
concentrations on hindlimb venous P02 and perfusion pressure. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min -1 with perfusion medium containing 2% bovine serum albumin and 
equilibrated against 95% 0 2-5% CO2 . Additions were 50 nM NE and 0.1 pt.M 
prazosin (PRAZ, A), 2.5 p,M NE, 0.1 1.1.M and 1 p.M prazosin (B), and 0.25 1AM 
5-HT, 1 p.M prazosin and 0.1 piN4 LY 53,857 (LY, C). NE, norepinephrine; 
5-HT, serotonin. 
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Figure 2.6 
	Time course for the effects of NE, 5-HT, and reversible occlusion 
at the knee on hindlimb VO2, perfusion pressure and lactate 
release. 
Hindlimbs were perfused as described in Figure 2.5. Treatments were 50 nM 
NE, 0.25 11M 5-HT and reversible hindlimb occlusion at the knee (Occlude). 
Values are means ± SE for 3 hindlimbs, when not visible, error bars are within 
, symbols. NE, norepinephrine; 5-HT, serotonin; V0 2 , oxygen uptake. 
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Figure 2.7 	Dose-response curves for NE and 5-HT on changes in hindlimb 
oxygen uptake, perfusion pressure and lactate release. 
Hindlimbs were perfused as described in Figure 2.5. Basal arterial and venous 
P02 were 694.9 ± 8.5 and 416.6 ± 12.9 mmHg respectively, equating to a basal 
V02 of 6.4 ± 0.2 lArnol.h4 .g-1 (n = 24). Basal perfusion pressure was 24.1 ± 0.7 
mmHg (n = 24) and basal lactate release was 6.7 ± 0.7 1.tmo1.11 -1 .g-1 (n = 13). 
Steady state values for each dose were measured after 15 min of either NE (0) 
or 5-HT (0) infusion. Values are means ± SE for at least 4 hindlimbs. When 
not visible, error bars are within symbols. * P < 0.05, 2.5 1AM NE-induced V02 
below basal, paired Student's t test (n = 16). NE, norepinephrine; 5-HT, 
serotonin; V02, oxygen uptake. 
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Figure 2.8 Effect of a-AR antagonists on the response to low-dose NE on 
hindlimb VO2 and perfusion pressure. 
Hindlimbs were perfused as described in Figure 2.5. Basal arterial and venous 
P02 were 675.6 ± 7.8 and 402.4 ± 12.4 mmHg respectively, equating to a basal 
V02 of 6.4 ± 0.3 (n = 12). Basal perfiision pressure was 21.9 ± 
1.1 mmHg (n = 12). After 15 min of infusion, 50 nM NE increased V0 2 by 3.8 
±0.2 pmo1.11-1 .g-1 , and perfusion pressure by 22.4 ± 1.2 mmHg (n = 12). 
Increasing concentrations of each antagonist were then infused: prazosin (0); 
yohimbine (A); ketanserin (I) and LY 53,857 (•). Values are means ± SE for 
3 hindlimbs with each treatment, expressed as a percentage of the maximal NE 
response for each hindlimb. When not visible, error bars are within symbols. 
AR, adrenoceptor; NE, norepinephrine; V0 2, oxygen uptake. 
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Figure 2.9 	Effect of cc-AR antagonists on the response to high-dose NE on 
hindlimb V02 and perfusion pressure. 
Hindlimbs were perfused as described in Figure 2.5. Basal arterial and venous 
P02 were 700.8 ± 8.7 and 405.3 ± 9.2 mmHg respectively, equating to a basal 
V02 of 6.7 ± 0.2 i_tmol.h -1 .g-1 (n = 9). Basal perfusion pressure was 21.8 ± 0.9 
mmHg (n = 9). After 15 min of infusion, 2.5 111%.4 NE decreased V0 2 by 0.4 ± 
0.3 wriol.h -1 .g-1 , and increased perfusion pressure by 189.9 ± 7.0 mmHg (n = 
9). Increasing concentrations of each antagonist were then infused: prazosin 
(•); yohimbine (A) and ketanserin (II). Data are expressed as a percentage of 
the maximal increase in V02 (4.1 iamo1.10.g-1 ) and perfusion pressure (206 
mmHg) mediated by NE . Values are means ± SE for 3 hindlimbs with each 
treatment. When not visible, error bars are within symbols. AR, adrenoceptor; 
NE, norepinephrine; V0 2, oxygen uptake. 
A
 O
xy
ge
n  
U
p
ta
ke
  
A  
P
er
fu
si
on
  P
re
ss
ur
e  
A
 La
ct
at
e  
R
el
ea
se
  
—5.5 —8.5 —7.5 	—8.5 
2 
200 
11 150 
E 100 
50 
0 
28 
21 
14 
7 
7 
—9.5 
4 
2 
0 
47 
log [NE] 
Figure 2.10 Effect of a i- and 13-AR antagonists on the NE dose-response curve 
on changes in hindlimb V02, perfusion pressure and lactate 
release. 
Hindlimbs were perfused as described in Figure 2.5. Basal arterial and venous 
P02 were 696.6 ± 7.0 and 429.8 ± 8.6 mmHg respectively, equating to a basal 
VO2 of 6.2 ± 0.2 p.mol.h -1 .g-1 (n = 28). Basal perfusion pressure was 24.6 ± 0.5 
mmHg (n = 28), and lactate release 6.9 ± 0.8 prnol.h -1 .g-1 (n = 14). NE dose-
response curves were obtained in the absence (0) or presence of 10 1.1,M (±)- 
propranolol (0) or 2.5 1.1.M prazosin (A). Antagonists were infused for at least 
15 min prior to commencement NE infusion. Values are means ± SE for at least 
3 hindlimbs, when not visible, error bars are within symbols. AR, adrenoceptor; 
NE, norepinephrine; V02, oxygen uptake. 
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receptors, as ketanserin, but not prazosin, blocked the 5-HT-mediated response 
(Section 2.3.2). 
Once the a 1 -ARs were blocked with prazosin, NE dose-dependently 
decreased V02 and stimulated lactate release associated with almost no change in 
perfusion pressure (Figure 2.10). These responses were qualitatively similar to that of 
the 13-agonist isoproterenol, although NE appeared to exhibit a lower 13-AR affinity 
(approx. 40-fold less, Figure 2.11). 
2.3.2 	Effects of 5-HT in the perfused hindlimb. 
5-HT dose-dependently increased perfusion pressure and decreased V02 
(Figure 2.7). A dose of 0.25 1.1M 5-HT increased perfusion pressure by 26.1 ± 3.2 
mmHg, a level comparable to that stimulated by 50 nM NE. However in contrast to 
NE, 0.25 p.M 5-HT increased venous P02 by 62.2 ± 8.3 mmHg, equivalent to a 
decrease in V02 of 1.5 ± 0.2 ptmol.h- '.g4 (n = 8), and decreased basal hindlimb 
lactate release by 0.2 ± 0.8 prnol.h -1 .g-1 (n = 6, Figures 2.5 & 2.6). Upon removal of 
5-HT a transient increase in lactate release of 7.6 ± 2.6 pimo1.11-1 .g-1 above basal was 
observed, which gradually returned towards basal. Another distinguishing feature of 
the 5-HT response was the absence of erythrocyte washout from the hindlimb during 
vasoconstriction. 
5-HT appeared to stimulate predominantly 5-HT2A-receptors, as ketanserin 
(0.1 1AM) (data not shown) and LY 53,857 (2.5 TIM) almost totally blocked the 5-HT-
mediated responses on perfusion pressure, V02 (Figure 2.12) and lactate release (data 
not shown). LY 53,857 was chosen to inhibit the 5-HT response as it had lower 
affinity for the a-AR (Figure 2.8). Prazosin (1 tiM) had no significant effect on the 5- 
HT response (Figure 2.5). Isoproterenol (50 TIM) inhibited 19 ± 11 % and 20 ± 7 % 
of the V02 and perfusion pressure responses, respectively, to 0.25 3.1M 5-HT (n = 3). 
Once the 5-HT2A-receptor stimulation was fully blocked with 10 nM LY 
53,857, 0.25 1.1M 5-HT caused a slight vasodilatation of approx. 1 mmHg, and a 
decrease in V02 of 0.5 ± 0.1 1.1mol.h-1 .g-1 (n = 2). Also in the presence of 10 TIM LY 
53,857, 5-HT dose-dependently opposed the response to 5 TIM angiotensin II (Figures 
2.13 & 2.14). 
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Figure 2.11 Dose-response curves for 13-agonists on hindlimb lactate release 
expressed as a proportion of the maximum response by each 
agonist. 
Hindlimbs were perfused as described in Figure 2.5. NE plus 2.5 11M prazosin 
(A) data was taken from Figure 2.10; isoproterenol (A) data from 
Hettiarachchi et al. (1992). Maximal doses of NE (5 AM) and isoproterenol (1 
1AM) increased lactate release by 4.8 ± 1.3 [tmol.h-1 .g-1 (n = 3) and 6.4 ± 0.1 
(n = 5), respectively. Values are means ± SE, expressed as a 
percentage of the maximal agonist response for each hindlimb. When not visible, 
error bars are within symbols. 
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2.2.3 	Effects of reversible hindlimb occlusion at the knee. 
Physical, reversible occlusion of flow to the lower hindlimb was achieved by 
tying a soft, rubber tourniquet below the knee. By dissection of tissue stained with 
injected Evans Blue dye, it was found that occlusion directly removed approx. 2.5 g 
(16.7%) of muscle from the circulation and restricted perfusion to a further irregular 
band of tissue immediately above the ligature that could not be accurately quantified 
but could represent up to an additional 10%. After 15 mm of hindlimb occlusion, 
perfusion pressure was increased by 3.5 0.6 mmHg, V0 2 decreased by 1.5 ± 0.3 
p,mol.h-1 .g-1 , (n = 4) and lactate release decreased by 1.8 ± 1.1 p.mol.h- l.g-1 (n = 2, 
Figure 2.6). Upon removal of the tourniquet, oxygen and pressure levels rapidly 
returned to basal, and a transient peak of lactate production was observed. 
2.3.4 	Effects of 5-HT in the perfused mesenteric artery arcade. 
In the isolated, perfused rat mesenteric artery arcade, steady state mean P0 2 
values were 628 ± 34 mmHg arterial and 574 ± 36 mmHg venous. The basal V0 2 
was 7.2 ± 0.7 psnol.h- l.g4 , and basal perfusion pressure 16 ± 5 mmHg (n = 10). 
These values were similar to those previously reported (Ye et al., 1990a). The basal 
lactate release was 5.5 ± 0.6 ptmol.h -1 .g -1 (n = 10). The contribution to basal 
metabolism of non-vascular tissue supplied by the vessels of the mesenteric artery 
preparation was assessed by infusing both the vasodilators nitroprusside (0.5 mM) and 
isoproterenol (1 p1M). Under these conditions V02 was found to be negligible (data 
not shown) suggesting minimal metabolism by the surrounding lymph and fat tissue. 
The effect of NE in the mesenteric artery has been reported previously and 
were qualitatively similar to those observed with 5-HT (Ye et al., 1990b). 5-FIT 
dose-dependently increased V0 2, perfusion pressure and lactate release (Figure 2.16). 
The maximum dose of 5-HT (6.7 11M) increased V0 2 by 9.1 ± 0.8 p.mol.h - l.g-1 , 
perfusion pressure by 11 ± 2 mmHg and lactate release by 6.6 ± 0.8 pmo1.11 -1 .g-1 (n = 
5, Figure 2.16). Nitroprusside (0.5 mM) blocked the 5-HT-mediated effects on 
perfusion pressure and V02 (Figure 2.15). Ketanserin (0.7 1.1,M) totally inhibited the 
response to 6.71AM 5-HT, and had no effect on that of NE (data not shown). 
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Figure 2.12 Effect of a 5-HT2-antagonist on the 5-HT dose-response curve on 
changes in hindlimb V0 2 and perfusion pressure. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min- I with perfusion medium containing 2% bovine serum albumin and 
equilibrated against 95% 0 2-5% CO2 . Basal arterial and venous P02 were 
639.2 ± 8.9 and 306.4 ± 4.5 mmHg respectively, equating to a basal oxygen 
uptake of 7.5 ± 0.3 p,mol.11-1 .g-1 (n = 8). Basal perfusion pressure was 17.8 ± 
0.3 mrnHg (n = 8). 5-HT was infused in the absence (0) or presence of either 
0.5 nM (•) or 2.5 nM LY 53,857 (A). LY 53,857 was infused for 30 min 
prior to commencement of 5-HT infusion. Values are means ± SE from at least 
three hindlimbs; where not visible, error bars are within symbols. 5-HT, 
serotonin; V02, oxygen uptake. 
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Figure 2.13 Effect of a representative dose of 5-HT in the presence of both a 
5-HT2-antagonist and angiotensin II on hindlimb venous P02 and 
perfusion pressure. 
HindliMbs were perfused as described in Figure 2.12. 5-HT (0.25 gM) was 
infused in the presence of LY 53,857 (10 nM) and angiotensin II (All, 5 nM). 
Values are means ± SE from three hindlimbs; where not visible, error bars are 
within symbols. 5-HT, serotonin. 
0 = 
4,) > 
E 
E 
•..-.• 
Pe
rf
u
si
on
  P
re
ss
ur
e  
-o 
100 0 
a, 
	
.,5 trf 	80 
I 0 
60 
Tdi 	g 
" ›, 40 
'Po I—' 
20 
,0 
0) 
.5 
I F.., 
r3.4 
7E1 .2 
0 
co 
1-4 
11. 
0 
0 
100 
80 
60 
40 
20 
53 
—9 	—8 	—7 	—6 	—5 
log [5—HT] 
Figure 2.14 Dose response curve for 5-HT in the presence of both a 5-HT2- 
antagonist and angiotensin II on hindlimb V0 2 and perfusion 
pressure. 
Hindlimbs were perfused as described in Figure 2.12. Basal arterial and venous 
P02 were 690.9 ± 6.5 and 344.4 ± 29.4 mmHg respectively, equating to a basal 
V02 of 8.0 ± 0.4 (n = 3). Basal perfusion pressure was 20.0 ± 0.6 
mmHg (n = 3). 5-HT was infused in the presence of LY 53,857 (10 nM) and 
angiotensin II (5 nM). Values are expressed as percentages of the maximal 
mean ± SE All responses; where not visible, error bars are within symbol. 
5 nM angiotensin II increased V02 by 3.9 ± 0.4 Ilmol.h-1 .g-1 and perfusion 
pressure by 23.8 ± 8.8 mmHg (n = 3). 5-HT, serotonin; V02, oxygen uptake. 
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Figure 2.15 Time course of 5-HT-mediated effects on venous P0 2 and 
perfusion pressure in isolated perfused mesenteric artery arcade. 
Mesenteric artery arcades from 200-250 g rats were perfused at 25°C and a 
constant flow rate of 1.5 ml.min-1 with perfusion medium containing 2% bovine 
serum albumin and equilibrated against 95% 02-5% CO2. 5-HT, serotonin; NP, 
nitroprusside. 
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2.4 	Discussion. 
It has previously been shown that in the constant-flow perfused rat hindlimb 
NE, angiotensin H and vasopressin stimulated dose-dependent increases in perfusion 
pressure and associated increases in V0 2 and lactate release (Colquhoun et al., 1988; 
Richards et al., 1991; Hettiarachchi et al., 1992). These effects were blocked by the 
smooth muscle vasodilator nitroprusside (Colquhoun et al., 1988; Hettiarachchi et al., 
1992), and appeared independent of skeletal muscle metabolism (Colquhoun et aL, 
1990; Hettiarachchi et al., 1992). The results of these studies led to a number of 
possibilities to account for the increases in metabolism (reviewed in Chapter 1, 
Section 1.3.2; Colquhoun & Clark, 1991). A provocative suggestion was that the 
energy required to constrict the vascular wall contributed a major portion of the 
increase in metabolism observed (Chapter 1, Section 1.3.2.4). 
The present study confirms the earlier work performed in this laboratory, and 
by others upon infusion of NE into the hindlimb. Infusion of NE stimulated both ar 
and 0-AR. The overall effect was the rapid onset of a sustained increase in perfusion 
pressure which was only slightly increased upon I3-AR blockade at doses of NE 
greater than 50 nM. Neither rauwolscine (data not shown) nor yohimbine had high 
affinity for the a-AR, and may have been non-selectively binding a i -ARs at the doses 
used (Wilson et al., 1991). The apparent absence of an a2-AR response may be due 
to a lack of sufficient basal tone using an in vitro perfusion technique (McGrath et al., 
1990). 
In association with vasoconstriction, 1 nM-0.25 p.M NE dose-dependently 
increased hindlimb V02 and lactate release via stimulation of al-AR. During 
prolonged NE infusion and doses above 50 nM, lactate release included a minor 
contribution by 0-AR-stimulated glycogenolysis. 
At doses of NE greater than 0.25 pM, vasoconstriction was associated with 
dose-dependent decreases in V02 and lactate release from the maximal values 
obtained with 0.1 pM NE. A dose of 2.5 pIVI NE decreased hindlimb metabolism to 
values approaching basal despite increases in perfusion pressure above 200 mmHg. 
The same profile of increased V0 2 followed by decreases in V02 below basal despite 
large increases in resistance has been previously reported in constant-flow perfused 
hindlimbs at 37°C with erythrocytes (Grubb & Folk, 1976) and 25°C without 
erythrocytes (Cote etal., 1985). It was proposed that the decrease in V02 was due to 
closure of some capillaries, thereby limiting the surface area for oxygen diffusion 
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(Grubb & Folk, 1976). At this high, dose of NE, 0-AR-stimulated decreases in VO2 
and increases in lactate release became more apparent, and were consistent with the 
observed response to isoproterenol in the hindlimb (Hettiarachchi et al., 1992), 
although isoproterenol stimulated the 0-AR vasodilatory and glycogenolytic 
responses at lower doses. It has previously been reported that 50 nM isoproterenol 
inhibited the pressure and V02 responses to 5 nM angiotensin II and 15.6 nM NE, 
and, by analogy, it would be expected that the 0-AR stimulation by the high doses of 
NE would also vasodilate the angiotensin II response. This was not determined due 
to problems of synergy between NE (a 1 -AR)- and angiotensin II-mediated 
vasoconstriction, an effect previously reported (Prins et al., 1992). Thus in the 
presence of propranolol the high dose NE response on perfusion pressure and V02 
were greater, suggesting the inhibition of V0 2 by NE involved both a i- and 0-AR 
stimulation. 
The effects of 5-HT in the hindlimb were not the same as those of NE. 5-HT 
(50 nM-0.75 I_tM) induced a dose-dependent increase in perfusion pressure, but 
surprisingly inhibited Vo 2 uptake to levels well below basal. Both oxygen and 
pressure effects in the present study were totally blocked by LY 53,857 and 
ketanserin, but not prazosin, indicating that 5-HT-mediated vasoconstriction occurred 
via 5-HT2 (more specifically 5-HT2A)-receptors in the hindlimb, a phenomenon also 
reported in the dog hindlimb (Blackshear et al., 1985), rat jugular vein and aorta 
(Cohen et al., 1983), rabbit mesenteric artery (Cain & Nicholson, 1989), and to a 
general extent in most blood vessels including rabbit femoral and tibial arteries (van 
Nueten, 1985). The vasoconstrictor effects in the rat cremaster muscle have been 
reported to be due to stimulation of 5-HT 2A or 5-HI2c receptors (Alsip & Harris, 
1991). 
A further disparity between the effects of 5-HT and NE was that 5-HT 
decreased lactate production to levels slightly below basal during the infusion period, 
and upon removal, a washout of lactate was observed. The changes in both lactate 
release and V02 observed upon 5-HT infusion and removal are very similar to those 
obtained upon reversible occlusion of the hindlimb below the knee, and remain 
consistent with the observed association between V02 and lactate release 
(Hettiarachchi et al., 1992). Thus the decrease in lactate release observed during 
5-HT infusion may be due to a decrease in the perfused region, although the percent 
decrease from basal was markedly less than that observed in V0 2 . This may reflect 
the metabolic fuels used during vasoconstriction, 5-HT tending to utilize anaerobic 
58 
metabolism thus producing lactate (see Chapter 3). The washout of lactate upon 
removal of 5-HT may indicate increased flow to previously underperfused regions. 
This explanation would depend on 5-HT causing selective constriction of major 
arteries or arterioles to decrease flow to some regions of the hindlimb. If this were so 
a shunting mechanism in the vascular system may be involved to allow the constant 
flow. 
Part of the explanation for the decreased metabolism also lies in the direct 
decrease in V02 mediated by 5-HT in the absence of vasoconstriction. In the 
presence of the 5-HT2 antagonist LY 53,857 (10 nM), 0.25 p.M 5-HT decreased VO 2 
by 0.5 ± 0.1 limol.h-1 .g4 without increasing perfusion pressure (n = 2). This 
decrease is approx. 30% of the inhibition of V0 2 observed in the absence of LY 
53,857 and could potentially be directly attributed to the vasodilatory action of 5-HT. 
Unfortunately no direct orphan 5-HT-receptor antagonists were available, so the 
contributions of vasodilator and constrictor components could not be fully 
determined. Alsip and Harris (1991) reported that the vasodilatory action of 5-HT 
was due to stimulation of receptors on smaller arterioles, and is consistent with the 
dilation observed against angiotensin II. 5-HT appeared to have higher affinity for the 
dilatory receptor, as dilatation was observed at a 4-fold lower dose than constriction. 
However, since the overall effect was vasoconstriction, the receptors may be located 
at different sites within the arterial tree, 5-HT 2A-receptors at sites upstream from 
orphan 5-HT-receptors (Alsip & Harris, 1991). When larger rats were perfused at 
higher constant-flow rates, thereby increasing basal tone, the dilatory effect of 5-HT 
was observed before the constriction effect (data not shown). In addition, recent data 
from constant-pressure perfused hindlimbs (Ji-Ming Ye, personal communication) has 
shown 5-HT mediated a large increase in flow at doses below 0.1 i.tM, suggesting 
stimulation of orphan 5-HT-receptors, and at higher doses decreased flow rate, 
presumably due to stimulation of 5-HT2A receptors. 
The observed washout of a small number of erythrocytes upon infusion of 
NE, but not 5-HT tends to suggest NE was causing a small portion of the flow to 
reach previously underperfiised regions, whereas 5-HT was not. 
The difference in metabolic effects could be attributed to the possibility that 
the two agonists act at different regions of the vascular tree. This view is supported 
by studies showing the location of adrenergic nerve terminals and receptors, which 
appear to increase in number surrounding the small arteries and arterioles (Fuxe & 
Sedvall, 1965; Nilsson et al., 1986; Hirst & Edwards, 1989). Also, the sensitivity to 
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ablutninally applied NE decreases with increasing arteriolar size (Gray, 1971). In 
contrast, 5-HT was reported to vasoconstrict larger arteries, and not small arteries or 
arterioles (Hollenberg, 1985; Blackshear et al., 1985; Alsip & Harris, 1991), and 
dilate smaller arterioles (Alsip & Harris, 1991). A study performed by Lamping et al. 
(1989) demonstrated that in the feline coronary microcirculation 5-HT stimulated 
constriction in arteries and arterioles larger than 90 pm but dilated arterioles smaller 
than 90 pm, and vasopressin (another thermogenic vasoconstrictor in the hindlimb, 
Colquhoun et al., 1988) constricted arterioles less than 90 pm but had no effect on 
larger arteries. In addition the total inhibition of the NE response by 50 riM 
isoproterenol (Colquhoun et al., 1990) may also suggest the vasoconstriction was 
occurring on smaller vessels, as I3-AR were proposed to be located on small resistance 
vessels and precapillary sphincters (Lundvall & Hillman, 1978; Lundvall et aL, 1982). 
For the same reasons, the lack of inhibition of the 5-HT response supports the 
proposal that 5-HT 2A receptors are located on larger vessels. 
The effects of 5-HT in a less complex vascular system, the isolated perfused 
mesenteric artery arcade, were then determined. In the absence of vascular tone the 
V02 by the preparation was minimal, suggesting a lack of contribution to metabolism 
by surrounding lymph and fat. This contrasts with the maximally dilated hindlimb 
where there is significant oxygen consumption (Ye et al., 1990b; Colquhoun et al., 
1990), presumably due to skeletal muscle metabolism. Prior experiments involving 
the perfusion of isolated rat mesenteric artery network by Ye et al. (1990a) showed 
that NE induced an increase in perfusion pressure and oxygen uptake, consistent with 
the vascular contribution to vasoconstrictor-induced increases in metabolism. The 
existence of 5-HT2A receptors in isolated rabbit mesenteric artery was reported by 
Cain and Nicholson (1989) who showed that 5-HT-induced constriction in the range 
0.3-3.0 p.M was inhibited by 30 nM ketanserin whereas 0.1 1.1M prazosin had no 
effect. In the present study with rat mesenteric artery it was found that 5-HT induced 
dose-dependent vasoconstriction with an associated increase in V0 2 and lactate 
release via stimulation of 5-HT2A receptors. These results showed that for a less 
complex vascular system 5-HT-stimulated vasoconstriction was associated with an 
increase in V02, thereby supporting the possibility that the observations in the 
hindlimb were not due to a direct 5-HT-mediated inhibition of smooth muscle 
metabolism. 
These results, in conjunction with literature reports, suggest NE and 5-HT 
contribute to the control of hindlimb metabolism by site-selective vasoconstriction. 
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Lower doses of NE stimulated al-AR probably located on arterioles within the 
microcirculation, increased vascular smooth muscle metabolism, and may also have 
redistributed flow to highly metabolically active regions. Conversely, 5-HT2- 
receptors and possibly a separate subgroup of al-AR are proposed to be located at 
discrete vascular sites on larger blood vessels that, when stimulated, selectively 
redistributed blood-flow (functional vascular shunting), resulting in reduction of 
oxygen and glucose delivery to metabolically active hindlimb tissues. 
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CHAPTER 3 
Metabolic characteristics of vasoconstriction. 
3.1 	Introduction. 
The contrasting effects of norepinephrine (NE) and serotonin (5-HT) on 
oxygen uptake (V0 2) in association with vasoconstriction in the constant-flow 
perfused rat hindlimb described in Chapter 2 suggest that metabolism may be 
controlled in the resting state by alterations in flow distribution. The different 
anatomical location of hormone receptors may have important implications in vivo. 
During systemic hypoxia, flow is diverted away from nutritive capillaries without 
compromising tissue need (Harrison et al., 1990b) by altering the locus of myogenic 
tone to larger blood vessels (Bertuglia et al., 1991), predominantly by increased 
sympathetic nerve activity (Mian & Marshall, 1991a). In general, larger vessels are 
usually able to maintain constriction during hypoxic conditions (Shibata & Briggs, 
1967; Altura & Altura, 1976; De Mey & Vanhoutte, 1983). Conversely, small blood 
vessels tend to dilate in response to low oxygen tensions (Carrier et al., 1964; Duling, 
1972; Harris et al., 1976). This may be due to local regulatory processes or an 
increase in dependency on oxidative metabolism with decreasing vessel size. 
This chapter focuses on the metabolic characteristics of vasoconstriction by 
NE and 5-HT. As 5-HT and high doses of NE are proposed to interact at sites on 
larger vessels (Blackshear et aL, 1985; Alsip & Harris, 1991; Tuncer et al., 1992) 
than low doses of NE (Gray, 1971; Hirst & Edwards, 1989; Lamping et al., 1989), 
the possibility that the sites may be distinguished on the basis of their oxidative and 
glycolytic capacity was examined. To assess oxygen-dependency, the effects of 
vasoconstrictors were examined when coupled mitochondrial oxidative 
phosphorylation was either interrupted or placed under hypoxic conditions. In 
addition, carbohydrate-dependency of vasoconstriction was determined by omitting 
glucose from the perfusion medium. 
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3.2 	Materials and methods. 
3.2.1 	Perfused hindlimbs. 
Surgery was performed on 180-200 g rats as outlined in Section 2.2.1.2.1. 
Experiments were performed at 25°C and 4.0 ± 0.1 ml.min -1 with 2% bovine serum 
albumin (BSA) added to the perfusion medium. Additional details are given in 
Section 2.2.1. During hypoxic perfusions 95% N2-5% CO2 replaced 95% 0 2-5% 
CO2 . 
To avoid organic solvent perturbation of the system, a water soluble 
mitochondrial uncoupler, sodium azide was used. 
3.2.2 	Statistical analysis. 
The statistical significance of differences between groups of data were 
assessed by the unpaired, two-tailed Student's t test. Significant differences were 
recognized at P < 0.05. 
3.3 	Results. 
3.3.1 	Effects of vasoconstrictors. 
Under fully aerobic basal conditions, mean arterial P02 was 697.5 ± 4.8 
mmHg (11= 23), mean venous P02 was 425.2 ± 7.4 mmHg (n = 23) with a V02 of 6.6 
± 0.1 and the perfusion pressure was 23.1 ± 0.6 mmHg (n = 23, Table 
3.1). These parameters remained constant for at least 3 h if no additions were made. 
Infusion of 50 nM NE and 0.25 1AM 5-HT produced comparable increases in 
perfusion pressure of approximately 100% above basal. In association with the rise in 
pressure, 50 nM NE induced an increase in V02 of 57.3 ± 5.1 % (n = 6), whereas 
5-HT decreased V02 from basal by 24.8 ± 4.4 % (n = 8, Table 3.2). NE-induced 
effects approached steady state within 5 min of infusion and remained constant 
provided NE was not withdrawn. 5-HT effects were different from those of NE and, 
although showing relatively rapid onset, continued to increase gradually throughout 
the period of infusion. Venous P02 and perfusion pressure values were taken 15 min 
after agonist infusion. Basal conditions were achieved rapidly upon removal of either 
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Inhibitor Pa02 
(mmHg) 
Pv02 
(mmHg) 
V02 
( umol. 	g- I ) 
Pressure 
(nunHg) 
No Inhibitor 36 697.5 ± 4.8 425.2 ± 7.4 6.6 ± 0.1 23.1 ± 0.6 
N2-0O2 12 27.8 ± 2.7 2.8 ± 0.4 0.6 ± 0.1 21.9 ± 0.7 
Cyanide (1 mM) 10 699.5 ± 8.3 658.5± 12.3 1.0± 0.2 22.7± 1.3 
Azide (1 RIM) 8 684.2 ± 14.4 220.0 ± 15.9 11.0 ± 0.4 22.0 ± 1.6 
Table 3.1 	Effects of hypoxia, cyanide, and azide on hindlimb V02 and 
perfusion pressure under basal conditions. 
Values are means ± SE. n, no. of hindlimb perfusions; P a02, arterial P02; 
Pv02, venous P02; V02, oxygen uptake. A gas mixture of 95% N2-5% 
CO2 was used to induce hypoxia. 
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Inhibitor 
50 	NE 0.2511M 5-HT 
V02 
(jAmo1.11-1 .g4 ) 
Pressure 
(mmHg) 
n V02 
(p.mo1.11-1 .g-1 ) 
Pressure 
(mmHg) 
n 
No Inhibitor 10.1 ± 0.3 41.3 ± 2.0 6 4.6 ± 0.3 46.9 ± 3.3 8 
(57.3 ± 5.1%) (97.5 ± 10.5%) (-24.8 ± 4.4%) (145.9 ±22.5%) 
N2-0O2 0.8 ± 0.1 25.1 ± 0.7 7 0.6 ± 0.1 51.1 ± 6.7 7 
(0%) (4.3 ± 0.4%) (0%) (136.5 ± 25.2%) 
Cyanide (1 BIM) 0.9 ± 0.2 25.3 ± 1.9 6 0.8 ± 0.2 49.2 ± 3.7 6 
(0%) (7.2 ± 3.1%) (0%) (129.2 ± 32.3%) 
Azide (1 iiiM) 11.5 ± 0.3 24.8± 1.8 5 7.7 ± 0.4 58.0 ± 9.2 5 
(4.0 ± 1.1%) (3.6± 1.4%) (-30.0 ± 2.5%) (139.5 ±22.6%) 
Table 3.2 	Effects of NE and 5-HT on hindlimb V02 and perfusion pressure 
during hypoxia and in the presence of cyanide or azide. 
Values are means ± SE, with percentage change from basal given in 
parentheses. Where appropriate, values were taken 15 min after 
commencement of agonist. Basal V02 and perfusion pressure values are 
given in Table 3.1. A gas mixture of 95% N2-5% CO2 was used to 
induce hypoxia. NE, norepinephrine; 5-HT, serotonin; V0 2, oxygen 
uptake; n, no. of hindlimb perfusions. 
65 
agonist (Figure 3.1). 
3.3.2 Oxygen-dependence. 
The effects of hypoxia, cyanide, and azide on hindlimb V0 2 and perfusion 
pressure under basal conditions are summarized in Table 3.1. Infusion of potassium 
cyanide (1 mM) almost totally inhibited V0 2, and sodium azide (1 mM) led to an 
increase in V02 consistent with partial uncoupling of oxidative phosphorylation. 
Gassing with 95% N2, 5% CO2 decreased P02 levels almost to zero. No significant 
effect on basal perfusion pressure was observed for any of these treatments. 
Table 3.2 shows the effects of hypoxia, cyanide, and azide on -NE- and 5-HT-
mediated changes in pressure and V02 . Whereas the vasoconstrictor effect of 50 nM 
NE were almost totally opposed (approximately 95%) by each of these treatments, 
0.25 OA 5-HT was able to maintain constriction without being significantly affected 
(Table 3.2). Addition of agonists in the presence of cyanide or hypoxia had no effect 
on V02. In the presence of azide, NE increased V0 2 by only a marginal amount (4.0 ± 
1.1 %; ii = 5) and 5-HT decreased V02 by 30.0 ± 2.5 % (n = 5) from 11.0 ± 0.3 to 
7.7 ± 0.4 l_tmol.h-1 .g-1 , an effect of approximately the same proportion as that seen 
when azide was absent. 
3.3.2.1 Dose-dependent effects of NE. 
Hypoxia, cyanide and azide abolished NE-mediated effects at concentrations 
below 50 nM. At higher concentrations (50 nM-1 iiM), a dose-dependent increase in 
pressure occurred (Figure 3.2). Under hypoxic conditions the constriction induced by 
1 1AM NE was markedly inhibited (76 ± 3%, n = 5) by ketanserin (0.1 IAM) (data not 
shown) and almost totally inhibited by prazosin (50 nM) (91 ± 2%, n = 3; Figure 3.3). 
Similar results were obtained in the presence of cyanide (data not shown). 
When hindlimbs were perfused with medium equilibrated against 95% 02- 
5% CO2, the vasoconstriction induced by 50 nM NE and by 0.25 Al 5-HT was 
inhibited by 14 ± 4% (n = 3) and 100% (n = 3) respectively upon infusion of 0.1 
ketanserin. Addition of 25 nM prazosin totally blocked all NE-induced responses but 
presumably had no effect on 5-HT-mediated vasoconstriction at this low dose (1 1AM 
prazosin had no effect, Chapter 2, Figure 2.5). 
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Figure 3.1 	Effects of hypoxia, cyanide, and azide on NE- and 5-HT-mediated 
changes in hindlimb venous P02 and perfusion pressure. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min-1 with perfusion medium containing 2% bovine serum albumin. 50 
TIM NE and 0.25 jtM 5-HT were infused for 15 mm under each condition. 
Perfusion medium, initially equilibrated against 95% 02-5% CO 2, was either 
maintained (A, C, and D) or switched to one equilibrated against 95% N2-5% 
CO2 (B), as shown. Other additions were 1 mM potassium cyanide (C) or 1 
mM sodium azide (D). Representative traces are shown, and mean values from 
all experiments are given in Table 3.2. NE, norepinephrine; 5-HT, serotonin. 
From Dora et al. (1992). 
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Figure 3.2 	Effect of hypoxia, cyanide and azide on dose-response curve for 
NE on hindlimb perfusion pressure. 
Hindlimbs from 180-200 g rats were perfiised at 25°C and a constant flow rate 
of 4 ml.min-1 with perfusion medium containing 2% bovine serum albumin. 
Perfusion media for hindlimbs were equilibrated against 95% N 2-5% CO2 (•); 
or against 95% 02-5% CO 2 in the absence (0) or presence of 1 mM potassium 
cyanide (A) or 1 mM sodium azide (•). For each treatment, basal perfusion 
pressures and oxygen tensions are given in Table 3.1. Values are means ± SE 
for a minimum of 3 perfusions; when not visible, error bars are within symbol. 
NE, norepinephrine. 
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Figure 3.3 Dose-response curves for prazosin against NE on hindlimb 
perfusion pressure under hypoxic conditions. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min-1 with perfusion medium containing 2% bovine serum albumin and 
equilibrated against 95% N 2-5% CO2. Mean basal perfusion pressure was 20.3 
± 0.3 mmHg, and oxygen tensions were 24.3 ± 6.2 mmHg (arterial) and 0.5 ± 
0.4 mmHg (venous). Values are means ± SE for 3 hindlimbs; when not visible, 
error bars are within symbols. Prazosin was infused in the presence of 1 1.1M 
NE. NE, norepinephrine. 
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3.3.3 Carbohydrate-dependence. 
The presence of glycogen stores in both skeletal and smooth muscle cells 
complicated the determination of carbohydrate-dependence of agonist-induced 
vasoconstriction. It was considered that elimination of glucose from the perfusion 
medium and exposure to cyanide would markedly deplete smooth muscle glycogen 
stores in a manner analogous to Furchgott (1966), who found glycogen stores of 
rabbit aorta were largely depleted by exposure to anoxia in the absence of glucose for 
about 1 hour. Under these conditions the transient nature of vasoconstriction by 5- 
HT suggested that at least those smooth muscle cells with 5-HT 2 receptors became 
glycogen-depleted and thus carbohydrate-free. The reversible nature of cyanide-
induced inhibition of V0 2 then allowed determination of the carbohydrate-dependence 
of vasoconstriction. 
Removal of glucose from the perfusion medium had no significant effect on 
basal hindlimb V0 2, lactate release or perfusion pressure. In addition the responses to 
50 nM NE and 0.25 1AM 5-HT for the 15-min period of infusion were not affected 
(data not shown). However, when cyanide (1 inM) was present and glucose was 
omitted, it was noted that 5-HT (0.25 1.1M) was no longer able to mediate a constant 
vasoconstrictive effect; rather, a transient increase in perfusion pressure was followed 
by a gradual return to basal pressure (Figure 3.4). During the period of 5-HT-
mediated increased perfusion pressure in the presence of cyanide, hindlimb lactate 
efflux increased markedly from a basal value of 10.8 ± 0.3 to a peak value of 24.3 ± 
1.6 jimol.h 1 .g 1 corresponding to the peak in perfusion pressure, and then decreased 
to basal within 2 min. The average pressure peak for 5-HT in the presence of cyanide 
and the absence of glucose was 61.1 ± 3.5 mmHg, representing an increase of 28.8 ± 
2.5 mmHg (n = 4). The period during which constriction could be maintained during 
these conditions was surprisingly constant (24.5 ± 2.5 min; n = 4). In some of these 
experiments, muscle rigor became apparent and pressure steadily increased despite 
removal of agonist; thus cessation of constriction was less readily discernible. 
On those occasions when muscle rigor was not observed, it was found that 
the cyanide effects on V02 were reversible (Figure 3.4). 30 min after cyanide 
removal, V02 was 7.0 ± 0.4 lAmol.h4 .g-1 (n = 6). Under these conditions and still in 
the absence of glucose, 0.25 JAM 5-HT-mediated effects were of the same magnitude 
as that observed when glucose was present (Figure 3.5). However, the effects of 50 
nM NE on perfusion pressure and lactate efflux were significantly reduced (Figure 
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Figure 3.4 Effect of glucose-free perfusion medium on the hindlimb response 
to a representative dose of 5-HT in the absence and presence of 
cyanide. 
Representative traces for venous P0 2 and perfusion pressure are given for 
hindlimbs (n = 3) perfused at 4 ml.min -1 with glucose-free medium equilibrated 
against 95% 02-5% CO 2 . 5-HT (0.25 pM) was infused before, during and 
after treatment with potassium cyanide (1 mM). 
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Figure 3.5 Carbohydrate-dependence of the hindlimb response to NE and 
5-HT. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min-1 with perfusion medium containing 2% bovine serum albumin. 
V02, perfusion pressure and lactate release were monitored in the presence of 
glucose (M) and absence of glucose and marked depletion of smooth muscle 
glycogen stores (M, glycogen-depletion method described in Section 3.3.3). 
Mean basal V02, lactate release and perfusion pressure were 6.7 ± 0.4 
1 .g4 , 7.8 ± 0.8 i_tmol.h-1 .g-1 and 21.6 ± 0.6 mmHg (n = 6) respectively in the 
presence of glucose, and 7.0 ± 0.4 gmol.h- 1 .g- 1 , 7.4 ± 0.5 pinol.h- 1 .8- 1 and 23.5 
± 0.8 mmHg (n = 6) respectively when carbohydrate was markedly reduced. 
Values obtained after 10 min of 50 nM NE or 0.25 iiM 5-HT infusion (n = 3) 
are expressed as means ± SE. N.D., not determined; NE, norepinephrine; 5-HT, 
serotonin; V02, oxygen uptake. 
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3.5). Subsequent reintroduction of glucose to the medium increased the NE response 
towards that observed in the presence of oxygen and glucose (change in perfusion 
pressure of 16.5 ± 1.5 mmHg, n= 2). 
3.4 	Discussion. 
The main observation from this study was that hindlimb vasoconstriction 
induced by the agonists NE and 5-HT was affected differently when either coupled 
oxidative phosphorylation was interrupted or when smooth muscle carbohydrate 
levels were markedly reduced. Whereas 0.25 p.M 5-HT-induced vasoconstriction was 
not significantly affected by hypoxia, addition of cyanide, azide, or reduction of 
available carbohydrate, vasoconstriction produced by 50 nM NE was almost totally 
opposed by these perturbations. In addition, at higher doses of NE, 5-HT-like effects 
were observed. 
Overall, these findings suggest that there is a biochemical heterogeneity of 
smooth muscle in vessels supplying hindlimb tissue. Vascular smooth muscle 
stimulated to constrict by 5-HT or high doses of NE, appears capable of either 
aerobic or anaerobic metabolism, depending on the supply of fuels, and becomes 
dependent on exogenous glucose to maintain energy requirements for 
vasoconstriction when glycogen reserves presumably become exhausted and oxidative 
phosphorylation is inhibited. In contrast, vessels stimulated by lower doses of NE 
appear to be totally dependent on oxidative metabolism and are also partially 
dependent on glycolytic activity. In general, the data do not appear to be consistent 
with the proposal (Paul et al., 1979) that metabolism in vascular smooth muscle 
(coronary artery) is functionally compartmentalized, with suprabasal oxidative 
metabolism associated primarily with the energy requirements of the actin-myosin 
ATPase and aerobic glycolysis linked to the energy requirements of membrane-related 
processes. This may, of course, be related to the size of vessel Paul et al. (1979) used 
in their studies. 
The differential ability of various smooth muscle preparations to respond to 
vasoconstricting agents under hypoxic conditions has been observed previously. The 
major determinants appear to be anatomical location and vessel wall thickness. For 
example, most (Altura & Altura, 1976; De Mey & Vanhoutte, 1983; Shibata & 
Briggs, 1967) but not all (Coburn et al., 1979; Pittman & Duling, 1973) early studies 
on larger arterial segments demonstrated that high doses of both epinephrine and NE 
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could induce vasoconstriction under hypoxic and anoxic conditions. This was shown 
to be glucose-dependent (Altura & Altura, 1976; De Mey & Vanhoutte, 1983; 
Shibata & Briggs, 1967). At more physiological doses, both NE and epinephrine 
constricted to between 10 and 30% of the normoxic response, and there was a dose 
curve shift to the right (Detar & Bohr, 1968; Hellstrand et al., 1977). Anoxic 
conditions have been reported to either augment (van Nueten & Vanhoutte, 1980) or 
attenuate (Nair & Dyer, 1972; Schmidt et cd., 1990) 5-HT-induced vasoconstriction. 
Similarly, when oxygen was present but carbohydrate reduced, generally only 
slightly attenuated (Furchgott, 1966; Coe et al, 1968), although sometimes markedly 
attenuated (Altura & Altura, 1970; Adams & Dillon, 1989) NE- or epinephrine-
induced vasoconstriction was observed. In the present study, the ability of NE to 
stimulate vasoconstriction in the absence of glucose in the perfusion medium, but not 
when the glycogen stores were partially depleted, is consistent with studies showing 
glycogen was utilized as the primary oxidative substrate during active tension 
generation (Lynch & Paul, 1983, 1987), and activity of glycogen debrancher enzyme 
limited glycogen utilization (Lynch et al., 1989) in partially glycogen-depleted NE-
stimulated vessels. However, the ability of 5-HT to maintain vasoconstriction even in 
carbohydrate-depleted conditions is consistent with the findings of Lynch et al. (1989) 
with KCI in the carotid artery. Thus the data presented here provides further evidence 
supporting the heterogeneity of blood vessel metabolism. 
Glycolytic capacity is also determined by vessel wall thickness. Diffusion of 
oxygen through the layers of smooth muscle is predicted to decrease with increases in 
number of layers (Pittman & Duling, 1973), and, depending on the density and 
distribution of vasa vasorum, the more distal layers may need larger supplies of 
anaerobic substrates such as glycogen to maintain energy requirements. In general, 
smaller vessels dilate more readily in response to low oxygen concentrations than 
larger arteries (Carrier et al., 1964; Duling, 1972; Harris, 1976). This may imply that 
the metabolic requirement for oxygen is more acutely developed and that glycogen 
stores are lower in smaller vessels, which are unable to hold pressure unless oxygen is 
present. Alternatively, hypoxia may have no direct dilating effect on small vessels but 
rather may cause an imbalance between local relaxing and constricting factors. 
The apparent difference in oxygen and carbohydrate dependency between 
sites of constriction may suggest that NE normally acts at sites further down the 
arterial tree than does 5-HT. Work by others has found that 5-HT generally 
constricts larger arteries (Blackshear et al., 1985; Hollenberg, 1989; Lamping et aL, 
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1989; Alsip & Harris, 1991) and the sensitivity to NE, at least on the abluminal 
surface of vessels, decreases with increasing arteriolar size (Gray, 1971). Increases in 
pressure due to low doses of NE are associated with increased V0 2 (Grubb & Folk, 
1976; Richter etal., 1982; Cote et al., 1985; Colquhoun et al., 1988) and are blocked 
by nitroprusside (Colquhoun et al., 1990) and prazosin (see Section 2.3.1), and 
therefore the sites are likely to be aradrenergic and located on smaller vessels. At 
high doses of NE, vasoconstriction appears to be mediated at another group of 
adrenergic sites that also are blocked by prazosin. These represent a subgroup of a i -
adrenoceptor (AR) sites that have a relatively low affinity for NE, a high affinity for 
ketanserin, and, like 5-HT sites, are located on larger vessels. Alternatively, the 
receptors stimulated by only high doses of NE may be located abluminally, the 
endothelial cell layer of arterioles forming a diffusion barrier (Lew et al., 1989). 
5-HT-mediated vasoconstriction appears to result in an inhibition of hindlimb 
V02 due to shunting of perfusate away from microvascular elements involved in 
thermogenesis (Dora et al., 1991) without opening direct arteriovenous shunts (see 
Section 7.3.3). Supporting evidence that 5-HT acts at sites on larger arteries to 
induce vascular shunting of flow also comes from experiments in this study in which 
azide was used to uncouple, in part, oxidative phosphorylation. V0 2 was increased 
by azide, but 5-HT-induced vasoconstriction was not significantly different from 
control, and the percentage decrease in V0 2 due to 5-HT action was similar in 
magnitude to that when 5-HT was used alone (Table 3.2). 
The ability to induce site-selective vasoconstriction may play an important 
physiological role. For example, systemic hypoxia has been shown to increase blood 
flow to canine femoral artery dramatically, although flow was diverted through high-
flow non-nutritive shunts, resulting in a reduction in overall capillary flow but 
maintenance of tissue oxygenation (Harrison et al., 1990b). In rat spinotrapezius 
muscle, the locus of vasomotion during systemic hypoxia changes from the small 
arterioles (A4) to the transverse arterioles (A3, Bertuglia et al., 1991; see Chapter 8, 
Figure 8.1 for arterial branching nomenclature). The increase in tone has been 
predominantly attributed to sympathetic nerve a l -AR stimulation (Mian & Marshall, 
1991b), suggesting a role for the increase in nerve density at the transverse arteriole 
roots (Saltzman et al., 1992). Another function for site-selective vasoconstriction 
might be in situations of trauma, in which involvement of 5-HT is likely but not 
established, and acute haemorrhage (reviewed by Lewis & Post, 1982). However, 
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under these conditions, plasma levels of 5-HT are lower than normal, probably the 
result of uptake by circulating platelets and endothelial cells, particularly in the 
pulmonary artery (Bhat & Block, 1990). If a role for 5-HT-mediated site-selective 
vasoconstriction exists, it should be important to note that synergism between 5-HT 
and NE is likely because low levels of 5-HT can amplify the vasoconstrictor effects of 
NE, such as in the femoral artery (van Nueten & Janssens, 1989). 
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CHAPTER 4 
Sub-classification of al-AR- and 5-HT-receptor stimulation. 
4.1 	Introduction. 
Infusion of norepinephrine (NE) into the constant-flow perfused rat hindlimb 
at 25°C stimulated an increase in oxygen uptake (V0 2) and lactate release in 
association with vasoconstriction over the dose range 1-250 nM (Chapter 3). At 
higher doses the increases in metabolism were inhibited to levels below basal despite 
further rises in pressure. The responses to NE were totally blocked by the a l -
adrenoceptor (AR) antagonist prazosin, and only slightly augmented by the 13-AR 
antagonist propranolol (Section 2.3.1). 
The ability of NE to stimulate prazosin-sensitive responses that were 
independent of oxidative-metabolism at high doses, but not at low doses, suggested 
the presence of different a l -AR subtypes in the hindlimb (Dora et al., 1992, Chapter 
3). Thus since it was possible that two subgroups of a l -AR were controlling 
hindlimb metabolism by opposing mechanisms, it was considered of interest to further 
characterize the subgroups involved. Recently, rat a 1 -ARs have been classified into 
subtypes according to their extracellular Ca 2+-dependence during vasoconstriction 
(Han et al., 1987), and by use of selective a l -AR antagonists (Han & Minneman, 
1991; Ruffolo etal., 1991). 
a LA-AR stimulation is coupled to a pertussis toxin-sensitive G-protein 
(Gilman, 1987) which causes an influx of Ca2+ through receptor-operated Ca 2+- 
channels (Figure 4.1). In various preparations it has been observed that 5-methyl 
urapidil (5-MU) has a high affinity for a iA-ARs (Han & Minneman, 1991). 
a n3-AR stimulation is coupled to a pertussis toxin-insensitive G-protein 
(Gilman, 1987). Subsequent activation of phospholipase C and formation of inositol 
triphosphate (IP3) signals the mobilization of intracellularly-bound calcium (Berridge 
& Irvine, 1984; Figure 4.1). Hence am-AR stimulated constriction was independent 
of extracellular Ca2+ (Han et al., 1987). Chloroethylclonidine (CEC) has high affinity 
for a ig-ARs (Han & Minneman, 1991). There is growing pharmacological and 
structural evidence, however, for intra- and inter-species subdivision of ARs 
(reviewed in Ruffolo etal., 1991). 
A B 
Figure 4.1 	Receptor-mediated events leading to vasoconstriction in vascular 
smooth muscle. 
I: cciA-AR coupled to a pertussis toxin sensitive G-protein with high affinity 
for low doses of NE, prazosin and 5-MU. 
II: am-AR or 5-HT2A-receptor coupled to a pertussis toxin insensitive G-
protein with high affinity for either high doses of NE and CEC or 5-HT and 
LY 53,857, respectively. 
A: Voltage-gated Ca2÷-channe1 stimulated by 5-HI 1 -like receptor agonists. 
B: Receptor-operated Ca 2+-channel. 
C: Ca2+-channel stimulated by rises in intracellular Ca2+. 
AR, adrenoceptor; NE, norepinephrine; 5-HT, serotonin; 5-MU, 5-methyl 
urapidil; CEC, chloroethylclonidine; 1133, inositol 1,4,5-triphosphate; DAG, 1,2- 
diacylglycerol; G, G-protein; SR, sarcoplasmic reticulum. 
Modified and extended from Suzuki et aL (1990). 
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Smooth muscle 5-H1-'2A receptor stimulation has been linked to generation of 
IP3 and subsequent Ca2+ release from internal stores (Doyle et al., 1986) in a manner 
similar to am-AR-mediated release. Recently the constrictor response to 5-HT has 
been attributed to stimulation of two separate receptors in isolated dog saphenous 
vein (Sumner et aL, 1992). 5-HT 1 -like, but not 5-HT2A-, receptor stimulation 
appears dependent on extracellular Ca2+ for vasoconstriction, and thus the two 
receptor subtypes may be classified according to their extracellular Ca2+-dependence 
in a manner similar to the a 1 -ARs. 
In this study, the extracellular Ca2+-dependence of NE- and 5-HT-induced 
effects were determined in the rat hindlimb. In addition, selective a l -AR antagonists 
were employed to further characterize the NE-mediated responses. 
4.2 	Materials and methods. 
4.2.1 	Perfused hindlimbs. 
Surgery was performed on 180-200 g rats as outlined in Section 2.2.2. 
Experiments were performed at 25°C and 4.1 ± 0.1 ml.min -1 with 2% bovine serum 
albumin (BSA) added to the perfusion medium. Additional details are given in 
Sections 2.2.3-2.2.6. 
4.2.1.1 	Modification of extracellular [Ca2+]. 
In some experiments the Ca2+ concentration was manipulated by adding 
ethyleneglycol-bis-(b-aminoethyl ether) N,N,N',N-tetraacetic acid (EGTA) and/or less 
Ca2+ to the perfusion medium. Perfusions were performed using medium containing 
1.27 mM Ca2+ and 1.27 mM EGTA, 0.1 mM Ca2+, or no added Ca2+ and 0.1 mM 
EGTA. When equimolar Ca2+ and EGTA were added to the perfusion medium at 
25°C the free [Ca2+] was 3.0 ± 0.1 1AM (n = 4), measured with a Selectrode Ca2+ 
electrode (Denmark) and TPS Programmable Ion Analyser (Australia). 
Hindlimbs were allowed to equilibrate with medium containing 1.27 mM 
Ca2+ for 30 min. Perfusion medium with altered Ca 2+ concentrations were then 
introduced and due to the resulting transient increase in perfusion pressure (Table 
4.1), equilibration under these Ca2+-manipu1ated conditions continued for at least a 
further 60 min. 
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Most perfusions were performed in the presence of 10 1.1.M (±)-propranolol. 
Antagonists, except CEC, were infused throughout the experiments and were allowed 
to equilibrate for at least 20 min prior to infusion of NE. CEC is an alkylating agent 
which interacts in an apparent irreversible fashion. CEC was infused for 20 min three 
times (10 min between each addition) then removed before NE addition, according to 
the method described by Suzuki et aL (1990). In prior experiments, increasing the 
repeated infusions of CEC did not further attenuate the response to NE. It was also 
noted that part of the CEC response was reversible as despite repeated CEC 
pretreatment, infusion of CEC in the presence of NE slightly (< 10%) attenuated the 
NE-mediated response. However, to remain consistent with literature methods 
(Suzuki et al., 1990; Han & Minneman, 1991; Piascik et al., 1991; Oriowo et al., 
1992; Oriowo & Ruffolo, 1992), CEC was not infused in the presence of NE. 
4.2.2 Statistical analysis. 
The statistical significance of differences between groups of data were 
assessed by the unpaired, two-tailed Student's t test. Significant differences were 
recognized at P < 0.05. 
4.3 	Results. 
Under basal conditions and in the presence of 1.27 mM Ca2+ in the medium, 
mean arterial and venous P02 were 670.8 ± 5.2 and 363.7 ± 10.2 mmHg, respectively 
(ii = 47) with a V02 of 7.1 ± 0.2 1.tmol.114 .g-1 , and perfusion pressure was 21.6 ± 0.5 
mmHg (n = 47). 
The transition from 1.27 mM to the lower [Cal] caused a transient spike in 
perfusion pressure which returned to basal within 40 min in each perfusion (Table 
4.1). The size of the pressure peak was less when medium containing 0.1 mM Ca 2+ 
was added, but not significantly different to the peak observed with the other Ca 2+ 
perturbations (one-way analysis of variance). Once perfusion pressure had returned 
to basal, there was no significant difference between basal perfusion pressure between 
Ca2+ perturbations (Table 4.1). 
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[Ca21* 
OnND 
Perfusion Pressure 
(mmHg) 
VO2 
(lAmol.h-1 .g.1 ) n 
Peak 	Basal 	Basal 	Change 
1.27 	 21.6 ± 0.5 	7.1 ± 0.2 	 47 
0.10 	35.0 ± 2.6 	24.0 ± 1.7 	6.4 ± 0.3 	-1.3 ± 0.8 	3 
0.003 	52.0 ± 4.3 	25.5 ± 1.3 	7.0 ± 0.4 	-1.8 ± 0.7 	4 
Ca2+-free 	48.0 ± 2.7 	20.6 ± 0.3 	6.8 ± 0.2 	-0.8 ± 0.2 	15 
Table 4.1 	Effect of perfusion medium Ca 2+ perturbations on basal hindlimb 
conditions. 
Ca2+ with or without EGTA was added to the medium as described in the 
Methods. V02, oxygen uptake, values obtained at steady state; n, no. 
hindlimb perfusions. 
*, nominal extracellular [Ca21. 
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4.3.1 	NE-mediated effects. 
Vasoconstriction stimulated by NE dose-dependently increased perfusion 
pressure but had a biphasic V02 response in the rat hindlimb (Figure 4.2, described in 
detail in Chapter 2). Vasoconstriction stimulated by low doses of NE was associated 
with increases in VO2 (< 0.25 p.M) and higher doses of NE began to inhibit the 
increase in V02 towards basal (Figure 4.2). In some perfusions (Figures 4.3-4.5) 
propranolol was present in the perfusion buffer to inhibit 0-AR-mediated 
vasodilatation (Chapter 2, Figure 2.10). 
4.3.1.1 	Perfusion medium Ca2+ perturbations. 
Each reduction in extracellular [Ca2+] progressively shifted the NE dose-
response curve to the right and attenuated the maximum rise in perfusion pressure 
(Figure 4.2). Decreasing [Ca2 ] selectively attenuated the component of NE-
mediated vasoconstriction associated with increases in V0 2 . When Ca2+ was 
eliminated from the perfusion medium, the NE-induced dose-dependent increases in 
perfusion pressure were immediately associated with decreases in V0 2 (Figure 4.5). 
The maximal dose of NE (25 pM) increased perfusion pressure by 16.3 ± 1.8 mmHg 
and inhibited V02 by 3.1 ± 0.7 prnol.h - '.g' (n = 3). 
4.3.1.2 	Effects of a1-AR antagonists on the response to NE in the presence of 
extracellular Ca2+ 
Both 5-MU and CEC shifted the NE pressure response curve to the right and 
reduced the maximum pressure obtained (Figure 4.3). CEC (10 pM) shifted the NE 
V02 response curve to the right without affecting the maximum V0 2, yet the 
inhibitory effect of NE on VO2 was still observed. 5-MU (0.25 p.M) shifted the NE 
V02 response to the right, but only stimulation of V0 2 was observed. The maximum 
V02 was not altered, and increasing the NE dose did not lead to inhibition of V0 2 . 
Higher doses of CEC (100 p.M) and 5-MU (1 pM) began to reduce the maximum 
V02 (and pressure) response to NE (data not shown). 
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Figure 4.2 	Effect of varying the extracellular [Ca 2+1 on the response to NE on 
hindlimb V02 and perfusion pressure. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.rnin-1 with 1.27 mM Ca2+ (0), 0.1 mM Ca2+ (h), 1.27 rnM Ca2+ and 
1.27 rnM EGTA (0), or no Ca2+ plus 0.1 mM EGTA (0) added to the 
perfusion medium. Values are means ± SE of at least 3 hindlimbs for each Ca 2+ 
perturbation. When not visible, error bars are within symbols. NE, 
norepinephrine; V02, oxygen uptake. 
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Figure 4.3 Effect of al-AR antagonists on the dose-response curves for NE on 
hindlimb V02 and perfusion pressure in the presence of 
extracellular Ca2+. 
Hindlimbs were perfused as described in Figure 4.2 with medium containing 
1.27 mM Ca2+ and 10 1.1.M (±)-propranolol. NE was infused in the absence (0) 
and presence of 0.25 piM 5-MU (A) or 10 IiM CEC (•). Values are means ± 
SE of at least 3 hindlimbs for each treatment. When not visible, error bars are 
within symbols. AR, adrenoceptor; V02, oxygen uptake; NE, norepinephrine; 
CEC, chloroethylclonidine; 5-MU, 5-methyl urapidil. 
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Although both 5-MU and CEC reduced the magnitude of NE-mediated 
changes in pressure and V02, the relationship between the change in V02 and 
perfusion pressure was not affected, and interestingly fitted the same curve (Figure 
4.5). 
4.3.1.3 	Effects of a1-AR antagonists on the NE response in the absence of 
extracellular Ca2+ 
After equilibration in Ca2+-free conditions, hindlimbs were treated with the 
same doses of antagonists in the same manner as when Ca 2+ was present. Both CEC 
(10 p.M) and 5-MU (0.25 p.M) almost totally opposed the NE-mediated response 
(Figure 4.4). 
4.3.2 	5-HT-mediated effects. 
Vasoconstriction stimulated by 5-HT dose-dependently directly inhibited 
V02 in the rat hindlimb (Figure 4.6, and Chapter 2). 
4.3.2.1 	Perfusion medium Ca2+ perturbations. 
When the perfusion medium [Ca2+] was reduced, the V02 and pressure 
response to 0.25 p.M 5-HT was slightly augmented when 0.1 mM Ca 2+ was added to 
the medium, but generally not affected (Table 4.2). In Ca2+-free perfusions, however, 
5-HT mediated rises in perfusion pressure were attenuated without affecting the 
decrease in V02 (Figure 4.6). 
4.3.3 	Additivity of NE- and 5-HT-mediated effects. 
In extracellular Ca2+-free perfusions, both NE and 5-HT dose-response 
curves reached maximal values (Figures 4.4 & 4.6). When infused separately, 25 p.M 
NE and 5 pM 5-HT induced similar maximal rises in perfusion pressure and inhibition 
of V02. The maximal additive increases in perfusion pressure were 16.3 ± 4.0 mmHg 
and decreases in V02 were 4.0 ± 0.6 pmo1.11-1 .8-1 (n = 4), and were independent of 
agonist infusion order (Figure 4.7). These preliminary results suggest the NE and 
5-HT responses were only partially additive, and warrant further investigation. 
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[ca2+]* 	 A 902 	A Perfusion Pressure 	n 
(111M) (J2mol.h-1 .g- 1 ) (mmHg) 
1.27 	 -1.5 ± 0.2 	 26.1 ± 3.2 	8 
0.10 	 -1.9 ± 0.3 	 37.8 ± 2.64 	3 
0.003 	 -1.6 ± 1.2 	 26.9 ± 7.3 	3 
Ca2+-free 	 -1.4 ± 0.2 	 7.8 ± 0.84 	6 
Table 4.2 	Effect of perfusion medium Ca 2+ perturbations on the hindlimb 
response to 5-HT. 
Rat hindlimbs were perfused at a constant flow rate of 4 ml.min -1 with 
varying amounts of Ca2+ added to the perfusion medium as described in 
Table 4.1. Values for changes above basal mediated by 0.25 uM 5-HT 
are means ± SE. V02, oxygen uptake; 5-HT, serotonin; n, no. of hindlimb 
perfiisions; *, nominal extracellular [Ca2 ]; 4 , significantly different (P < 
0.05) from response with 1.27 mM Ca 2+, unpaired Students t test. 
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Figure 4.4 	Effect of a l-AR antagonists on the dose-response curves for NE on 
hindlimb VO2 and perfusion pressure in the absence of 
extracellular Ca2+. 
Hindlimbs were perfused as described in Figure 4.2 with Ca2+-free medium 
containing 0.1 mM EGTA and 10 .i.N4 (±)-propranolol. NE was infused in the 
absence (•) and presence of 5-MU (A, 0.25 i.tM) or CEC (•, 10 IA). Values 
are means ± SE of at least 3 hindlimbs for each treatment. When not visible, 
error bars are within symbols. AR, adrenoceptor; V02, oxygen uptake; NE, 
norepinephrine; CEC, chloroethylclonidine; 5-MU, 5-methyl urapidil. 
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Figure 4.5 Dose-dependent effects of NE on changes in hindlimb V0 2 versus 
changes in perfusion pressure. 
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Hindlimbs were perfused as described in Figure 4.2 in the absence (upper panel, 
data from Figure 4.2) or presence (lower panel, data from Figure 4.3) of 10 4M 
(±)-propranolol. The upper panel shows the NE dose-response curves when 
perfusion medium [Ca21 was varied by adding 1.27 mM Ca 2+ (0), 0.1 mM 
Ca2+ (A), 1.27 mM Ca2+ and 1.27 inM EGTA (0), or no Ca2+ and 0.1 mM 
EGTA (0) to the perfusion medium. The lower panel shows the NE dose-
response curves in the absence (0) and presence of the selective oc i -AR 
antagonists 5-MU (A, 0.25 iiM) or CEC (•, 10 1AM). Values are means ± SE 
of at least 3 hindlimbs for each treatment. When not visible, error bars are 
within symbols. AR, adrenoceptor; V02 , oxygen uptake; NE, norepinephrine; 
CEC, chloroethylclonidine; 5-MU, 5-methyl urapidil. 
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Figure 4.6 Effect of removing extracellular Ca 2+ on the response to 5-HT on 
hindlimb V02 and perfusion pressure. 
Hindlimbs were perfused as described in Figure 4.2 with 1.27 mM Ca2+ (0) or 
no Ca2+ and 0.1 mM EGTA (•) added to the perfusion medium. Values are 
means ± SE of at least 3 hindlimbs for each [Ca21. When not visible, error bars 
are within symbols. V02, oxygen uptake; 5-HT, serotonin. 
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Figure 4.7 Additivity of maximal NE and 5-HT responses on hindlimb V02 
and perfusion pressure in the absence of extracellular Ca 2+. 
Hindlimbs were perfused as described in Figure 4.2 with no Ca 2+ and 0.1 mM 
EGTA added to the perfusion medium. Basal V02 was 7.6 ± 0.7 gmol.h -1 .g-1 
and perfusion pressure 22.3 ± 0.8 mmHg. When infused separately, maximal 
doses of NE (25 1AM) and 5-HT (5 1AM) stimulated similar rises in perfusion 
pressure and decreases in V02; (Figures 4.4 and 4.6). When infused in the 
presence of each other, agonist infusion orders were either: (A) a maximal dose 
of NE (E) followed by a maximal dose of 5-HT (M) (n = 2); or (B) a maximal 
dose of 5-HT followed by a maximal dose of NE (n =2). Values are presented 
as a proportion of the total combined response with two hindlimbs for each 
treatment sequence. The total responses on V0 2 and perfusion pressure were - 
4.5 ± 1.3 and -3.4 ± 0.2 pimol.h -1 .g-1 , and 20.8 ± 7.2 and 11.8 ± 1.8 mmHg, 
respectively, for NE added before and after 5-HT. NE, norepinephrine; 5-HT, 
serotonin; V02, oxygen uptake. 
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4.4 	Discussion. 
These experiments provide further evidence for the ability of vascular smooth 
muscle to respond differently to low doses of NE and 5-HT. It was demonstrated 
that removal of Ca2+ from the perfusion medium resulted in the abolition of the 
vasoconstriction and associated increase in V0 2 normally induced by NE at doses 
below 100 nM. 5-HT and doses of NE greater than 100 nM induced extracellular 
Ca2+-independent vasoconstriction which was markedly reduced in comparison to 
normal Ca2+ perfusions. Both the NE and 5-HT-induced vasoconstriction in the 
absence of extracellular Ca2+ was associated with decreases in V0 2 . 
It has previously been shown that the Ca2÷-channel antagonist nifedipine 
almost totally blocked the response to a low dose of NE in the constant-flow perfused 
rat hindlimb (Colquhoun et al., 1990). In this study Ca 2+ channel antagonists were 
not utilized due to the multiplicity of their effects, including blockade of a-ARs 
(reviewed in Smith, 1983). However, a disadvantage of removing perfusion medium 
Ca2+ was the possibility of internal Ca2+ store depletion. 11P 3 -signalled release of 
Ca2+ from the sarcoplasmic reticulum usually stimulates Ca 2+-influx and 
replenishment of internal Ca2+-stores (Putney, 1987). Problems associated with 
extracellular Ca2+-remova1 were demonstrated by Gouw et al. (1989) when the 
response to 5-HT in rat aorta was slightly attenuated by Ca2+-entry blocking agents, 
but markedly reduced in Ca2+-free medium. In Ca2+-free conditions internal Ca2+- 
stores were depleted and responses to agonists were time-dependent (Gouw et al., 
1989). This possibility of time dependency was not fully addressed in this study, 
although the responses to a maximal dose of 5-HT were maintained for a 60 min 
infusion period (data not shown), and dose-response curves for each agonist were 
usually completed within 60 min. 
The 5-HT-mediated rises in perfusion pressure were markedly attenuated in 
Ca2+-free medium, yet the decreases in V02 were only slightly affected. The partial 
dissociation of these two events suggests the attenuated pressure response is unlikely 
to be explained by depletion of Ca 2+-stores. It appears that the vasoconstriction 
directly associated with the inhibition of V0 2 was not affected, suggesting the 
mechanism for the inhibitory effect on V0 2 was controlled by and associated with 
small changes in perfusion pressure. The dilatation mediated by orphan 5-HT-
receptors (described in Chapter 2, Section 2.3.2) was not investigated in Ca 2±-free 
conditions, but it remains possible that both constriction and dilatation were 
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associated with the inhibition of V0 2. There is growing evidence for at least two 
5-HT receptors stimulating vasoconstriction in skeletal muscle (Alsip & Harris, 1991; 
Sumner et al., 1992). Evidence suggests that these receptors may be distinguished on 
their Ca2±-dependence for vasoconstriction. In dog saphenous vein, vasoconstriction 
mediated by stimulation with low doses of 5-HT, and stimulation of 5-H1' 1 -like 
receptors with the agonist sumatriptan was dependent on extracellular Ca 2+, whereas 
the response to higher doses of 5-HT was not (Sumner et aL, 1992). These workers 
suggested stimulation of 5-HT 1 -like receptors was associated with both an influx of 
Ca2+, predominantly via voltage-dependent channels, and an inhibition of adenylate 
cyclase (Sumner et al., 1992). The higher dose 5-HT response would presumably be 
due to stimulation of 5-HT2A-receptors coupled to 1P 3-formation and Ca2+-release 
from intracellular stores (Doyle et al., 1986). In this study it appears that stimulation 
of 5-HT2A, but not 5-HT 1 -like receptors leads to vasoconstriction associated with 
inhibition of VO2 . This possibility could be further investigated by infusion of 
sumatriptan into the hindlimb both in the presence and absence of extracellular Ca 2+. 
The NE-stimulated biphasic VO2 response could also be separated by use of 
Ca2+-free medium. Han et al. (1987), showed that stimulation of a iA-AR caused an 
influx of Ca2+ into cells via G-proteins coupled to receptor-operated Ca 2+ channels, 
whereas stimulation of a m-AR resulted in Ca2÷ release from the sarcoplasmic 
reticulum via IP 3 formation. In this study, their classification scheme suggests that 
the observed NE-stimulated vasoconstriction associated with increases and decreases 
in VO2 were due to a iA-AR- and a m-AR activation, respectively. 
Agonist-mediated vasoconstriction that was blocked by receptor-operated 
Ca2+-channel antagonists (eg. nifedipine) or may have been associated with 1P 3 -
induced intracellular Ca2+ release is consistent with pharmacomechanical coupling 
(see Chapter 1, Section 1.2.1.2.1 for a description of the forms of excitation-
contraction coupling). However in this study, IP3 generation was not determined, thus 
allowing the possibility of electromechanical coupling with high doses of NE and/or 5- 
HT. This raises the possibility that the different metabolic (Chapter 3) and Ca 2+- 
dependencies of vasoconstriction are due to the compartmentalization of vascular 
smooth muscle metabolism. Glycolytic metabolism has been shown to be associated 
with plasma membrane ion motion (Paul et al., 1979), and may provide energy for 
vasoconstriction stimulated via electromechanical coupling. Conversely, oxidative 
phosphorylation may supply energy during vasoconstriction stimulated via 
pharmacomechanical coupling. 
92 
There is accumulating evidence that classification of receptor subtypes solely 
according to extracellular Ca2+-dependence may not be justified, as there appear to be 
more than two a i-AR subtypes. Another approach to classify al-AR is use of 
selective c4-AR antagonists. 5-MU and CEC have been shown to relatively 
selectively antagonize a- and a m-AR, respectively, in rat tissues (Suzuki et al., 
1990; Han & Minneman, 1991). However, the results obtained in this study do not 
agree with the latter classification of a l -AR. Both 5-MU and CEC had some affinity 
for the receptor stimulated by lower doses of NE, as in their presence the NE dose-
response curves were shifted to the right. However the magnitude of the maximal 
increase in V02 and the association between changes in V02 and perfusion pressure 
remained unchanged (lower panel, Figure 4.5). A selective low-dose NE antagonist 
would be expected to alter this relationship in a manner similar to removal of 
extracellular Ca2+, where small rises in perfusion pressure led to direct inhibition of 
V02 (upper panel, Figure 4.5). Indeed, the results were opposite to expected in that 
5-MU, but not CEC, blocked the inhibitory effect of NE on V0 2 1 .. In addition, both 
5-MU and CEC inhibited the extracellular Ca 2+-independent vasoconstriction, despite 
earlier reports of 5-MU not interfering with NE-induced liP3 formation (Suzuki et al., 
1990). These preliminary results suggest 5-MU was inhibiting a non a iA-AR 
response according to the extracellular Ca 2+-dependency classification, and may 
represent a further subgroup of a 1 -ARs. 
Discrepancies in rat aorta al-AR sub-classification have been alluded to 
previously (Piascik et al., 1991; Oriowo & Ruffolo, 1992). Oriowo and Ruffolo 
(1992) concluded that CEC and WB 4101 were not sufficiently reliable tools for a 1- 
AR subclassification, and proposed another subclass of a i -AR in rat aorta. These 
authors also suggested a l -AR could not be classified according to extracellular Ca 2+- 
dependence as proposed by Minneman (1988), and indeed have long proposed that a 
1. 	The conflicting results with CEC in the presence and absence of Ca 2÷ in the 
perfusion medium may represent a dose problem. Perhaps a higher dose of CEC (10 
< [CEC] < 100 1AM) was required to block the inhibitory effect of NE on V02 
when Ca2+ was present in the medium, as was expected if CEC selectively blocked 
extracellular Ca2+-independent, a1B-AR-stimulation. Ideally, Schild plots should be 
generated to determine the relative affinity of al-antagonists for the stimulatory and 
inhibitory NE-mediated responses on V0 2. However the apparent problems of 
multiple receptor subtypes and the possible differences in receptor subtype population 
size would need to be addressed (methods reviewed by Kenalcin, 1987). 
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single a l-AR may activate two signal-transduction processes depending on the 
intrinsic efficacy of the agonist for the receptor (reviewed in Oriowo et al., 1992). 
This possibility would warrant future investigation by careful use of the partial al-AR 
agonist dobutamine and the irreversible c4-AR antagonist phenoxybenzamine as 
described by Oriowo etal. (1992). 
However, this latter possibility is partially resolved and may be fully resolved 
in the future by molecular biology techniques. There is emerging evidence for intra-
and inter-species heterogeneity of a 1 -ARs (Lomasney et al., 1991b; Schwinn et al., 
1990, 1991; reviewed by Lomasney et al., 1991a and Roth et al., 1991). Northern 
blot and in situ hybridization studies have shown that of the four cloned a1-ARs 
(a IA- , a1l3", aic- and am-AR) all except the a ic-AR are expressed in rat tissues, 
with the a 1A-AR (and possibly am-AR)  being expressed in skeletal muscle 
(Lomasney et al., 1990a; Perez et al., 1991). The apparently low levels of skeletal 
muscle a 1 -ARs may be explained by the observation that within skeletal muscle, cc i -
ARs are expressed predominantly on arterial blood vessels and not skeletal myocytes 
(Rattigan et al., 1986; Martin et al., 1990). This would make detection of small, 
discreet populations of a t -AR subtypes in skeletal muscle difficult, and thus 
pharamacological evidence should also be considered important. 
Clones for the various a 1 -ARs have been generated and expressed in cell 
lines to determine their respective signal-transduction pathways (reviewed by 
Lomasney et al., 1991a). It is already well accepted that certain domains within 
sequences are characteristic of receptor signalling. In am-AR the N-terminal portion 
of the third extracellular loop plays a major role in determining the selectivity of 
receptor-G protein coupling (Cotecchia et al., 1992). All three a l-AR subtypes are 
coupled to phospholipase C via a pertussis toxin-insensitive GTP-binding protein, 
leading to the release of Ca2+ from intracellular stores, although efficiency of coupling 
varies between subtypes (Schwinn etal., 1991). 
Despite the obvious differences in amino acid sequences between receptor 
subtypes, evidence is growing that a single receptor subtype can couple to multiple 
effector systems (Lomasney et al., 1991a), supporting the earlier work by Ruffolo and 
co-workers (reviewed in Oriowo et al., 1992). Insertion of the specific sequence 
conferring PI hydrolysis activity into the 132-AR resulted in a chimeric AR which 
could activate both PI hydrolysis and adenylate cyclase (Cotecchia etal., 1992). Thus 
direct comparisons can now be made between amino acid sequences which determine 
the selectivity of G protein coupling. However, expression would only be the first 
step and may not necessarily be of functional significance. If, for example, only one 
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c4-AR was expressed in rat hindlimb vasculature but had sequences for both signal 
transduction pathways, then it must be assumed that heterogeneity in second-
messenger-coupled processes, for example the presence of internal Ca2+-stores, 
account for the varied V02 responses. 
It has been previously reported that small, resistance vessels were dependent 
on Ca2+ influx during vasoconstriction whereas larger vessels were not. In constant-
flow perfused rat hindlimb the responsiveness of the microvasculature to NE indicated 
an increasing dependence on external Ca 2+ as vessel size decreased towards 
capillaries (Sutter et al., 1977). The NE-induced response in rabbit mesenteric 
resistance vessels was more sensitive to inhibitors of Ca2+ influx than the aorta 
(Cauvin & van Breeman, 1985; Cauvin et al., 1985). In addition, only high doses of 
NE could stimulate extracellular Ca2+-independent vasoconstriction in the aorta 
(Cauvin & Van Breeman, 1985; Cauvin et al., 1985). In canine femoral artery the 
NE-induced contractile response was inhibited 70% by removing Ca2+ from the 
bathing solution (Eskinder et al., 1989). In the same preparation, other workers 
(ICoga et al., 1989) reported that NE-induced vasoconstriction was prazosin-sensitive 
for all doses of NE in arteries, but only at high doses of NE in veins 2 .. Hynes and 
Duling (1991) ascribed the general dependency of small vessels on extracellular Ca2+ 
to the rapid depletion of internal Ca2±-stores in arterioles, at least partly due to the 
smaller proportion of sarcoplasmic reticulum per cell (Devine et al., 1972; Ashida et 
al., 1988), but also proposed smaller vessels had more active Ca 2+ influx and efflux 
mechanisms, thus being more dependent on extracellular Ca 2±. In their cheek pouch 
preparation (in which they studied 60-90 pm perfused arterioles) the vasoconstrictor 
response to the a i -AR agonist phenylephrine was abolished when the bathing solution 
[Cal] was reduced to 10 pM (Hynes & Duling, 1991). These authors also reported 
a heterogeneity in response of the arterioles, as those responding to only high doses of 
phenylephrine were less sensitive to removal of medium Ca2+. Thus it appears that a 
proportion of small vessels have greater than normal internal Ca 2+-stores. 
2. 	This raises the possibility that both high doses of NE and 5-HT also 
constricted veins. Many workers suggested veins were less extracellular Ca 2+- 
dependent for constriction than arteries (van Nueten & Vanhoutte, 1981). Sybertz et 
al. (1986) reported that rat hindlimb venous vasculature was more responsive to NE 
in Ca2+-free perfusion than arterial vasculature. Using the present hindlimb perfusion 
method, it was not possible to assess venous constriction in this study. 
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The ability to categorize the V02 effects according to extracellular Ca 2+- 
dependence provides further evidence that the low doses of NE were stimulating 
blood vessels metabolically distinct from those stimulated by high doses of NE and 
5-HT. It was previously reported that the responses to these hormones could be 
separated when coupled mitochondrial oxidative phosphorylation was interrupted 
(Dora etal., 1992, Chapter 3). Low doses of NE were totally dependent on oxidative 
metabolism whereas doses of NE greater than 50 nM, and all doses of 5-HT, were 
capable of anaerobic vasoconstriction. The results obtained here are consistent with 
the proposal that the thermogenic, low-dose (high-affinity) response to NE was due 
to constriction of extracellular Ca2±-dependent resistance arterioles within the skeletal 
muscle microcirculation (Gray, 1971; Sutter et al., 1977), whereas 5-HT was 
constricting larger blood vessels (Alsip & Harris, 1991; Sumner et al., 1992) and 
causing a redistribution of flow such that thermogenic regions within the hindlimb 
received less flow (Dora et al., 1991, 1992). Since high doses of NE caused an 
inhibition of V02 in the absence of extracellular Ca2+, it seems likely that the 
constriction sites for NE were also on larger blood vessels (Sutter et al., 1977). The 
possibility that both NE and 5-HT stimulated vasoconstriction at the same anatomical 
location was partially addressed by examination of the additivity of effects in Ca 2+- 
free conditions. From the preliminary studies it appeared that the vasoconstriction 
induced by the two hormones were only partly additive, suggesting some 
homogeneity in stimulation mechanism and location. 
Although plasma Ca2+ is never fully removed in vivo, extracellular Ca2+- 
dependency of vasoconstriction has provided a useful method of dissociating the 
effects of NE on V02 . Whether NE was stimulating subgroups of a 1 -ARs with 
different signal-transduction mechanisms or the same a i-AR located on different 
blood vessels is a moot point. The ability of NE to cause the differential effects on 
V02 has important implications in vivo. Access of 02, nutrients and hormones to 
skeletal muscle may be controlled by the level of tone on different blood vessels. 
Alterations in tone, be it from circulating or neuronal sources, and sensitivity to 
vasoactive agents in disease states such as hypertension and atherosclerosis may 
compromise tissue need and be responsible for conditions associated with these 
diseases. 
In summary, the receptors stimulated by NE and 5-HT may be sub-classified 
according to their extracellular Ca2+-dependence and the use of selective receptor 
antagonists. Table 4.3 outlines the evidence supporting each receptor sub-
classification. 
Effect on 	Dependence on 
Agonist ± Pressure V02 Aerobic 	[Ca2+] 3 	Selective Proposed 
Antagonist 	 Metabolism: Antagonists Receptor 
NE+Prou  
low-dose 	T 	T 	yes 	yes 	? 	cciA(like) 
high-dose 	T 4, no no 	Prazosint 	ri 
— 1B(iike) 
5-MU 
CEC 
NE+Praz 
low-dose 	nil 	nil 
high-dose 	4, 4, 	* 	slight * Propranolol 
	
0 
5-HT 
low/high 	T 	4, 
high-dose 	T * 
5-HT+LY 
low/high 	4, 	4, 
no 	no 	LY 53,857t 5-HT2A 
no yes 	LY 53,857 5-HT 1 -like? 
* 	* 
	* 	orphan 5-HT 
96 
Table 4.3 	Summary of evidence for sub-classification of AR- and 5-HT- 
receptor stimulation in constant-flow perfused rat hindlimb. 
Results indicative of receptor sub-division from this Chapter and Chapters 
2 (T) and 3(t) are summarized. AR, adrenoceptor; V02 , oxygen uptake; 
[Ca210, extracellular Ca2+; NE, norepinephrine; low-dose NE, < 0.1 11M 
NE; 5-HT, serotonin; low-dose 5-HT, < 0.25 iiM 5-HT; CEC, 
chloroethylclonidine; 5-MU, 5-methyl urapidil; LY, LY 53,857; *, not 
addressed in this study, warrants future investigation. 
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CHAPTER 5 
Effect of vasoconstrictors on insulin-mediated glucose uptake. 
5.1 	Introduction. 
The effects of vasoconstrictors on hindlimb metabolism has been limited to 
determination of oxygen uptake (V0 2) and lactate release (Chapter 3). However, the 
metabolism of glucose is more frequently associated with skeletal muscle. Insulin 
(James et al., 1988) and exercise (Douen et al., 1990) have both been shown to 
translocate the unique GLUT 4 glucose transporters to skeletal myocyte cell 
membranes from distinct internal stores (Douen et al., 1990; Marette et al., 1992) by 
an as yet not frilly determined mechanism. 
The rat hindlimb and representative incubated muscles have both been used 
to determine the effects of hormones on skeletal muscle glucose transport, disposal 
and net uptake, usually employing various radiolabelled analogues of glucose (James 
et al., 1985; Wallberg-Henriksson et aL, 1988). In the constant-flow perfused 
hindlimb, the effects of epinephrine (Chiasson et al., 1981; Richter et al., 1982a), 
insulin (Ruderman et aL, 1971, 1977; Chiasson etal., 1981; Schadewaldt etal., 1985) 
and the combination of epinephrine and insulin (Chiasson et al., 1981; Richter et al., 
1982a) on glucose uptake have been determined. 
The above studies clearly indicated an epinephrine-mediated increase in 
hindlimb glucose uptake, although Chiasson et al. (1981) ascribed the uptake to 13- 
adrenoceptor (AR) stimulation, whereas Richter et al., (1982a) proposed an a-AR 
stimulation. Upon further investigation, Chiasson et al. (1981) found a lack 13-AR 
stimulation of glucose uptake into striated muscle, which was consistent with the 
results from isolated, incubated soleus muscles (Sloan et al., 1978). Thus Chiasson et 
al. (1981) proposed that in the hindlimb epinephrine was stimulating glucose uptake 
into adipose tissue. However, both 13-AR mediated rises in cAMP (van Putten & 
Krans, 1985) and stimulation of protein kinase C (Saltis et al., 1991) have been 
shown to increase adipocyte glucose uptake, thus leaving the issue as to which AR 
subtype was responsible for increasing hindlimb glucose uptake in some doubt. 
Insulin has been shown by many groups to increase glucose uptake into 
hindlimb tissue (Ruderman et aL, 1971; Chiasson et al., 1981; James et al., 1985; 
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Kubo & Foley, 1986; Klip et aL, 1987). Insulin also increases glycogen synthesis by 
directly stimulating glycogen synthase activity. 
The inhibitory effect of epinephrine on insulin-stimulated glucose uptake is 
generally accepted to be due to 13-AR stimulation. Chiasson et aL, 1981 showed that 
epinephrine, via 13-  but not aradrenoceptor (AR) stimulation, caused an attenuation 
of insulin-stimulated glucose uptake. 13-AR stimulation is believed to oppose the 
actions of insulin by increasing the rate of glycogenolysis and thus causing an increase 
in tissue glucose 6-phosphate concentration, which in turn inhibits the rate of glucose 
phosphorylation without affecting the rate of glucose transport (Challiss et al., 1986). 
Glucose uptake is decreased due to an increase in glucose transport out of cells 
(Chiasson etal., 1981). 
Both 13-AR stimulation (Dimitriadis et al., 1991; Hettiarachchi et al., 1992) 
and insulin (Dimitriadis et aL, 1991) have been shown to increase lactate release from 
skeletal muscle preparations by increasing glycolytic activity, 13-AR stimulation 
increasing glycogenolysis (Dimitriadis et al., 1991) predominantly in fast-twitch white 
fibres (Richter et al., 1982a) and insulin increasing cytosolic glucose. The 
combination of 13-AR and insulin stimulation was not additive on lactate release 
(Challiss et al., 1986; Dimitriadis et al., 1991) presumably due to build up of glucose 
6-phosphate. a-AR stimulation has been shown not to increase incubated skeletal 
muscle lactate release (Hettiarachchi et al., 1992), although smooth muscle increases 
lactate production during constriction (Paul, 1980; Lundholm et al., 1983; 
Hettiarachchi etal., 1992). 
Recent interest in the link between blood flow and skeletal muscle insulin-
mediated glucose uptake has shown that in insulin-resistant patients, insulin-mediated 
increases in blood flow to skeletal muscle appears impaired (reviewed by Baron et al., 
1993). As insulin-mediated vasodilatation does not appear to involve a specific 
receptor (Wambach & Liu, 1992) it may be possible that the delivery of insulin (and 
glucose) to the skeletal muscle microcirculation may be reduced (reviewed by Julius et 
al., 1992). Since both norepinephrine (NE) and serotonin (5-HT) have been shown to 
differentially affect metabolism of, and flow through, the hindlimb (Chapter 2, Dora et 
aL, 1991), we have examined the effects of 5-HT and NE on insulin-mediated glucose 
uptake in the constant-flow perfused rat hindlimb. A comparison was also conducted 
with isolated incubated muscles where nutrients were supplied by diffusion from the 
outside rather than through the vascular system. 
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5.2 	Materials and methods. 
5.2.1 	Perfused hindlimbs. 
This series of experiments could not be performed at 25°C due to difficulties 
in accurately measuring small basal and 'insulin-mediated glucose uptake at this 
temperature (Table 5.2). The increased rates of metabolism at higher temperatures 
necessitated the use of higher flow rates and 4% BSA. While using a non-
recirculating system, it was decided that experiments would be performed at either 
32°C with large rats or 37°C with small rats, thereby reducing cost, enabling accurate 
measurement of glucose-uptake and not compromising tissue oxygen delivery. 
Surgery was performed on either 70-80 g or 240-270 g rats as outlined in 
Section 2.2.1.2.1, except both hindlimbs were perfused and flow rates increased 
(described in more detail in relevant sections). Experiments were performed at either 
25, 32 or 37°C with 4% bovine serum albumin added to the perfusion medium. 
Additional details are given in Section 2.2.1. 
V02 was calculated as described in Section 2.2.1.6 using the appropriate 
Bunsen coefficient (Christoforides et al., 1969). The effluent was periodically 
sampled (at times indicated) for measurement of glucose and lactate levels, or 
otherwise discarded. The hindlimbs were allowed to equilibrate for 30-35 min before 
venous sampling or hormone additions were commenced. Effluent lactate levels were 
determined according to the method of Gutmann and Wahlefeld (1974) as described 
in Section 2.2.2. Perfusate glucose concentration was determined using the GOD-
Perid method (Boehringer Mannheim, Germany). Glucose uptake was calculated 
from the arterio-venous differences in perfusate glucose concentration multiplied by 
the perfusate flow rate divided by the weight of muscle. 
5.2.1.1 	Experiments involving 5-HT 
The temperature of the perfusion cabinet, heat exchanger, jacketed oxygen 
electrode and arterial inflow line were adjusted to 32°C and monitored throughout 
experiments. For each experiment, both hindlimbs from 240-270 g rats were perfused 
at a constant flow rate (15 ml.min-1 ) with Krebs-Henseleit bicarbonate buffer 
containing 2.5 mM CaCl2, 8.3 triM glucose and 4% bovine serum albumin (BSA). In 
these larger rats, perfused muscle mass was estimated at one-sixth of the rat's body 
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mass, consistent with Ruderman et al. (1971). 
The dose of insulin was also chosen to give a maximal effect on glucose 
uptake (Chiasson et al., 1981). Stock solutions of insulin (3 p.M) in perfusion 
medium (with BSA), 5-HT (2.1 mM) in 0.1% ascorbic acid/0.9% NaCl or their 
vehicles were infused at the times indicated at a rate of 1 in 200 of the flow rate into 
the perfusion line prior to a combined small bubble trap and mixing chamber that was 
continuously mixed by a magnetic stirrer. 
5.2.1.2 	Experiments involving NE. 
The temperature of the perfusion cabinet, heat exchanger, jacketed oxygen 
electrode and arterial inflow line were adjusted to 37°C and monitored throughout 
experiments. For each experiment both hindlimbs from 70-80 g rats were perfused at 
a constant flow (8 ml.min -1 ) with Krebs-Henseleit bicarbonate buffer containing 2.5 
mM CaC12, 8.3 mM glucose and 4% bovine serum albumin (BSA). Preliminary 
results showed that the relationship for hindlimb mass as a proportion of total body 
mass (Ruderman et al., 1971) did not hold for small rats. Thus the mass of perfused 
muscle in the small rats was determined by injecting filtered Evans Blue dye at the end 
of control perfusions and weighing the dissected stained muscle to give the regression 
equation (n = 6): 
perfused muscle mass (g) = 0.141 x body mass (g) - 2.53 
Stock solutions of insulin (3 ii,M) in perfusion buffer, NE (0.2 or 2 mM) in 
0.1% ascorbic acid/0.9% NaC1, (±)-propranolol (2 mM) in 0.9% NaCl or prazosin 
(0.5 mM) in 10% dimethyl sulfoxide {(CH3 )2S0} were infused at the times indicated 
at a rate of 1 in 200 of the flow rate into the perfusion line prior to a combined small 
bubble trap and mixing chamber that was continuously mixed by a magnetic stirrer. 
5.2.2 	Incubated muscles. 
Soleus (20-30 mg) and extensor digitorum longus (20-30 mg) muscles were 
dissected from 60-80 g rats and attached (2 per experiment) to stainless steel springs 
to maintain their approximate in vivo length. The muscles were incubated in flasks 
containing 5 ml of Krebs-Ringer bicarbonate buffer of the same composition as used 
in the perfusion experiments. The flasks were maintained at 32°C and continuously 
101 
gassed with 95% 0 2-5% CO2. After 40 min the muscles were transferred to new 
flasks containing a fresh 5 ml of buffer and either the hormones at concentrations used 
in the perfusion experiments or their vehicles as indicated. After 20 min 2-deoxy-D-
[ 1 -3 1- ]glucose4U- 14C]sucrose was added and the incubations continued for a total of 
90 min. At the end of the incubation the muscles were removed, blotted dry, weighed 
and freeze-dried overnight. After reweighing to determine the dry weight the muscles 
were homogenized in 2 ml of water. The homogenate was centrifuged (8000 g for 15 
min) and the supernatant counted for radioactivity. Samples of incubation medium 
were also counted for radioactivity. The R'g (.tmol.h- '.g') was calculated from the 
following expression:- 
2 x [3H d.p.m. in muscle - (14C  d.p.m. in muscle x 3 H d.p.m./14,  u p m. ratio in buffer)]  
dry wt muscle (g) x (lmoles per ml glucose in buffer / 3H d.p.m. per ml in buffer) 
5.2.3 	Statistical analysis. 
The significance of difference between treatments of perfusions and 
incubations were tested either by one way analysis of variance and least significant 
difference analysis (Snedecor & Cochran, 1980) using the SAS statistical package 
(SAS Institute Inc., Cary, N.C.), or the unpaired, 2-tailed Student's t test. Values of 
P < 0.05 were taken as significant. 
The significance of difference within treatments were tested using the paired, 
2-tailed Student's t test. 
5.3 	Results. 
Basal perfusion conditions for the various rat sizes, temperatures and flow 
rates are given in Table 5.1. Raising perfusion temperature markedly increased basal 
V02 and lactate release. Rates of metabolism increased with decreasing rat size and 
increased with flow rate in accordance with previous findings at 25°C (Ye et al., 
1990b, Hettiarachchi et al., 1992); and the results of others (Table 5.1). 
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Size 
(g) 
Temp 
(°C) 
Flow 
Rate 
(ml.min-1 ) 
902 
(p.mo1.10.g-1 ) 
Lactate 
Release 
Perfusion 
Pressure 
(nunHg) 
70-80 25 1.5* 12.9 ± 0.6 N.D. 22.3 ± 0.8 6 
25 4•0** 15.5 ± 0.6 10.04 31.0 ± 1.5 2 
37 4.0** 23.7± 0.5 31.6± 1.2 28.6 ± 0.4 44 
110-120 25A 1.2* 9.1 ± 0.7 8.4± 1.3 19.0± 0.7 5 
180-200 258 4.0* 6.6 ± 0.1 7.4 ± 0.5t 22.5 ± 0.4 65 
25C 4.0** 6.9 ± 0.2 4.1 ± 0.4: 22.6 ± 0.6 27 
25D 16.0* 8.0 ± 0.5 6.6± 1.3 58.8± 1.2 20 
378 5.0** 18.0 ± 2.4 4.8 ± 0.6 N.D. 8 
37F 16.0* 42.0 ± 15.0 9.0 ± 3.0 63.3 ± 1.3 8 
240-270 32 7•5* 10.0 ± 0.2 11.6 ± 0.9 24.6 ± 0.4 20 
Table 5.1 Relationship between rat size, perfusion temperature and flow 
rate on basal hindlimb perfusion conditions. 
Perfusion medium contained 4% bovine serum albumin (BSA) and 2.5 
mM Ca2+ in all experiments except those performed at 25°C which 
contained 2% BSA and 1.27 mM Ca2+. Values are means ± SE. V02, 
oxygen uptake; n, no. of hindlimb perfusions; N.D., not determined; A, 
from Hettiarachchi et aL, 1992; B, from Chapter 3; C, from Chapter 4; D, 
from Chapter 8; E, from Ruderman et aL (1971), medium contained 
erythrocytes; F, from Chapter 8, medium contained erythrocytes; flow rate 
as ml.min-1 .hindlimb-1 ; *, one hindlimb perfused; **, two hindlimbs 
perfused; n=1;t ,n= 5; n = 23. 
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5.3.1 	Experiments involving 5-HT at 32°C. 
Consistent with our previous studies using hindlimbs perfused at 25°C 
(Chapter 2, Dora et al., 1991), 5-HT increased perfusion pressure and inhibited V02 
in a dose-dependent manner at 32°C (Figure 5.1). The effects on V0 2 and pressure 
were totally reversible upon removal of 5-HT. A maximal dose of 5-HT (10 p.M) was 
used in this study. This series of experiments was performed prior to the development 
of surgical technique required for the 70-80 g rats used in experiments involving NE. 
Subsequent perfusions have shown that the response to 0.25 p.M 5-HT at 25°C was 
also apparent in 80 g rats (decrease in basal V02 of 7.0 gmol.h-1 .g-1 associated with 
an increase in perfusion pressure of 35 mmHg, n = 1). 
Figure 5.4 summarizes the average values obtained 50 min after 
commencement of treatment (termed "steady-state") in this study. In control 
perfusions, V02 and perfusion pressure remained constant for the 90 min 
experimental period (Figure 5.2, left panels). The hindlimb perfusion pressure before 
additions was 24.6 ± 0.4 mmHg (n = 20) at the flow rate of 15 ml.min. Under no 
conditions did venous PO 2 fall below 250 mmHg (arterial P02 was constant at 680 ± 
3 mmHg, n = 20). However neither hindlimb lactate release nor glucose uptake were 
constant during control perfusions. Lactate release gradually increased from approx. 
10 to 16 prnol.h-1 .g-1 over the initial 20 min, then remained constant at approx. 14.5 
lAmol.h-1 .g4 for the remaining 35 min (Figure 5.3, upper left panel). Glucose uptake 
gradually increased from approx. 5 to 10 pmol.h - l.g-1 over the initial 10 minutes and 
then declined to settle at approx. 8 pmol.h-1 .g-1 by 90 min (Figure 5.3, lower left 
panel). 
5.3.1.1 	Effects of insulin in perfused hindlimbs. 
Insulin (15 nM) had no effect on perfusion pressure even though it caused a 
small increase in V02 (8%) (Figure 5.2 left panels). Insulin markedly stimulated 
lactate release and glucose uptake to steady-state values 1.8-fold and 2.9-fold, 
respectively, above corresponding controls (Figure 5.3 left panel). 
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Figure 5.1 	Effects of perfusion temperature, flow rate and rat size on the 
dose-dependent VO2 and perfusion pressure effects of 5-HT in 
hindlimbs. 
Basal perfusion conditions are given in Table 5.1. Each dose of 5-HT was 
infused constantly for 10 min into either one hindliinb of 180-200 g rats 
perfused at 4 ml.min -1 and 25°C (0, n = 5, from Chapter 2) or 16 ml.min-1 and 
25°C (0, n =3, from Chapter 6); or two hindlimbs of 250 g rats perfused at 15 
ml.min-1 and 32°C (A, n = 3). Values are means ± SE. 5-HT, serotonin; n, no. 
of hindlimb perfusions. 
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Figure 5.2 	Effects of insulin, and 5-HT in the absence and presence of 
insulin, on hindlimb V0 2 and perfusion pressure. 
Both hindlimbs from 250 g rats were perfused at a constant flow rate of 15 
ml.min-1 at 32°C in a non-recirculating mode. The following constant infusions 
were commenced at the times stated below to give the final concentrations 
shown and these were maintained until the end of the perfusion: 50 min, vehicle 
(0); 50 min, 10 1.1M 5-HT (0); 40 min, 15 nM insulin (II); 40 min, 15 nM 
insulin and 50 min, 10 piM 5-HT (A); 40 min, 10 1..IM 5-HT and 50 min, 15 nM 
insulin (A). Values shown are means ± SE for 4 perfusions. When not visible, 
the error bar is within the symbol. 5-HT, serotonin; V0 2, oxygen uptake. 
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Figure 5.3 	Effects of insulin, and 5-HT in the absence and presence of 
insulin, on hindlimb lactate release and glucose uptake. 
Hindlimbs were perfized as described in Figure 5.2. The following constant 
infusions were commenced at the times stated below to give the final 
concentrations shown and these were maintained until the end of the perfusion: 
50 min, vehicle (0); 50 min, 10 11M 5-HT (II); 40 min, 15 nM insulin (II); 40 
min, 15 nM insulin and 50 mm, 10 1.1M 5-FIT (A); 40 min, 10 JIM 5-FIT and 50 
min, 15 nM insulin (A). The arterial perfusate concentration of glucose was 
8.3 mM and glucose uptake was calculated from the arterio-venous difference 
from venous samples taken at the times shown. Values shown are means ± SE 
for 4 perfusions. When not visible, the error bar is within the symbol. 5-HT, 
serotonin. 
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Figure 5.4 	Average steady-state effects of insulin, and 5-HT in the presence 
and absence of insulin, on hindlimb 90 2, perfusion pressure, 
lactate release and glucose uptake. 
Data for the values obtained at the end of the perfusion period (50 mm after 
commencement of treatment at t = 90 min) from Figures 5.2 and Figure 5.3 
were averaged for control (0); 15 nM insulin (I•1); 5-HT (E);  5-HT + 15 nM 
insulin (a); 15 nM insulin + 5-HT (a). Values are means ± SE of four 
perfusions for each treatment. Significance of differences (P < 0.05) were 
assessed using one-way ANOVA: 4 , control different from insulin or 5-HT; 
*, insulin different from 5-HT + insulin or insulin + 5-HT; 5-HT, serotonin; 
V02, oxygen uptake. 
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5.3.1.2 	Effects of 5-HT in perfused hindlimbs. 
The present effects mediated by 5-HT were sustained over the period of 
constant infusion, yet both pressure and V02 did commence a gradual partial return 
towards basal levels. At 59 min perfusion pressure was 99.4 ± 3.1 mmHg (n = 4) and 
V02 was 3.9 ± 0.5 i_tmol.h -1 .g-1 (n = 4). By 90 min perfusion pressure had 
significantly (P < 0.05, paired Student's t test) decreased to 85.1 ± 1.8 mmHg (n = 4) 
and V02 significantly (P < 0.001, paired Student's t test) increased to 5.5 ± 0.6 
(n = 4) (Figure 5.2, left panels). 
After 5 min of infusion, 5-HT initially markedly and significantly (P < 0.01, 
unpaired Student's t test) attenuated lactate release to levels only half that found under 
basal conditions. Over the remainder of the perfusion period, lactate release returned 
to control levels (Figure 5.3, upper left panel). Despite an initial trend of decreased 
glucose uptake, 5-HT did not significantly alter hindlimb glucose uptake compared to 
the vehicle perfusion (Figure 5.3, lower left panel). 
5.3.1.3 	Effects of insulin plus 5-HT in perfused hindlimbs. 
Insulin did not alter the 5-HT-mediated vasoconstriction or inhibition of 
V02, whether added before or after 5-HT. However it was apparent that insulin, 
when added after 5-HT, tended to augment the pressor effect but this was not a 
statistically significant effect due to an increase in variability (Figure 5.2). 
When 5-HT was added following insulin, the stimulatory effect of the latter 
on lactate release and glucose uptake was reduced, and this was most apparent soon 
after 5-HT addition. Whether added before or after insulin, lactate release gradually 
returned to control levels (Figure 5.3, upper panels). If added before insulin, 5-HT 
decreased the insulin-mediated glucose uptake at all time points (Figure 5.3, lower 
panels). Infusion of 5-HT before or after insulin significantly inhibited steady-state 
insulin-mediated glucose uptake (Figure 5.4). Thus for perfusions where insulin was 
added first, 5-HT resulted in a 28.9% reduction in the glucose uptake stimulation due 
to insulin and for perfusions where 5-HT was added first, the stimulation was reduced 
by 31.6%. 
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5.3.1.4 	Effects of insulin, 5-HT, and insulin plus 5-HT in incubated muscles. 
Glucose uptake by isolated incubated soleus and extensor digitorum longus 
muscles is shown in Figure 5.5. Conditions of incubation were chosen to be identical 
to those of perfusion. However smaller rats were used to obtain muscles that 
weighed less than 30 mg to allow suitable oxygenation of the muscle during 
incubation. The medium contained 4% albumin and 8.3 mM glucose and pre-
incubation as well as incubation times were the same as those used in perfusion. 
Uptake was determined from the net radioactivity of 2-deoxyglucose and its 
phosphate ester contained by the muscle. Glucose uptake (R'g) by both muscles was 
not affected by 10 1AM 5-HT. Insulin (15 nM) significantly (P < 0.001, unpaired 
Student's t test) increased the rate of glucose uptake by 115% (soleus) and 154% 
(extensor digitorum longus). Even when added before insulin 5-HT had no significant 
effect on the insulin-mediated stimulation of glucose uptake in either muscle. 
5.3.2 	Experiments involving NE at 37°C. 
At 37°C, NE-mediated effects on perfusion pressure and 90 2 were 
qualitatively similar to those observed at 25°C (Chapter 2, Dora et al., 1992). NE 
dose-dependently increased perfusion pressure, and at low doses, mediated increases 
in V02, but at higher doses inhibited V0 2 at 37°C (Figure 5.6). The effects on V02 
and pressure were totally reversible upon removal of NE. In perfusions performed at 
25°C, decreasing the size of perfused rats from 180-200 g to 70-80 g (with the same 
relative flow rate per gram tissue) shifted the NE dose response curve for V02 and 
perfusion pressure to the right (Figure 5.6). Using 70-80 g rats, increasing the flow 
rate shifted the dose response curve to the left, and, at this high flow rate, increasing 
the perfusion temperature to 37°C shifted the dose curve to the right and increased 
the maximal V02  response. At 37°C, 1 IIM NE induced an almost maximal rise in 
V02  in association with increased perfusion pressure, and 10 11M NE inhibited V02 to 
values below basal in association with further rises in perfusion pressure (Figure 5.6). 
1 piM and 10 p.M NE were used in this study to mediate stimulatory and inhibitory 
effects on V02, respectively. 
Mean values ± SE for V0 2, perfusion pressure, lactate release and glucose 
uptake obtained 50 min after commencement of treatment (at 90 min) are given in 
Figure 5.11. In control perfusions, V02, perfusion pressure, lactate release and 
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Figure 5.5 	Effects of 5-HT, insulin and 5-HT plus insulin on glucose uptake 
by isolated incubated soleus and EDL muscles. 
Muscles (20-30 mg) were incubated with medium identical to that used for 
perfusions. After a preincubation period of 40 min, muscles were transferred to 
fresh medium and vehicle (0), 10 pM 5-HT ('), 15 nM insulin (MI) or 10 
p.M 5-HT + 15 nM insulin (11E) were added. 2-Deoxy-D-[1- 3H]glucose and 
[U- 14C]sucrose were added after a further 20 min and the incubations continued 
for a total of 90 min. Muscles were analysed for radioactivity as described in 
Methods. Values shown are means ± SE for 8 muscles (both limbs from four 
rats in each group). *P < 0.001 significantly different from vehicle. There was 
no significant difference between vehicle and 5-HT or between insulin and 
insulin + 5-HT. 5-HT, serotonin; EDL, extensor digitorum longus. 
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Figure 5.6 	Effects of perfusion temperature, flow rate and rat size on the 
dose-dependent V02 and perfusion pressure effects of NE in 
hindlimbs. 
Basal perfusion conditions are given in Table 5.1. Each dose of NE was infused 
constantly for 10 min into either one hindlimb of 180-200 g rats perfused at 
4 ml.min4 and 25°C (0, n = 5, from Chapter 2); or two hindlimbs of 70-80 g 
rats perfused at 3 ml.tnin 4 and 25°C (0, n = 4), 8 ml.min-1 and 25°C (A, n = 
2), or 8 ml.min-1 and 37°C (A, n = 2). Values are means ± SE; n, no. of 
hindlimb perfusions; NE, norepinephrine; V02, oxygen uptake. 
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glucose uptake remained constant for the 90 min experimental period (Figures 5.7 & 
5.8). 
	
5.3.2.1 	Effects of insulin in perfused hindlimbs. 
Insulin (15 nM) had little effect on perfusion pressure, but caused a small 
increase in V02 (7.0%) that was apparent 10 min after addition (Figure 5.7, left 
panels). Insulin markedly stimulated lactate release and glucose uptake to steady-
state effects 1.5-fold & 2.7-fold, respectively, above corresponding controls (Figure 
5.8, left panels). These effects of insulin were of similar magnitude to those observed 
at 32°C in larger rats. 
5.3.2.2 	Effects of low-dose NE in perfused hindlimbs. 
Low-dose NE (1 pM) caused a marked increase in V02 (1.5-fold) in 
association with vasoconstriction and these effects were maintained until the end of 
the perfusion (Figure 5.7, left panels). Lactate release was rapidly and significantly (P 
< 0.001, unpaired Student's t test) increased to a peak value (2.1-fold) which returned 
to steady state levels above basal (1.4-fold) (Figure 5.8, upper left panel), qualitatively 
consistent with results at 25°C (Chapter 2, Hettiarachchi et aL, 1992). Glucose 
uptake was also transiently and significantly (P < 0.05, unpaired Student's t test) 
increased (1.5-fold) and returned to steady-state levels approaching basal (1.2-fold) 
within 10 min (Figure 5.8, lower left panel). 
5.3.2.3 	Effects of insulin plus low -dose NE in perfused hindhmbs. 
Insulin appeared to have a vasodilatory effect against low-dose NE (1 p.M), 
as perfusion pressure was significantly reduced compared to NE alone (Figure 5.7, 
bottom panels, Figure 5.11). Insulin- and NE-mediated lactate release were additive 
and NE attenuated the insulin-stimulated glucose uptake (Figures 5.8 and 5.11). 
The effects of low-dose NE plus insulin on V02 and perfusion pressure were 
augmented by the 0-adrenoceptor (AR) antagonist propranolol (10 pM) and totally 
inhibited by the al -AR antagonist prazosin (2.5 pM) (Figure 5.7, right panels). 
Propranolol, but not prazosin, reduced the NE plus insulin-mediated steady state 
lactate release without affecting the initial peak. Prazosin inhibited the NE-stimulated 
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Figure 5.7 	Effects of insulin, and low-dose NE in the presence and absence of 
insulin and AR antagonists, on hindlimb V02 and perfusion 
pressure. 
Hindlimbs from 70-80 g rats were perfused at a constant flow rate of 8 m1.min -1 
at 37°C in a non-recirculating mode as described in Methods. The following 
constant infusions were commenced at 40 min to give the final concentrations 
shown and these were maintained until the end of perfusion: no addition (0); 
15 nM insulin (0); 1 1AM NE (0); 1 1AM NE + 15 nM insulin (II); 1 .LN/1 NE + 
15 nM insulin + 10 1.tM (±)-propranolol (A); 1 JIM NE + 15 nM insulin + 2.5 
prazosin (V). Values are means ± SE for 4 perfusions. When not visible, 
error bars are within symbols. AR, adrenoceptor; NE, norepinephrine; V0 2, 
oxygen uptake. 
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Figure 5.8 	Effects of insulin, and low-dose NE in the presence and absence of 
insulin and AR antagonists, on hindlimb lactate release and 
glucose uptake. 
Hindlimbs were perfused, and additions were made, as described in Figure 5.2. 
The following constant infusions were commenced at 40 min to give the final 
concentrations shown and these were maintained until the end of perfusion: no 
addition (0); 15 nM insulin (0); 1 pM NE (•); 1 pLM NE + 15 nM insulin (II); 
1 p.M NE + 15 nM insulin + 10 pM (±)-propranolol (A); 1 pM NE + 15 nM 
insulin + 2.5 AM prazosin (V). Values are means ± SE for 4 perfusions. When 
not visible, error bars are within symbols. AR, adrenoceptor; NE, 
norepinephrine. 
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peak in lactate release. Propranolol, but not prazosin, reversed the NE-mediated 
inhibition of insulin-stimulated glucose uptake (Figure 5.8, right panels). 
	
5.3.2.4 	Effects of high-dose NE in perfused hindlimbs. 
High-dose NE (10 1.1.M) stimulated prazosin-sensitive increases in perfusion 
pressure associated with inhibition (32% below basal) of V02 (Figure 5.9). V02 was 
transiently increased during the rise in perfusion pressure (data not shown), but after 5 
min of infusion had already fallen to levels below basal. Lactate release was markedly 
reduced compared to that observed upon addition of low-dose NE, although the 
steady state level after 20 min was elevated. High-dose NE had no effect on glucose 
uptake (Figure 5.10, left panels). 
5.3.2.5 	Effects of insulin plus high -dose NE in perfused hindlimbs. 
Insulin slightly attenuated (7.1%) the high-dose NE-mediated rise in 
perfusion pressure and inhibition of V0 2 (Figure 5.9, right panels). High-dose NE 
plus insulin was not additive on lactate release, and insulin-stimulated 
glucose uptake was markedly and significantly impaired in the presence of NE (Figure 
5.10, right panels, Figure 5.11). 
Propranolol augmented the NE plus insulin-mediated effects on V02 and 
perfusion pressure, and the combination of prazosin plus propranolol almost totally 
blocked the rise in perfusion pressure, but stimulated V02 (Figure 5.9, right panels). 
This effect was similar to that observed upon infusion of approx. 25 nM NE (Figure 
5.1), and was consistent with a 13-AR-mediated vasodilatation of the vasoconstriction 
associated with increases in V02 (Chapter 2, Colquhoun et al., 1990). Higher doses 
of prazosin abolished the stimulation of VO2 and perfusion pressure (data not shown). 
Propranolol totally opposed the high-dose NE and insulin-stimulated lactate 
release despite augmenting the effects on VO2 and pressure. Propranolol slightly 
attenuated the NE-mediated inhibition of insulin-stimulated glucose uptake (Figure 
5.10, right panels). 
Prazosin markedly attenuated the high-dose NE-mediated inhibition of 
lactate release, and demonstrated that 13-AR-stimulation inhibited insulin-mediated 
glucose uptake (Figure 5.10 right panels). 
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Figure 5.9 	Effects of insulin, and high-dose NE in the presence and absence 
of insulin and AR antagonists, on hindlimb V02 and perfusion 
pressure. 
Hindlimbs were perfused, and additions made as described in Figure 5.2, except 
10 1.1M NE was used. The following constant infusions were commenced at 40 
min to give the final concentrations shown and these were maintained until the 
end of perfusion: no addition (0); 15 nM insulin (0); 10 1.1,M NE (0); 10 i_tM 
NE + 15 nM insulin (II); 10 I.LM NE + 15 nM insulin + 10 I.LNI (±)-propranolol 
(A); 10 i.IM NE + 15 nM insulin + 2.5 i.t.M prazosin (V); 10 I.LM NE + 15 TIM 
insulin + 10 JAM (±)-propranolol + 2.5 p.M prazosin (•). Values are means ± 
SE for 4 perfusions. When not visible, error bars are within symbols. AR, 
adrenoceptor; NE, norepinephrine; V0 2, oxygen uptake. 
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Figure 5.10 Effects of insulin, and high-dose NE in the presence and absence 
of insulin and adrenoceptor antagonists, on hindlimb lactate 
release and glucose uptake. 
04,4 
Hindlimbs were perfused and additions made as described in Figure 5.4. The 
following constant infusions were commenced at 40 min to give the final 
concentrations shown and these were maintained until the end of perfusion: no 
addition (0); 15 nM insulin (0); 10 i_tM NE (I); 10 i.tM NE + 15 niVI insulin 
(II); 10 ptM NE + 15 nM insulin + 10 1.1M (±)-propranolol (A); 10 111■4 NE + 
15 nM insulin + 2.5 1.1M prazosin (V); 10 p.M NE + 15 nM insulin + 10 1.11V1 
(±)-propranolol + 2.5 p.M prazosin (•). Values are means ± SE for 4 
perfusions. When not visible, error bars are within symbols. AR, adrenoceptor; 
NE, norepinephrine. 
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Figure 5.11 Average steady-state effects of insulin, and NE in the presence and 
absence of insulin and AR antagonists, on hindlimb V0 2, 
perfusion pressure, lactate release and glucose uptake. 
Values obtained 50 min after commencement of treatment (at 90 min) from 
Figures 5.2-Figure 5.5 were averaged for control (El); 15 nM insulin (I); NE 
(a); NE + 15 nM insulin (a); NE + 15 nM insulin + 10 p.M (±)-propranolol 
( ); NE + 15 nM insulin + 2.5 p.M prazosin (x); NE + 15 nM insulin + 10 
pM (±)-propranolol + 2.5 pM prazosin (El). Values are means ± SE of four 
perfusions for each treatment. Significance of differences (P < 0.05) assessed 
using one way ANOVA: 4 , control different from insulin or NE; *, insulin 
different from insulin + NE ± antagonist combinations; §, NE different from 
insulin + NE. AR, adrenoceptor; NE, norepinephrine; V0 2, oxygen uptake. 
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The combination of 13- and a l-AR blockade slightly attenuated (not 
significant) the insulin-stimulated lactate release and glucose uptake (Figure 5.10). 
Interestingly, no peak in lactate release was observed upon addition of NE despite the 
increases in 902, suggesting al-AR lactate release is associated with 
vasoconstriction. 
Mean values ± SE for 902, perfusion pressure, lactate release and glucose 
uptake obtained 50 min after commencement of treatment (at 90 min) are given in 
Figure 5.11. 
5.4 	Discussion. 
The present study confirms the previous findings of 13-AR and insulin 
stimulated increases in hindlimb glucose uptake and lactate release (Chiasson et al., 
1981; Richter et aL, 1982). It also confirms the low dose NE a l -AR stimulated 
increases in 902 and lactate release (Chapter 2) and high dose NE a l -AR-stimulated 
and 5-HT2A-stimulated inhibition of hindlimb 902 and lactate release (Chapter 2, 
Dora et al., 1991, 1992). These results were qualitatively similar despite quantitative 
changes when perfusion medium, temperature and flow rate and rat size were 
altered 1 -. Also of interest was the lack of appreciable effect by low-dose NE on 
hindlimb glucose uptake, remaining consistent with a lack of a l -AR mediated glucose 
uptake proposed by Chiasson etal. (1981) but not Richter etal. (1982a). 
In general, the basal and maximum insulin-stimulated rate of glucose uptake 
compared well with rates obtained by other workers (Chiasson et al., 1981; Kubo & 
Foley, 1986; Klip et al., 1987; Richter et al., 1988), whether erythrocytes were or 
were not included in the perfusion medium (Table 5.2). 
Evidence was also obtained supporting the vascular effects of 
supraphysiological doses of insulin. 15 nM insulin vasodilated against both low and 
1. 	One striking feature of the NE response in small rats was the large increases in 
902 associated with only small rises in perfusion pressure. This may have been due 
to different flow patterns through the hindlimb of younger rats. In hamster cremaster 
muscle, Sarelius et al. (1981) observed that age significantly modified microvascular 
parameters related to tissue oxygen supply. The microcirculation in juvenile hamsters 
was characterized by small intercapillary distances, short capillary lengths and 
tortuous vessels (Sarelius etal., 1981). 
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Rat 	Flow 
Size 	Rate 	Temp RBC 	Glucose Uptake 	[Insulin] n 
(g) 	(rnl. min- I) 	(°C) 	(+1-) (pmol. WI. g- I) (mIliml) 
Basal Insulin 
240-270 8 25 1.4 ± 0.2 4.9 ± 0.1 10.0 2 
240-270 15 32 9.8 ± 0.5 24.4 ± 0.7 2.0 4 
70-80 8 37 16.5 ± 1.2 44.8 ± 1.8 2.0 4 
170-230 10 37 + 1.0 ± 0.6 14.6± 1.2 12.5 6A 
180-220 10 37 + 5.5 ± 1.0 19.3 ± 3.3* 1.0 5B 
200-230 8 37 # 12 25* 14.0 4C 
250-350 20 37 8.0 ± 0.8 42.0 ± 3.8* 1.0 15D 
Table 5.2 Effect of insulin on perfused hindlimb glucose uptake. 
Rats were perfused with constant flow at different temperatures (Temp) 
with or without erythrocytes (RBC) in the perfusion medium. Values are 
means ± SE; n, no. of hindlimbs; A, from Ruderman et al., 1971; B, from 
Chiasson et al., 1981; C, from Kubo & Foley, 1986; D, from Klip et al., 
1987; *, using average rat body mass and assuming 8.3% of body mass is 
skeletal muscle (Ruderman et al., 1971); 4, artificial erythrocyte 
substitute. 
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high doses of NE, but not against 5-HT. This is consistent with reports of 
vasodilatory actions of insulin against NE in rat tail artery (Alexander et aL, 1977), 
and against NE and 5-HT in perfused rat mesenteric artery (Wambach & Liu, 1992). 
In contrast, however, in the perfused rat mesenteric arcade, Townsend et al. (1992) 
found insulin augmented the NE-mediated (but not 5-HT-mediated) rises in pressure. 
Wambach and Liu (1992) concluded the vasodilatory action of insulin was not 
receptor-specific, and noted insulin could affect the activity of the Na±/K+-ATPase, 
the Ne1H+ antiporter and the Na+/Ca2+ antiporter (Ferrari & Weidmann, 1990). 
The present study exemplified the importance of flow distribution on 
hindlimb metabolism. The consistent theme was an inhibition of hindlimb metabolic 
effects in situations where it is proposed flow was being limited to muscle. It reports 
for the first time a marked high-dose NE- and 5-HT-mediated inhibition of insulin-
mediated glucose uptake and lactate release in the constant flow perfused rat hindlimb 
that was not apparent in unperfused incubated muscles. The present findings are 
consistent with our previous observations (Dora et al., 1991, 1992) where high-dose 
NE and 5-HT caused a marked inhibition of V02 concomitant with vasoconstriction 
in the perfiised hindlimb. The proposed explanation to account for the past (Dora et 
al., 1991, 1992) and present data focuses on the notion of vascular shunting in the 
hindlimb in which a subgroup of prazosin-sensitive a l -ARs with relatively low affinity 
for NE (Chapter 2) and 5-HT2A receptors mediate a marked constriction in large 
arterioles down stream from branch points for functional shunts leading to the venous 
circulation (Chapter 7). If this is the case, then complete or near-complete closure at 
these points would effectively return perfusate to the venous circulation, allowing 
constant flow, whilst preventing access of the perfusate to significant areas of the 
microvasculature. Such effects would not be evident when unperfused muscle is 
incubated (Sasson et aL, 1990) but would markedly affect nutrient delivery in 
perfused hindlimb. Thus sites where other vasoconstrictors such as norepinephrine, 
vasopressin and angiotensin II mediate increased V02 (Colquhoun et al., 1988) may 
be compromised by diminished supply of 02 resulting in a marked inhibition of V02. 
The occurrence of vascular shunting in skeletal muscle in vivo has profound 
implications for nutrient and hormone delivery as well as product removal and raises 
many questions concerning the influences that may operate to affect its control. In 
addition vascular shunting mediated by site-specific vasoconstrictors, such as NE and 
5-HT in the present study, may have implications for diabetes. There is growing 
interest in the relationship between hypertension and insulin resistance in both humans 
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and experimental animals. Indeed, the combination of glucose intolerance and 
hyperinsulinaemia seen in many hypertensive humans (Shen et al., 1988; reviewed by 
Julius et al., 1992), points to a defect in insulin-stimulated glucose uptake. Similarly, 
animal models such as the spontaneously hypertensive rat (SHR) (Mondon & Reaven, 
1988; Finch et al., 1990) and fructose-fed rat (Hwang et al., 1987) appear to be 
insulin resistant as well as hypertensive. However it is not clear whether the link 
between hypertension and insulin resistance is indicative of a causal relationship. For 
humans, the lowering of high blood pressure with antihypertensive drugs does not 
necessarily decrease plasma insulin concentration to normal. In some instances 
treatment of the hypertension accentuates the degree of hyperinsulinaemia (Sowers, 
1991). In others, particularly those treated with either the angiotensin-converting 
enzyme inhibitor, captopril (Pollare et al., 1989), the a i -AR antagonist, prazosin 
(Pollare et al., 1988; Swislocici et al., 1989) or the 5-HT2A antagonist, ketanserin 
(Janka et al., 1988; reviewed in Janssens et al., 1991), peripheral blood flow and 
insulin sensitivity may improve. The ability of prazosin and ketanserin to 
preferentially oppose the al-AR subgroup mediating an inhibition of V02 (Chapter 2, 
Figure 2.9) remains consistent with an improvement of insulin access to muscle. Thus 
whilst hypertension in insulin-resistant states has generally been attributed to 
hyperinsulinaemia with its enhanced sympathetic nervous system activation 
(Landsberg & Krieger, 1989), the relationship between cause and effect remains 
unclear for humans as well as animal models (Mondon & Reaven, 1988; Finch et al., 
1990; Buchanan et al., 1992; Bursztyn et al., 1992). From the previous (Dora et aL, 
1991, 1992) and present studies, the action of 5-HT on the perfused hindlimb has 
provided a useful model. 
However 5-HT may not be a physiological regulator of skeletal muscle 
vascular shunts in vivo, as circulating levels are low due to rapid uptake into platelets 
and other tissues (Bhat & Block, 1990). However, Barradas et al. (1988) found that 
circulating 5-HT levels were almost 3 fold greater in patients with NIDDM, 
presumably due to 5-HT release from platelets. In these latter patients, the 5-HT 
concentration range was between 0.1 and 1 1..tM (Barradas et aL, 1988). There is also 
some evidence that 5-HT may be taken up into sympathetic nerve endings (Verbeuren 
et al., 1983; Kawasaki & Takasaki, 1984; Urabe et al., 1991). Thus with the 
possibility of high local concentrations, the effects observed in this study may have 
physiological relevance. There have been numerous reports that in vivo 
administration of 5-hydroxytryptophan, the immediate precursor of 5-HT, produces 
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hypoglycaemia in a variety of animal models and in general these effects are blocked 
by 5-HT antagonists (see Wozniak & Linnoila, 1991, and references therein). The 
subtype of receptors involved in the hypoglycaemic response appears to be 5-HT1 and 
therefore may be different from the 5-HT 2A receptors involved in shunting in the 
hindlimb. In addition, the systemic administration of 5-HT receptor agonists can alter 
the neurochemical systems known to regulate the sympathetic nervous system. Thus 
a recent report (Chaouloff et al., 1990) that the 5-HT2 receptor agonist 1-(2,5- 
dimethoxy-4-iodopheny1)-2-aminopropane triggers a dose dependent increase in 
plasma glucose was concluded to be attributable to an intermediary involvement of 
catecholamines. The hyperglycaemic and hyperinsulinaemic effect of another 5-HT2 
agonist, a-methyl serotonin (Chaouloff et al., 1990) did not appear to be a central 
nervous system-mediated effect and could not be explained. 
Another controlling influence for vascular shunts may be exercise where local 
vasodilatation (Armstrong & Laughlin, 1983) and changes in blood flow have been 
demonstrated (Harrison et al., 1990a). This relationship is investigated in Chapter 6. 
Recently we have noted that high concentrations of norepinephrine can also 
result in apparent shunting in the perfused hindlimb (Dora et al., 1992). Thus it is 
possible that a major controlling mechanism involves sympathetic vasoconstrictor 
nerves (Iversen & Nicolaysen, 1990). From perfusion experiments on the isolated 
dog hindleg and on dog gastrocnemius, Pappenheimer (1941) proposed that reduced 
V02 was the result of sympathetic nerves acting on blood vessels to divert blood flow 
from capillaries to arteriovenous anastomoses. Duran and Renkin (1976) investigated 
this phenomenon in some detail, and although their conclusion differed from 
Pappenheimer's, they found that high frequency (8-16 Hz) supramaximal stimulation 
of the lumbar trunk led to an inhibition of V02 with a rise in resistance, but low 
frequency (0.5-4 Hz) stimulated increased V02 as well as resistance (Duran & 
Renkin, 1976). Intermediate frequency (4-8 Hz) stimulation was often associated 
with an initial fall followed by an increase in V02 and relatively constant resistance 
(Duran & Renkin, 1976). The observations in this study where low and high 
concentrations of norepinephrine stimulate then inhibit V0 2 respectively, during 
vasoconstriction of the hindlimb (Colquhoun et al., 1988; Dora et al., 1992) appear to 
be consistent with the nerve stimulation studies (Pappenheimer, 1941; Duran & 
Renkin, 1976). Thus it is possible that increased sympathetic nerve stimulation may 
also impair insulin-mediated glucose uptake. 
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To summarize, both 5-HT and high doses of NE, but not low doses of NE, 
cause marked acute insulin resistance in perfused hindlimb muscle that is not apparent 
when isolated muscles are incubated with 5-HT in vitro. It is proposed that the acute 
insulin resistance results from site-specific vasoconstriction on large arterioles to 
cause vascular shunting and diminished access by both insulin and glucose. Whether 
the findings have implications for the association between hypertension and insulin 
resistant diabetes will depend on whether shunting occurs in vivo and the prevailing 
regulatory mechanisms. 
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CHAPTER 6 
Effect of 5-HT during skeletal muscle contraction. 
6.1 	Introduction. 
Infusion of serotonin (5-HT) into the constant-flow perfused rat hindlimb 
causes a marked decrease in oxygen uptake (V0 2) and insulin-mediated glucose 
uptake (Chapters 2-5). These findings are consistent with the hypothesis of functional 
vascular shunting in the hindlimb where 5-HT mediates a marked constriction in large 
arteries, causing a redistribution of flow within the hindlimb. 5-HT-mediated 
complete or near complete closure at these points would effectively return perfusate 
to the venous circulation, allowing constant flow, whilst preventing or reducing 
access of the perfusate to areas of the microvasculature. Such effects would seriously 
impair nutrient delivery in perfused hindlimb, but would not be expected to be 
apparent when unperfiised muscle was incubated. 
Several studies have shown that changes in blood flow can alter the force 
exerted by a muscle contracting intermittently during an extended period. This has 
been demonstrated in normal man (Barcroft & Millen, 1939), in man with cardiac 
impairment (Donald et al., 1957) and in the isolated cat gastrocnemius-soleus 
(Hirvonen & Sonnenschein, 1962; Wright & Sonnenschein 1965). The 
communication among endothelial and smooth muscle cells normally causes 
vasodilatation and thereby hyperaemia to the exercising muscle by a combination of 
flow-dependent and endothelial cell-mediated relaxation (reviewed in Segal, 1992). 
Evidence suggests that the locus of flow control shifts from the microvessels up the 
resistance network by an as yet undetermined method of cell-to-cell communication 
involving the endothelium (Segal & Duling, 1986; Segal et al., 1989), to encompass 
the feed arteries, which are external to the muscle (Hilton, 1959; Folkow et al., 1971; 
Segal & Duling, 1986). 
However, in addition to vasodilatation, exercise in vivo also increases 
sympathetic nervous system activity, predominantly to redistribute cardiac output 
away from inactive areas. As exercise intensity increases, the maximal flow to 
contracting muscle can be limited by sympathetic vasoconstriction (Joyner et al., 
1990, 1992), apparently at the level of the feed arteries external to the active muscle 
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(Lind & Williams, 1979). The vasoconstriction overcomes the dilatation of the feed 
arteries (Folkow et al., 1971), thus suggesting diminished effectiveness of upstream 
communication. 
It is unknown whether upstream communication occurs in the constant-flow, 
perfused rat hindlimb preparation used in these studies. However, using the same 
perfusion system, exercise-stimulated vasodilatation decreased the vasoconstriction by 
angiotensin II (Colquhoun etal., 1990). 
In the present study the effect of 5-HT on tension development and 
contraction-induced increase in V02 by the electrically stimulated gastrocnemius-
plantaris-soleus muscle group in the constant-flow perfused rat hindlimb (with and 
without erythrocytes at 37 and 25°C, respectively) was examined. Also the effect of 
contraction-induced vasodilatation on 5-HT-mediated vasoconstriction was 
investigated. These results were compared to the effects of 5-HT on tension 
development by isolated, incubated muscles. 
6.2 	Materials and methods. 
6.2.1 	Perfused hindlimbs. 
Surgery was performed on 180-200 g rats as outlined in Section 2.2.2.1.2 
with the following alterations and additions. After cannulation and commencement of 
perfusion the rat was placed ventral side down. The skin was removed from the thigh 
of the left hindlimb, the sciatic nerve was exposed in the flank and cut to allow the 
positioning of the distal cut end in a suction electrode. The knee was secured by the 
tibiopatellar ligament and the Achilles tendon was attached to a Harvard Apparatus 
isometric transducer (Figure 6.1). 
Perfusions were performed in a temperature-controlled cabinet, and arterial 
perfusion medium was temperature-equilibrated by passage through an in-line heat 
exchanger and water-jacketed arterial line. In addition, the oxygen electrode was 
water-jacketed. In preliminary experiments, in-line thermistors monitored perfusion 
temperatures. 
The perfusate samples for net lactate output determination were taken at 2 
min intervals before and during commencement of treatments. The rates of lactate 
release and V02  were calculated from arteriovenous difference and flow rate as 
described in Chapter 2 (Section 2.2). 
Suction electrode 
Force transducer 
Perfusate flow 
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Chart recorder 
Figure 6.1 	Apparatus used to electrically stimulate and measure tension 
development in the GPS muscle group. 
180-200 g rats were placed dorsal side down temperature controlled 
conditions and perfused at a constant flow rate (for perfusion apparatus 
see Chapter 2, Figure 2.3). The knee was held in position and tension 
development in the GPS muscle group was monitored through the 
Achilles tendon. The lower hindlimb muscle groups were stimulated via 
the sciatic nerve. 5-HT or its vehicle were infused into the arterial line 
immediately prior to a small bubble trap/mixing chamber. GPS, 
gastrocnemius-plantaris-soleus; 5-HT, serotonin; CRO, cathode ray 
oscilloscope. 
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Arterial perfusion pressure was corrected for the pressure fall due to the 
resistance of the cannula. 
6.2.1.1 	Erythrocyte-free perfusions. 
The perfusions were performed at 25°C using modified Krebs-Henseleit 
buffer containing 8.3 mM glucose and 1.27 mM CaC12 with 2% bovine serum albumin 
(BSA). The buffer reservoir was gassed with 95% 02-5% CO 2 at 4°C to enable full 
oxygenation. At equilibration (after 30 min perfusion at 4 ml.min -1 ) and prior to 
electrical stimulation, the flow rate was increased to 17.0 ± 0.2 ml.min -1 . The resting 
length of the muscle was adjusted to attain maximum active tension upon stimulation 
(this normally required 4 or 5 tetanic stimulations). After attainment of a new steady 
state for V02 and perfusion pressure (10 min at the higher flow rate), electrical 
stimulation was commenced using 200 ms trains of 100 Hz 0.1 ms pulses applied 
every 2 s and adjusted (3-5 V) to attain full fibre recruitment. Tension development 
transmitted through the Achilles tendon, perfusion pressure and venous P0 2 were 
recorded continuously, and effluent perfusate samples were regularly collected for 
lactate analysis. 
Electrical stimulation of the sciatic nerve contracted approx. 30% of the 
perfused hindlimb mass, including the gastrocnemius, soleus, and plantaris muscle 
groups, hamstring muscles, deep portion of the crural muscles, and the lateral crural 
muscles (Rennie & Holloszy, 1977). Thus during the experiments, changes in 
perfusion pressure and metabolism were due to a combination of contracting lower-
limb and uncontracting upper-hindlimb tissue. Attempts at selectively perfusing the 
contracting mass via the femoral artery and vein resulted in collateral circulation to 
the upper hindlimb, thus making determination of lower leg metabolism inaccurate. 
6.2.1.1.1 	Effect of prior infusion of 5 -HT on skeletal muscle contraction. 
5-HT (0.25 1AM) was continuously infused for 6 min prior to and throughout 
sciatic nerve stimulation. This allowed assessment of steady-state 5-HT induced 
effects, and both the effects of 5-HT on contraction and vice versa. 
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6.2.1.1.2 	Effect of 5-HT during skeletal muscle contraction. 
5-HT (0.25 JIM) was infused for a brief 2 min period during the 20 min 
period of contraction-stimulation. , This allowed determination of the reversibility of 
the 5-HT effects during contraction. 
6.2.1.2 	Etythrocyte perfusions. 
For perfusions at 37°C, fresh bovine erythrocytes were washed 3 times using 
saline (0.9% NaC1), and 3 times using Krebs-Henseleit buffer and were added to 
modified Krebs-Henseleit medium containing 2.5 trdsn CaC1 2 and 4% BSA (35% 
haematocrit). Perfusion was initially commenced at 4 ml.min -1 for 30 min until 
equilibration and then the flow rate increased to 15.3 ± 0.2 ml.min -1 . As for the 
erythrocyte-free perfusions, the resting length of the muscles were then adjusted to 
attain maximum active tension. Samples of venous perfiisate were collected in gas-
tight syringes at basal conditions (approx. 2 min before electrical stimulation), 4 min 
after stimulation (before infusions) when plateau tension development was reached, 3 
min after vehicle or 5-HT infusion (when maximum changes due to 5-HT were 
attained), and 19 min after commencement of electrical stimulation. To determine the 
times for collecting these samples a continuous qualitative assessment of venous 
effluent oxygen content was made during initial perfusions using an in-line Clark-type 
oxygen electrode. Arterial samples were taken from an in-line arterial septum at basal 
conditions and at the completion of the perfusion which corresponded to approx. 25 
min after commencement of electrical stimulation. Samples of perfusate were 
analyzed for total oxygen content using a galvanic cell oxygen analyser (TasCon 
Oxygen Content Analyser, manufactured by the Physiology Department, University of 
Tasmania). Duplicate analysis of each collected sample took an average of 15 min. 
From estimates conducted by others (Ruderman et al., 1980) of 0.4 !mole 
lactate produced.m1 -1 .h-1 bovine erythrocytes and an estimated passage time of 1 min 
for the perfusion media through the apparatus and hindlimb at 15.3 ± 0.2 ml.min -1 , it 
was calculated that the erythrocytes would contribute only 0.5 This 
small contribution to lactate release by erythrocytes was ignored. 
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6.2.2 	Incubated muscles. 
Male hooded Wistar rats (60-70 g) were anaesthetized with an 
intraperitoneal injection of aqueous pentobarbital sodium (6-8 mg/100 g body 
weight) containing heparin (100 U/100 g body wt). The soleus and extensor 
digitorum longus (EDL) muscles from each leg were quickly and carefully removed 
and placed in 95% 0 2-5% CO2 gassed incubation buffer until use. 
A modified Krebs-Henseleit buffer was used which consisted of (mM): 118 
NaC1, 4.74 KC1, 1.19 KH 2PO4, 1.18 MgSO4, 25 NaHCO3 , 1.27 CaC12, 5 glucose, 5 
pyruvate, 35 mannitol and 5 HEPES. After gassing, the pH was 7.35 at 25°C. 
Incubations were conducted in a thermostatically-controlled chamber (Figure 
6.2). The incubation temperature was 25°C to improve the efficiency of contraction 
(Segal et al., 1986). The incubation chamber was gassed with 95% 0 2-5% CO2, 
which also served to mix the medium. For each experiment, the proximal and distal 
tendons of the muscles were secured to the metal support and the force transducer 
respectively and then tensioned to give maximal force during stimulation (Figure 6.2). 
After 10 min of preincubation, electrical stimulation was commenced using 
200 ms trains of 100 Hz 0.5 ms pulses applied every 2 s and adjusted (10-12 V) to 
attain full fibre recruitment. 
Tension development was recorded continuously during electrical 
stimulation. After the initial anaerobic phase, the contraction reached a sustained, 
aerobic, plateau level (15 min of stimulation). At this point either vehicle (control) or 
1 1.tM 5-HT (including tracer amounts of PH1-5-HT and [ 14g-sucrose) was added to 
the incubation chamber, and contraction continued for a further 10 mm. After 
cessation of stimulation, 5-HT-treated muscles were rapidly removed, weighed and 
freeze-dried. Freeze-dried muscles were homogenized in H20 and after 
centrifugation an aliquot of supernatant was taken for radioactive counting to 
determine the total content of [311]-5-HT and [ 14g-sucrose. A further aliquot of 
supernatant was used for HPLC analysis (C18 reverse phase, mobile phase 
methanol:H20 90:10) to determine the metabolism of [311]-5-HT. 
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Figure 6.2 	Isolated muscle incubation apparatus. 
Soleus or EDL muscles were attached to the gassed, temperature-controlled 
incubation chamber and directly to the force transducer. 5-HT was added 
directly to the incubation medium. EDL, extensor digitorum longus; 5-HT, 
serotonin; carbogen, 95% 02-5% CO2. 
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6.2.3 Statistical analysis. 
Two-tailed, unpaired Student's t test was used to determine the significance 
of difference between vehicle and 5-HT addition. Significant differences were 
recognized at P < 0.05. 
6.3 	Results. 
Electrical stimulation of the sciatic nerve contracted all the muscle groups in 
the lower leg in addition to some muscle groups above the knee, consistent with the 
findings of Rennie and Holloszy (1977). Thus the observed changes in perfusion 
pressure and metabolism were a combination of contraction-stimulated lower leg, and 
uncontracted upper hindlimb effects. 
6.3.1 	Erythrocyte -free perfusions. 
A distinct advantage of the perfused hindlimb at 25°C without erythrocytes 
was that venous P02 could be monitored continuously. Thus in the present 
experiments time course changes in V0 2 in relation to pressure and tension could be 
compared. 
Under basal conditions, prior to electrical stimulation (flow rate 17.0 ± 0.2 
ml.min-1), mean arterial and venous P0 2 were 678.1 ± 8.4 mmHg and 593 ± 11.1 
mmHg, respectively (n = 10) equating to a V02 of 8.0 ± 0.5 ilmol.h -1 .g-1 . Basal 
perfusion pressure was 58.8 ± 1.2 mmHg (n = 10), and lactate release was 6.5 ± 1.2 
j_tmol.11-1 .g-1 . The value for V02 under basal conditions was similar to that reported 
by this laboratory previously at flow rates greater than 8 ml.min4 (Ye etal., 1990b). 
Stimulation of the lower hindlimb muscle groups via the sciatic nerve caused 
an initial peak in tension development of 898 ± 50 g. The initial strong tension rapidly 
decreased to a plateau level of 211.1 ± 14.6 g after 6 min of stimulation (n = 10). The 
time taken to attain the plateau level of tension development coincided with the 
attainment of steady state for V02 and lactate release (approx. 4 mm). After 6 min, 
V02 had increased to 12.3 ± 0.7* and lactate release to 24.0 ± 1.7* 
Values for contraction-stimulated increases in V0 2 and lactate release were 
obtained using the entire hindlimb muscle mass, thus actual values/g contracting tissue 
may be 3 times greater [according to 30% contracting tissue, Rennie and Holloszy 
(1977)]. 
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iimol.h- l.g-1 . Perfusion pressure remained constant (59.5 ± 1.0 mmHg, n = 10) when 
vehicle alone was added. V02 and tension development remained constant for the 
duration of the perfusion (Figure 6.4). Lactate release increased 4.4-fold with 
electrical stimulation and then decreased steadily during stimulation to a level 
approximately 2-fold greater than the basal pre-stimulation value. 
	
6.3.1.1 	Effect of prior infusion of 5 -HT on skeletal muscle contraction. 
Infusion of 0.25 p.M 5-HT for 6 min increased perfusion pressure by 42.2 ± 
7.5 mmHg and decreased V0 2 and lactate release by 3.0 ± 0.4 innol.h-1 .g4 and 3.9 ± 
0.3 p.mol.h-1 .g-1 , respectively (n = 3, Figure 6.3). Initial peak tension upon 
commencement of sciatic nerve stimulation was not affected by prior infusion of 5-HT 
(971 ± 26 g, n = 3, Figure 6.4). However, prior infusion of 5-HT inhibited plateau 
tension (6 min) development by 62.1 ± 16.3 %, and contraction stimulated rises in 
V02 and lactate release by 75% and 40%, respectively (n = 3, Figure 6.3). During the 
stimulation period, 5-HT increased perfusion pressure a further 33.3 ± 13.8 mmHg (n 
= 3). 
6.2.1.2 	Effect of 5-HT during skeletal muscle contraction. 
Figure 6.4 shows time courses for the effects of 0.25 pIVI 5-HT and its 
vehicle on tension development, V0 2, lactate release and perfusion pressure. 5-HT 
inhibited plateau tension (6 min stimulation) development by 40%. The maximum 
inhibitory effect of 5-HT on tension development occurred 4 min after 5-HT infusion 
had ceased (Figure 6.4), and slowly returned to control levels by the end of the 
stimulation period. When 5-HT was infused for greater than two min, contraction did 
not return to control values even after 12 min of 5-HT removal (data not shown). 
Continuous recording of V02 showed that the 5-HT mediated inhibition of V0 2 
preceded the inhibition of tension development (Figure 6.4). In addition, infusion of 
5-HT almost (97%) totally inhibited the electrical stimulation-induced increase in 
Vo2, with the inhibition occurring rapidly and coinciding with the increase in pressure 
(Figure 6.4). However, the inhibition reversed slowly and did not attain pre-5-HT 
infusion values until at least 5 min after the infusion of 5-HT had ceased. 
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Figure 6.3 	Effect of 5-HT on V02, lactate release, perfusion pressure and 
tension development before and during skeletal muscle 
contraction. 
The rat hindlimb was perfused in a non-recirculating mode without erythrocytes 
at 25°C as described in Methods. The lower hindlimb muscle groups were 
made to contract by electrical stimulation of the severed sciatic nerve (flank) 
using a suction electrode, and tension in the GPS muscle group was measured 
using an isometric force transducer. 5-HT (0.2511M) or its vehicle were infused 
for the period indicated by the bar. Values are means SE for five control 
perfusions (0, from Figure 6.4) and three 5-HT-treated perfusions (•). When 
not visible, error bars are within symbols. 5-HT, serotonin, V0 2, oxygen 
uptake; GPS, gastrocnetnius-soleus-plantaris. 
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Figure 6.4 	Effect of 5-HT on V0 2, lactate release, perfusion pressure and 
tension development during skeletal muscle contraction. 
The rat hindlimb was perfused in a non-recirculating mode without erythrocytes 
at 25°C and lower hindlimb muscles contracted as described in Figure 6.3. 
5-HT (0.25 1.1.M) or its vehicle were infused for the period indicated by the bar. 
Values are means ± SE for five control perfusions (0) and five 5-HT-treated 
perfusions (0). When not visible, error bars are within symbols. 5-HT, 
serotonin; V02, oxygen uptake. 
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Contraction-mediated lactate release was transiently inhibited by 41% after 2 
min of 5-HT infusion, but within 2 nun of removal of 5-HT, had returned to control 
values. 
Infusion of 5-HT increased perfusion pressure by approx. 60 mmHg after 2 
min of infusion, representing an increase of 103% above basal pressure. The time 
course for the change in pressure indicated that the overall effect lasted approx. 5 min, 
the pressure returning to control, untreated levels. 
6.3.1 	Erythrocyte perfusions. 
6.3.1.1 	Effect of 5-HT during skeletal muscle contraction. 
Under basal conditions at high flow rate (15.3 ± 0.2 ml.min -1), mean arterial 
oxygen content was 7.89 ± 0.12 mmoUl, mean venous oxygen content was 6.88 ± 
0.13 mmo1/1 (n = 10) with a VO2 of 59.6 ± 3.1 1.tmol.h -1 .g-1 , and lactate release was 
12.3 ± 2.1 prnol.h -1 .g-1 . The values for V02 and lactate release under basal 
conditions were somewhat higher than those reported by Ruderman et al. (1971) but 
may result from the higher flow rate used in the present studies and test stimulations 
of the muscles to generate the force tension curve. V0 2 (Ruderman et al., 1980; Ye 
et al., 1990b) and lactate release (Ye et al., 1990b) are flow rate dependent in the 
perfused rat hindlimb. Basal perfusion pressure was 64 ± 2 mmHg (n = 8, Figure 
6.5), which was higher than erythrocyte-free perfusions despite similar flow rates. 
This was presumably due to the higher viscosity of the 4% BSA erythrocyte medium. 
Figure 6.5 shows the effect of electrical stimulation of the sciatic nerve on 
tension development, lactate release and perfusion pressure. Stimulation of the lower 
hindlimb muscle groups via the sciatic nerve produced an initial tension in the Achilles 
tendon of 1109 ± 127 g (n = 5) and 1082 ± 95 g (n = 5) for the control and 5-HT 
treated groups, respectively. These values were similar to that initially developed by 
the erythrocyte-free perfused hindlimb at 25°C. Tension then rapidly decreased to a 
plateau level of 335 ± 28 g (n = 5), control group and 312 ± 40 g (n = 5), 5-HT 
treated group, which was approx. 150% of that attained using erythrocyte-free 
perfused hindlimbs at 25°C, and remained constant for the duration of the perfusion 
(Figure 6.5). Lactate release initially increased 5-fold with electrical stimulation then 
decreased slightly to 2-fold basal levels (Figure 6.5). The perfusion pressure rose 
gradually by approx. 8 mmHg in the course of the perfusions. Stimulation per se 
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Figure 6.5 	Effect of 5-HT on lactate release, perfusion pressure and tension 
development during skeletal muscle contraction. 
The rat hindlimb was perfused in a non-recirculating mode with medium 
containing erythrocytes at 37°C, and lower hindlimb muscles contracted as 
described in Figure 6.3. 5-HT (0.25 41\4) or its vehicle were infused for the 
period indicated by the bar. Values are means ± SE for five control perfusions 
(0) and five 5-HT-treated perfusions (•). When not visible, error bars are 
within symbols. 5-HT, serotonin; V02, oxygen uptake. 
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appeared to have no immediate effect on perfusion pressure (Figure 6.5). The initial 
effect of electrical stimulation on V02 could not be quantitatively assessed as timing 
of sampling to correspond precisely with peak tension development was not possible. 
However continuous recording of the venous P02 in some of the erythrocyte-
perfusions suggested that there was no immediate change during this period. Table 
6.1 shows that V0 2 increased 1.5-fold during stimulation from 61.1 ± 4.1 to 92.5 ± 
5.9 pmol.h -1 .g4 . Again, continuous recordings suggested that this took 2-3 min to 
reach steady state (data not shown). Contraction-stimulated rises in V0 2 in 
erythrocyte-perfused hindlimbs when expressed per gram of contracting muscle are 
comparable to values obtained by others (Table 6.2). 
Figure 6.5 shows that a brief (2 min) infusion of 0.25 p.M 5-HT, commenced 
6 min after the start of electrical stimulation, increased perfusion pressure by approx. 
30 mmHg. Continuous recording of data showed that the effect was evident within 
seconds after commencement of infusion and began to rapidly reverse as soon as 
infusion ceased. However a residual pressure increase was consistently present for 
the remainder of the stimulation period. This is in contrast to the complete reversal of 
pressure effects in the absence of erythrocytes (Figure 6.4). When 5-HT was infused 
for longer than 2 min, the reversal of pressure after 5-HT removal was slower and 
remained elevated above control (data not shown). The increase in pressure was less 
than the change in pressure in the erythrocyte-free perfused hindlimb at 25°C (Figure 
6.4). 
Figure 6.5 also shows that after 3 min following 5-HT removal, there was a 
54% decrease in developed tension during the plateau aerobic phase from 329.3 ± 
25.2 g (n = 5) to 156.5 ± 47.9 g (n = 5). Tension slowly returned towards 
pre-5-HT levels, but remained below control values for the remainder of the 
stimulation period (Figure 6.4). 
Contraction-mediated lactate release in was transiently inhibited by 39% 
during 5-HT infusion from corresponding control values of 45.1 ± 2.3 p.mol.h - l.g-1 to 
24.4 ± 5.6 pmol.h- '.g4 after 2 min of 5-HT infusion. Within a further 2 min lactate 
release had returned to control values, which continually declined for the remainder of 
the stimulation period (Figure 6.5). 
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Perfusion Condition 
T0,. 
Time (min) Vehicle 0.25 I.LM 5-HT 
Basal 0 61.1 ± 4.1 58.1 ± 5.1 
Plateau Contraction* 6 92.5 ± 5.9 98.4 ± 12.4 
Maximal Response to 5-HT* 9 95.1 ± 9.6 64.6 ± 9.5 
End Contraction Period 19 71.8 ± 6.9 73.1 ± 15.1 
Table 6.1 	Effect of 5-HT on VO2 by perfused hindlimb during skeletal 
muscle contraction. 
The rat hindlimb was perfused and lower hindlimb muscles contracted as 
described in Figure 6.5. Venous effluent was sampled prior to and during 
contraction stimulation at the times indicated, and analysed as described in 
Methods. 5-HT (0.25 p.M) or its vehicle were infused for a two min 
period after plateau tension was obtained (Figure 6.5). Values are means 
± SE for five control perfusions and five 5-HT-treated perfusions. 5-HT, 
serotonin; V02, oxygen uptake; *, samples collected at times 
corresponding to changes in venous P02 observed with an in-line oxygen 
electrode. 
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Hindlimb 
Ref. 	 Mass Contracted 
TID2 
Basal* Contraction§ 
This Study 30% 1 . 59.6 ± 3.1 119.3 
Ruderman et al. (1971) 30% 1 - 14.6± 1.6 142.0 
Ruderman et al. (1971)t 30% 1 . 18.2 ± 2.4 90.7 
Richter et al. (1982a)t 30% 1 . 23.5 ± 1.1 128.3 
Spriet et al. (1985) 56%A 33.6 ± 1.3 122.0 
McAllister and Terjung (1991)t 80%A 20.4± 1.2 194.3 
Table 6.2 	Basal and contraction-stimulated V0 2 in erythrocyte-perfused rat 
hindlimbs. 
Hindlimbs or lower-limbs (4) of sedentary rats were perfused with 
constant, high flow rates at 37°C with modified Krebs-Henseleit medium 
containing either fresh or rejuvenated erythrocytes and 4% bovine serum 
albumin. Portions (% given) of the perfused mass were electrically 
stimulated to contract via the sciatic nerve. Arterial and venous effluent 
samples were analysed with blood-gas analysers. *, Values are means ± 
SE; §, maximum contraction-stimulated increases in V02 were 
recalculated assuming that only contracting tissue contributed to the rises 
in V02 ; A, from Rennie and Holloszy (1977); t, medium contained insulin. 
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Contraction-induced V02 was markedly inhibited (94%) by 5-HT (Table 
6.1), but after 13 min following 5-HT removal, V02 had returned to control levels 
(Table 6.1). 
6.3.3 	Incubated muscles. 
Comparison of all the data from both control and 5-HT groups showed that 
before addition of vehicle or 5-HT, electrical stimulation of the soleus and EDL 
muscles produced significantly different (P < 0.01) initial tensions of 22.8 ± 1.1 g and 
35.3 ± 2.7 g respectively (n = 6). After 15 min of stimulation, the tension rapidly 
decreased to significantly different (soleus vs. EDL) plateau levels of 11.4 ± 0.6 g and 
7.3 ± 0.5 g respectively (P < 0.001, n = 6) and remained relatively constant for the 
remainder of the incubation (Figure 6.6). 
Figure 6.6 shows that 5-HT had no significant effect on the tension 
developed by either the soleus or EDL muscles. This lack of an effect was not the 
result of poor penetration or excessive metabolism of 5-HT as [ 311]-5-HT diffused 
into, but was not significantly metabolized by the muscles (data not shown). 
6.4 	Discussion. 
The main observation from this study was that 5-HT inhibited the aerobic 
contractility of working muscle in the constant-flow perfused rat hindlimb, but not 
incubated muscles. This effect appeared to have occurred as a result of impaired 
nutrient delivery and was evident whether or not 5-HT was infused before and/or 
during the stimulation period. 
Two perfusion systems were used in the present study. The perfusions with 
erythrocytes at 37°C were conducted because of the possibility that oxygen delivery 
to working muscle would be inadequate if erythrocytes were omitted. However a 
disadvantage of the erythrocyte-perfused system was that continuous recording of 
V02 was not readily possible and intermittent perfusate samples were taken for 
oxygen content analysis. Perfusion with erythrocyte-free medium overcame this 
problem. 
The present studies show that the effects of both sciatic nerve stimulation 
and 5-HT were qualitatively similar for both types of perfusion. As shown in Figures 
6.4 and 6.5, during contraction, tension produced by the lower hindlimb muscle 
142 
 
50 
40 
30 
20 
10 
0 
50 
40 
30 
20 
10 
0 
  
Stimulation 
 
-  
  
 
SQL 
_ 
 
    
  
- 434aO-,•--e__._.__.__•_._...e_. 
  
- • 
 
I 	I 	I 	I 	 1 
0 	5 	10 	15 	20 	25 
Time (min.) 
Figure 6.6 	Effect of 5-HT on muscle tension development by electrically- 
stimulated isolated soleus and EDL muscles. 
Muscles were dissected, incubated and stimulated as described in Methods. 
Either the EDL or soleus muscles were attached to the incubation apparatus and 
electrically stimulated to contract. Tension generated by each muscle was 
measured using an isometric force transducer. Values are means ± SE with 3 
incubations for each treatment. Vehicle (0) or 5-HT (0, 1 1118/1) were added 15 
min after commencement of electrical stimulation and were present for the 
period indicated by the filled bar. 5-HT, serotonin; V02, oxygen uptake; EDL, 
extensor digitorum longus; SOL, soleus. 
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groups fatigued after an initial peak in tension. Richter (1984) proposed that the rapid 
initial fall in tension could be due to selective fatigue of the fast-twitch white fibres 
resulting from rapid glycogen depletion (Richter et al., 1982b). These fibres 
constitute approximately 60% of the gastrocnetnius-plantaris-soleus group (Ariano et 
al., 1973). Consistent with this report, the incubated EDL had a significantly greater 
initial tension when compared to the soleus, but fatigued to plateau levels significantly 
below the soleus (Figure 6.6). 
In both perfusion systems, sciatic nerve stimulation led to marked increases 
in V02 and lactate release in association with tension development but little change in 
perfusion pressure. 5-HT increased perfusion pressure, markedly decreased tension, 
and contraction-induced V0 2 and, to a lesser extent, lactate release in both perfusion 
systems. The latter suggests anaerobic metabolism was the predominant generator of 
energy during 5-HT-impaired contraction. The rapid reversal of the lactate release to 
control levels may also be due, at least in part, to the transient increases in lactate 
release observed after 5-HT removal (Dora et al., 1991, Chapter 2). This washout 
was presumably due to re-establishment of flow to previously oxygen-limited regions, 
and was similar to that observed upon re-establishment of flow to physically occluded 
regions (Chapter 2, Dora et al., 1991). 
However there were differences between the two perfusion systems that 
merit comment. Whilst peak tension development of the muscle group was similar in 
the two preparations, plateau tension development differed considerably with 324 ± 
23 and 211 ± 15 g, being the tension developed with erythrocyte perfusion at 37°C, 
and erythrocyte-free perfusion at 25°C, respectively 1 .. This difference may result 
1. 	Although not directly relevant to the present study on the effects of 5-HT, a 
comparison of Figures 7.4 and 7.5 reveals that the perfused hindlimb appears to 
perform more efficiently at 25°C without erythrocytes than at 37°C with erythrocytes. 
At 25°C the hindlimb developed 211 ± 15 g of tension and consumed an extra 3.8 
pmol 02 .h-1 .g-1 , equivalent to 55.5 g of tension/iAmol 02 .h- l.g-1 . At 37°C the ratio 
was far lower at 9.1 g of tension/p.mol 02 .h- l.g-1 . Contraction-stimulated lactate 
release at 25°C was half that at 37°C. Thus at 25°C and 37°C the ratios of 
tension:lactate release were 11.2 and 9.0 g of tension/p.mol lactate.h 4 .g-1 , 
respectively. There is no obvious explanation why tension development is more 
expensive at 37°C with erythrocyte-perfused hindlimbs. 
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from the superior oxygen delivery afforded by erythrocytes, or it may reflect lower 
efficiency of excitation-contraction coupling, and/or muscle performance, at the lower 
temperature (Stephenson & Williams, 1981). 
Another major difference between the two perfusion systems was the 
magnitude of the effect of 5-HT. When infused within the contraction period, during 
erythrocyte perfusions at 37°C, 0.25 11M 5-HT resulted in a pressure increase of 
approximately 30 mmHg. This compared to an increase of 60 mmHg in the 
erythrocyte-free perfusions at 25°C. An explanation as to why 5-HT-mediated 
vasoconstriction was less pronounced at 37°C may relate to a right-ward shift in the 
dose response curve for 5-HT at the higher temperature (Chapter 5, Figure 5.1), 
consistent with the observed increase in 5-HT pressure-sensitivity with cooling 
(Harker et al., 1991). However, when infused in the absence of contraction at 25°C, 
0.25 l_tM 5-HT increased pressure to steady-state levels only 42 mmHg above basal. 
Time course studies using erythrocyte-free perfused hindlimbs at 25°C 
(Figure 6.4) showed that the sequence of changes induced by 5-HT was increased 
perfusion pressure (vasoconstriction) closely associated with an inhibition of V02, 
followed by decreased contractility. This sequence and the lack of an effect in 
incubated muscles suggests that 5-HT does not impair contractility directly by 
receptor-mediated effects on skeletal muscle. Rather, the sequence is consistent with 
the hypothesis of functional vascular shunting (Dora et al., 1991, 1992). So far the 
evidence supporting the notion of 5-HT mediated vascular shunting in perfused rat 
hindlimb is indirect (Chapters 2, 3, and 5). In the present study it is proposed that 
5-HT constricted larger blood vessels, possibly feed arteries, to induce a partial 
redistribution of flow away from the working muscles thereby diminishing oxygen 
supply. This effect may have been fibre-type specific, presumably with flow 
decreasing to slow-oxidative fibres which have less capacity for anaerobic contraction 
metabolism. The feed arteries have been shown to be active sites of blood flow 
control to contracting muscle, with soleus muscles exhibiting a greater range of flow 
control than EDL (Williams & Segal, 1993). 
The effect of 5-HT to redistribute perfusate flow and concomitantly decrease 
contractility in the perfused hindlimb are similar to effects of sympathetic nervous 
system activity observed in vivo. During low intensity exercise in vivo, in addition to 
local vasodilatation, there is also an increase in sympathetic nervous system activity, 
predominantly to redistribute cardiac output away from inactive areas. However, as 
145 
exercise intensity increases, the maximal flow to contracting muscle can be limited by 
sympathetic vasoconstriction (Joyner et al., 1990, 1992). This occurs at the level of 
the feed arteries external to the active muscle (Lind & Williams, 1979), overcoming 
the contraction-induced dilatation suggesting diminished effectiveness of upstream 
communication (as reviewed by Segal, 1992). 
It is unknown whether upstream communication occurs in the constant-flow, 
perfused rat hindlimb preparation used in these studies. However, using the same 
perfusion system, exercise-stimulated vasodilator release decreased the 
vasoconstriction by angiotensin II (Colquhoun et al., 1990). Skeletal muscle 
contraction did not overcome the 5-HT-induced vasoconstriction in this study thus 
providing evidence supporting the notion of 5-HT stimulating vasoconstriction at 
different sites to thermogenic vasoconstrictors (such as angiotensin II) within the 
muscle bed. 
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CHAPTER 7 
Vasoconstrictor-mediated alterations in flow distribution. 
7.1 	Introduction. 
The results in this thesis have clearly demonstrated that vasoconstriction in 
the constant-flow perfused rat hindlimb can differentially control tissue metabolism. It 
has been proposed that vasoconstriction by low doses of norepinephrine (NE) leading 
to increases in hindlimb oxygen uptake (V02) and lactate release was at least partly 
due to work done during constriction of arteriolar smooth muscle, and a possible 
redistribution or recruitment of flow to highly metabolically active regions (described 
in more detail in Chapter 1). Conversely, vasoconstriction by serotonin (5-HT) and 
high doses of NE leading to decreases in hindlimb V0 2 and lactate release appeared to 
occur at sites metabolically distinct from lower doses of NE. Since 5-HT is known to 
constrict relatively larger blood vessels than those constricted by angiotensin II, 
vasopressin and low doses of NE (Gray, 1971; Blackshear et al., 1985; Hirst & 
Edwards, 1989; Lamping et al., 1989; Tuncer et al., 1992), partial or complete 
closure of the 5-HT-sensitive vessels may either redistribute flow to less metabolically 
active tissue, or deny flow to some regions. 
These apparently anomalous metabolic effects of vasoconstrictors do not 
appear to be due to direct effects on skeletal muscle metabolism and therefore raise 
questions about the control of flow through the rat hindlimb vasculature. Techniques 
used to measure changes in flow within the microvasculature of an organ include: 
(a) dilution measurements of bolus injected nondiffusible indicators such as dyes 
(Starr & Frasher, 1975) and labelled erythrocytes or dextrans (Baker et al., 1982); or 
diffusible indicators such as radiolabelled xenon (Lassen, 1964) or other gasses 
(Gronlund et al., 1989; Harrison etal., 1990b); 
(b) entrapment of bolus injected radio- or fluorescently-labelled markers such as 
microspheres (Laughlin etal., 1982; Piiper etal., 1985; Gorski etal., 1986; Iversen & 
Nicolaysen, 1990; Bassingthwaighte et al., 1987, 1990), or soluble flow markers 
(Bassingthwaighte et al., 1990); 
(c) measurement of erythrocyte velocities and flow distribution in 
transilluminated surface capillaries of muscles using intravascular microscopy 
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(Eriksson & Myrhage, 1972; Sullivan & Pittman, 1982; Lindbom & Arfors, 1984; 
DeLano etal., 1991; Tyml & Budreau, 1991); and 
(d) 	physical observation of vascular architecture by digestion or clearing tissue 
surrounding methyl-methacrylate (Potter & Groom, 1983; Kimura et al., 1990) or 
silicone rubber (Williams & Segal, 1992) casts. 
Each of the above techniques has inherent advantages and disadvantages 
(reviewed by Hyman, 1971; Bassingthwaighte, 1986; Duling & Damon, 1987; Austin 
etal., 1989; Lipowsky et aL, 1988). Indicator dilution techniques can be carried out 
on intact, undisturbed tissues, and most do not alter flow patterns. However, vascular 
tissue adherence and permeability can be limitations to accuracy of measurement. 
Microspheres do not leave the lumen, yet their use has many disadvantages. These 
include: partial or complete obstruction of flow through vessels in which they lodge; 
alteration of the apparent size of vessels when forced through by backpressure; no 
indication of flow heterogeneity within capillaries; the occurrence of rheological 
biasing; and, when using radiolabelled spheres, stochastic and reference errors must be 
considered (reviewed by Austin et al., 1989). Both flow markers and microspheres 
have the potential to show temporal alterations in the distribution of flow, but do not 
distinguish true flow heterogeneity from spatial heterogeneity (Duling and Damon, 
1987) and do not give an indication of relative tissue metabolism. Vascular corrosion 
casts usually contain toxic components and have high viscosity. These factors can 
alter flow patterns within the circulation (reviewed by Lametschwandtner et al., 
1990), especially in the presence of vasoconstrictors. 
In this study, the techniques employed were dye efflux kinetics, entrapment 
of labelled dextran and injection of microspheres. 
7.2 	Materials and methods. 
7.2.1 	Perfused hindlimbs. 
Surgery was performed on 180-200 g rats as outlined in Section 2.2.1.2.1. 
Experiments were performed at 25°C with 2% BSA added to the perfusion medium. 
Additional details are given in Section 2.2.1. In fluorescein-labelled dextran 
entrapment studies both legs of each rat were perfused. This minimized the possibility 
of pressure-induced redistribution of flow through collateral circulation. In these 
experiments the perfusion protocol was as previously except the contralateral 
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common iliac was not tied and the perfusion flow rate was doubled. The hindlimb 
skeletal muscle mass was assumed to be twice that of one hindlimb. 
7.2.2 	Evans Blue dye efflux kinetics. 
A dye injection technique was used to estimate changes in volume of tissue 
perfused. Evans Blue dye was used as it could be detected during the experimental 
period by use of an in-line spectrophotometer. A constant volume injector 
(Pharmacia Fine Chemicals, Sweden) was incorporated into the hindlimb perfusion 
apparatus prior to the hindlimb. This enabled a 35 pl pulse of filtered (Millipore 0.45 
p.m) Evans Blue dye (5 mg.min-1 oxygenated perfusion media) to be injected into the 
arterial line with minimal, and transient alteration in hindlimb pressure. A Hitachi 
model 101 spectrophotometer was positioned immediately beyond the hindlimb, and 
by incorporating an in-line flow-through cuvette, continuous changes in absorbance 
(630 nm) of venous perfusate were monitored. The initial increase in absorbance was 
rapid relative to decrease from maximum, thus data were only analysed for the latter. 
In addition, due to technical limitations, mean transit times through the hindlimb could 
not be monitored, thereby not permitting the Stewart-Hamilton technique of indicator 
dilution (described by Lipowsky et al., 1988). 
Dye absorbance was linearly related to dye concentration. At steady state 
V02 and pressure and when the effluent was free of residual erythrocytes, dye 
injections were commenced. Absorbance was recorded continuously and three 
separate injections of dye were made once steady state conditions were obtained 
before, during, and after infusion of 5-HT or NE. To assess the effect of a deliberate 
diminution of perfused tissue the hindlimb was reversibly tied off below the knee with 
a soft rubber tourniquet, thereby decreasing the perfused muscle mass from 
approximate values of 15 to 12.5 g, and dye was injected as above. A separate rat 
was used for each treatment. 
Reproducibility and rapidity of efflux profiles suggested leakage from the 
lumen was minimal, or at least consistent. When studying flow through the feline 
mesentery, Starr and Frasher (1975) reported than in the presence of 3% bovine 
albumin, a solution of 5% Evans blue did not produce vascular leakage or any other 
adverse effect visible through a microscope. 
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7.2.3 	Entrapment of fluorescein-labelled dextran. 
Fluorescein-labelled dextran (Fluorescein isothiocyanate, FITC, ay. mol. wt. 
150,000, Pharmacia Fine Chemicals, USA) was used in this study to reduce the 
possibility of vascular leakage and to enable detection at low concentrations without 
the need for radioisotopes. Svensjo et al. (1978) found that upon intravenous 
injection of FITC-dextran (ay. mol. wt. 150,000) only a few leakage sites per cm2 of 
cheek pouch or cremaster muscle were observed, mostly through postcapillary 
venules. However, the number of leakage sites increased upon topical application of 
histamine or bradylcinin (Svensjo et al. (1978). 
5-HT has also been shown to produce increases in vascular permeability to 
macromolecules subsequent to endothelial cell separation in the postcapillary venules 
(reviewed by Grega, 1986). Thus in preliminary studies, the washout of tracer 
amounts of [ 14q-sucrose (2x104 dpm.m1-1 in 0.5 mM unlabelled sucrose) in addition 
to FITC-dextran was determined. In situations where the sucrose space was 
increased due to tissue oedema, the sucrose washout was delayed, but FITC-dextran 
washout was not markedly affected (data not shown). In addition, FITC-dextran 
washout patterns were compared in the presence and absence of 5-HT, and no 
significant difference observed (data not shown). 
FITC-dextran was dissolved in perfusion medium to a final concentration of 
1 mg.m14 and infused into the hindlimb at one-hundredth the perfusion flow rate. 
Fluorescence was detected using an Arninco-Bowman Spectrofluorometer, excitation 
and emission wavelengths set at 494 and 528 nm, respectively. Venous effluent 
samples (0.5, 1 or 2 min) were collected with an ISCO Retriever II fraction collector 
and centrifuged to remove erythrocytes (IEC DPR-6000 centrifuge, 2000 g). After 
10 min of FITC-dextran infusion, and in the presence of FITC-dextran, either NE (0.1 
ptM) or 5-HT (1 pt.M) were infused for a minimum of 10 min until steady state 
pressure and V02 were obtained. The protocol then involved either: 
Protocol /: Removal of the agonist until basal V02 and perfusion pressure were 
obtained (15 min) then cessation of FITC-dextran infusion. After a defined 
period (t = 6, 10 or 15 min) the agonist was reinfused and measurement of 
washout of entrapped marker commenced (Figure 7.2); or 
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Protocol II: Cessation of FITC-dextran infusion after a defined period (t = 6, 10 or 
15 min) before removal of the agonist and measurement of washout of 
entrapped marker (Figure 7.2). 
The difference in the two protocols was Protocol I involved agonist-induced 
entrapment in a recruited space, whereas Protocol II involved agonist-induced 
entrapment in a space denied access from the basal-perfused space. t was varied to 
determine whether entrapped spaces were slowly perfused or totally denied flow. 
The summed differences between control and treated washout curves were 
transformed to FITC-dextran concentrations from standard curves. The vascular 
volumes could be estimated by comparison to the steady-state concentration of FITC-
dextran during infusion. 
The total basal vascular space was also determined to allow determination of 
the proportion entrapped by agonists. The FITC-dextran was infused and allowed to 
equilibrate in the untreated hindlimb. The rat was disconnected, marker removed 
from the apparatus inflow and outflow tubing, and the rat reconnected (4 min 
unperfused). The washout from the hindlimb was then determined. The volume 
contained in the arterial and venous cannulas was also determined and subtracted 
from space values. 
7.2.4 	Microsphere injection. 
To assess whether 5-HT-induced vasoconstriction was redistributing flow 
through direct arterio-venous (A-V) shunts in the liindlimb, rnicrospheres were 
injected in the absence and presence of 1 1.1N4 5-HT. 
The size distribution of the polystyrene spheres (Latex Beads, aqueous 
suspension, Sigma, USA) was determined to be 12.12 ± 2.93 p.m (mean ± SD, n = 
177), ranging in size from 5-20 gm (Figure 7.2). 15 (1-3 x 10 6) of the tnicrosphere 
suspension was added to 1.5 ml perfusion medium and sonicated for 1 hr to break up 
aggregates. 
In control perfusions, the sonicated suspension was drawn into a 1 ml syringe 
and rapidly injected through a 3-way tap into the arterial perfusion line. The other 
arm of the tap was used for flushing. 
In 5-HT-treated hindlimbs, the sonicated suspension was drawn into a low 
dead-space 1 ml syringe with needle built in (270, Terumo, USA) and injected into 
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the arterial line through the infusion port. 
Immediately upon injection of the microspheres, effluent perfusate was 
collected directly into centrifuge tubes in 5 min fractions for 10 min. Samples were 
centrifuged for 15 min at 2000 g, and the supernatant aspirated. The pellet was 
resuspended and transferred after weighing to an eppendorf tube. 10 j.tl of detergent 
(DECON 90, Selby Max, Australia) was added to dissolve erythrocyte membranes. 
All samples were vortex mixed and sonicated for 1 hr before counting using a light 
microscope and haemocytometer. 
7.2.5 	Statistical analysis. 
The statistical significance of differences between groups of data were 
assessed by either paired or unpaired, two-tailed Student's t test. Significant 
differences were recognized at P < 0.05. 
The exponential equations in Figure 7.4 were iteratively fitted using EXPFIT 
(Guardabasso etal., 1991). 
7.3 	Results. 
7.3.1 	Evans Blue dye efflux kinetics. 
The steady state mean perfusate P0 2 values for the rat hindlimb were 687 ± 8 
mmHg arterial and 443 ± 8 mmHg venous (n = 11). These values were obtained after 
a 30 min equilibration period. The basal V02 was found to be 5.9 ± 0.2 1.tmol.h4 .g-1 
(n = 11). Basal steady state lactate production was 8.4 ± 0.3 imol.11 -1 .g-1 (n = 8) and 
basal pressure was 24 ± 1 mmHg (n = 11). The basal steady state values for V02, 
perfusion pressure and lactate release remained constant for the duration of control 
experiments (vehicle only) and were similar to those reported previously from this 
laboratory (Colquhoun et al., 1988, 1990; Hettiarachchi et al., 1992). 
Figure 7.1 shows the results of the dye injection studies. Three injections of 
Evans Blue dye were made before, during and after infusion of agonists or occlusion 
of the hindlimb. Averages for each set of three injections were calculated and 
thereafter pooled between rats to obtain means ± SE for the control perfusion and 
each treatment. No significant difference was noted between the averages before and 
after each treatment. Values for absorbance were plotted as a function of time with 
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Figure 7.1 	Dye washout profiles and difference curves in the constant-flow 
perfused rat hindlimb. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min 1 with perfusion medium containing 2% bovine serum albumin and 
gassed with 95% 02-5% CO2 . Panel A shows the effect of infusion of NE (0, 
75 riM) on the time course for Evans Blue dye washout. Panel B shows the 
effect of 5-HT (A, 0.5 11M) and panel C shows the effect of reversible hindlimb 
occlusion at the knee (•). Panels A-C also show data for the control 
conditions involving no infusion of agonist or muscle occlusion (0). Panels 
D,E, and F show the respective difference curves obtained by subtraction of 
control (no addition) values. Dye was injected under steady state conditions, 
further experimental details are given in Methods. Averages for each set of 
three injections within each experiment were calculated. Values shown are 
means ± SE of the averages from five different rats for each separate treatment. 
*, significantly different from corresponding control value (P < 0.05), paired 
Student's t test. NE, norepinephrine; 5-HT, serotonin. 
From Dora et al. (1991). 
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the maximum value arbitrarily at 0 time as this maximum value of effluent dye 
absorbance represents the most common path length or transit time through the 
perfused tissue. Assuming that passage of dye through functional shunts is quicker 
because of shorter length and faster flow than through capillary beds, the peak value is 
inversely related to the volume of capillary bed or volume of tissue perfused. The 
results indicate that NE at a dose which increased pressure by 31 ± 5 mmHg and 902 
by 4.4 ± 0.4 ilmol.h -1 .g-1 (68%, n = 5) significantly decreased maximum absorbance 
values from control values of 1.54 ± 0.04 to 1.50 ± 0.05 (3%). Conversely at a dose 
which increased pressure to the same extent as that observed with NE (31 ± 2 
mmHg), yet decreased V0 2 by 1.8 ± 0.3 imol.h.g 1 (30%, n = 5), 5-HT 
significantly increased maximum absorbance from 1.54 ± 0.05 to 1.69 ± 0.05 (9%). 
The occluded hindlimb decreased 90 2 by 1.3 ± 0.2 imnol.11 -1 .g- I (23%) yet increased 
maximum absorbance from 1.57 ± 0.06 to 1.67 ± 0.05 (6%). Since dye concentration 
and total flow remain constant, these observed changes in maximum absorbance are 
reflected in changes in rate of dye washout; 5-HT and the occluded hindlimb inducing 
a more rapid washout than observed with control conditions and NE a lesser decrease 
in rate of dye washout. Upon infusion of NE the presence of a small quantity of 
erythrocytes was observed in the perfusate which were not observed upon infusion of 
5-HT. Doses of NE greater than 0.1 JIM, which involved increases in pressure 
greater than 40 mmHg yet had reached maximal increases in 90 2, led to an alteration 
in the dye washout curve such that maximum absorbance values were further 
decreased. 
7.3.2 Entrapment of fluorescein-labelled dextran. 
In experiments where two hindlimbs were perfused, the steady state mean 
perfusate P02 values for the rat hindlimb were 692 ± 7 mmHg arterial and 402 ± 19 
mmHg venous (n = 27). These values were obtained after a 30 min equilibration 
period. The basal 902 (assuming the perfused skeletal muscle mass was twice that of 
one perfused hindlimb) was found to be 6.9 ± 0.2 jimol.h -1 .g-1 , and basal perfusion 
pressure was 23 ± 1 mmHg (n = 27), neither value significantly different to the basal 
values obtained in Chapter 2 for one hindlimb. Basal lactate release, however, was 
significantly lower (P < 0.01) at 4.1 ± 0.4 (n = 5). This value is within the range of 
values obtained for one hindlimb. 
During the entrapment experiments 0.1 JAM NE increased V0 2 by 3.1 ± 0.1 
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jAmo1.h4 .g-1 (43 ± 4 %) and perfusion pressure by 32 ± 2 mmHg (142 ± 22 %) above 
basal values. Both these proportions were significantly (P < 0.001, P < 0.02, 
respectively) less than the corresponding effects of NE when one hindlimb was 
perfused. However in a separate study, 0.25 1AM NE increased 902 by 3.9 ± 0.5 
iAmol.h- l.g-1 , lactate release by 17.0 ± 2.9 gmol.h - l.g-1 and perfusion pressure by 68 
± 15 mmHg above basal (n = 5), all values corresponding to those obtained when one 
hindlimb was perfused. In addition, a quantity of erythrocytes was observed upon 
infusion of NE. 
A dose of 1 li,M 5-HT decreased V02 by 3.7 ± 0.2 prnol.h-1 .8-1 (50 ± 4 %) 
and increased perfusion pressure by 66 ± 7 mmHg (329 ± 28 %) above basal values, 
neither proportion significantly different from experiments where one hindlimb was 
perfused. 
Constant infusion of FITC-dextran (10 pg.m1 -1 final) had no effect on 
perfusion pressure or V0 2 , and had reached plateau fluorescence within 10 min. In 
hindlimbs where 0.1 1.1M NE was infused for 10 min in the presence of FITC-dextran 
and subsequently reinfused t = 6 min after FITC-dextran removal (according to 
protocol I), a transient increase in relative intensity was observed in comparison to 
control (Figure 7.3 A). The difference between the two curves transformed to an 
entrapped volume of 220 ± 191.11 (n = 4, Figure 7.4). When t was increased to 15 min 
the entrapped volume decreased to 85 ± 5 pl (n = 2, Figure 7.4). When 0.1 1AM NE 
was infused according to protocol II (t = 6 min), the entrapped volume was found to 
be negligible (data not shown). 
In hindlimbs where 1 iiM 5-HT was infused in the presence of FITC-dextran 
and not removed until t = 6 min after FITC-dextran removal (according to protocol 
II), the relative intensity increased slightly and remained elevated for approx. 14 min 
in comparison to control (Figure 7.3 B). The difference between the two curves 
transformed to an entrapped volume of 105 ± 13 ill (ti = 4, Figure 7.4). When t was 
increased to 15 min the volume decreased to 50 ± 10 I.A.1 (n = 2, Figure 7.4). When 1 
i_LM 5-HT was infused according to protocol I and t = 6 min, the entrapped volume 
was found to be negligible (data not shown). 
The total vascular volume of untreated hindlimbs was 2.36 ± 0.04 ml (n = 4, 
Figure 7.3 C). As the entrapped volume by both NE and 5-HT appeared to be time 
dependent, suggesting a component of slow washout (Figure 7.4), the estimation of 
entrapped volume at the point of FITC-dextran removal was obtained by 
extrapolation of the curves to t = 0 min. Exponential curves were fitted for each 
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Figure 7.2 	Perfusion protocol for determining the entrapment of FITC- 
dextran during infusion of NE or 5-HT. 
NE (0.1 1AM), 5-HT (1 IAM) or FITC-dextran (10 1.1g.m1 -1 ) were infused for the 
time indicated by bars. The period indicated by t varied between experiments 
(see Figure 7.4), and in this example was 10 min. Venous effluent samples were 
intermittently collected to measure relative intensity throughout the periods of 
FITC-dextran infusion, and then more frequently from t = 0 min, the time of 
FITC-dextran removal. 
Protocol /: Removal of the agonist until basal V02 and perfusion pressure 
were obtained (15 min) then cessation of FITC-dextran infusion. After 
a defined period (t) the agonist was reinfused and measurement of 
washout of entrapped marker commenced; or 
Protocol //: Cessation of FITC-dextran infusion after a defined period (t) 
before removal of the agonist and measurement of washout of 
entrapped marker. 
FITC, fluorescein isothiocyanate; NE, norepinephrine; 5-HT, serotonin. 
Modified from Newman (1992). 
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Figure 7.3 Time course of the washout of NE- and 5-HT-mediated and total 
entrapped spaces in perfused hindlimb. 
Both hindlimbs of rats were perfused at 8 ml.min -1 as described in Figure 7.3 
and 10 ps.m1 -1 FITC-dextran was infused for 10 min to reach equilibrium. The 
data are expressed as a percent of the maximum relative intensity. Panel A 
followed protocol I and shows the washout of FITC-dextran when NE was (•, 
0.1 pM, t = 6 min) or was not (0) reinfused. Panel B followed protocol II and 
shows the washout of FITC-dextran when 5-HT (A, 1 1.1M, I = 6 min) or was 
not (A) removed. Panel C shows the washout of trapped FITC-dextran from 
untreated hindlimbs (*) once the inflow and outflow tubing was devoid of 
marker. Time = 0 min refers to the removal of FITC-dextran (t = 0, A & B) or 
the reconnection of flow to the rat (C). Values are means ± SE for 4 hindlimbs. 
When not visible, error bars are within symbols. FITC, fluorescein 
isothiocyanate; NE, norepinephrine; 5-HT, serotonin. 
Modified from Newman (1992). 
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Figure 7.4 Effect of time on the apparent volume entrapped by NE and 5-HT 
in perfused hindlimbs. 
Both hindlimbs of rats were perfused at 8 ml.min 1 as described in Figure 7.3. 
The perfusion protocol was as given in Figure 7.2, where NE (0, 0.1 p.M) and 
5-HT (0,1 1.LM) were infused as described by Protocols / and II, respectively, 
and t was increased from 6 min to include data for 10 and 15 min. The data 
were calculated to represent volumes as described in Section 7.2.2. Exponential 
equations were iteratively fitted using EXPFIT (Guardabasso et aL, 1991) and 
extrapolated to time = 0 mm, the point when FITC-dextran was removed. 
Values are means ± SE for 4 hindlimbs for t= 6, and 2 hindlimbs each for t = 10 
and 15 min. When not visible, error bars are within symbols. FITC, fluorescein 
isothiocyanate; NE, norepinephrine; 5-HT, serotonin. 
Modified from Newman (1992). 
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treatment with r values of 0.977 and 0.915 for NE and 5-HT, respectively. The 
extrapolated volumes were 0.42 ml for NE and 0.18 ml for 5-HT (Figure 7.4). Thus 
the total basal vascular volume accessed by NE was approx. 18% and that closed off 
by 5-HT was 8%. 
7.3.3 	Microsphere injection. 
The size distribution of the injected microspheres is given in Figure 7.5 (A). 
The major proportion of spheres were between 8 and 16 1.1.M in diameter. In control 
experiments, only 0.7 ± 0.3 % (n = 3) of injected microspheres were observed in the 
venous effluent, whereas in 5-HT-treated hindlimbs, a greater proportion (1.9 ± 0.4 
%, n = 3) of injected spheres were recovered (P < 0.05, unpaired Student's t test). Of 
the spheres that were recovered, the distribution was not significantly different 
between control and 5-HT treated groups, although more 7.25 um spheres were 
observed in 5-HT treated hindlimbs compared to control (Figure 7.6). With either 
treatment, few spheres greater than 15 pm were observed in the venous effluent. 
7.4 	Discussion. 
The purpose of this study was to determine whether the observed changes in 
hindlimb metabolism induced by the vasoconstrictors NE and 5-HT under constant-
flow perfusion conditions could be explained by changes in flow distribution within 
the rat hindlimb vasculature. The studies were performed in the absence or presence 
of vasoconstrictors and were determined by three methods. Firstly, efflux kinetics of 
bolus injected Evans blue dye were compared between control, NE- or 5-HT-treated 
and flow-restricted hindlimbs. Secondly, fluorescein-labelled dextran was trapped in 
the absence or presence of NE or 5-HT and subsequent washout was monitored. This 
method also allowed an estimation of trapped volume compared to total basal volume. 
Finally, unlabelled microspheres over a wide size distribution were injected in the 
absence or presence of 5-HT, and the effluent washout numbers were counted and 
compared. 
The dye experiments suggested that 75 LIM NE significantly altered the 
distribution of flow through the hindlimb in conjunction with the increases in 
perfusion pressure and V0 2 . In each experiment the effect of NE was to slightly 
lower the maximum absorbance of dye washout in comparison to basal. This, in 
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Figure 7.5 	Effect of 5-HT on the washout of injected microspheres in 
perfused hindlimb I. 
Hindlimbs from 180-200 g rats were perfused at 25°C and a constant flow rate 
of 4 ml.min - I with perfusion medium containing 2% bovine serum albumin and 
gassed with 95% 02-5% CO2 . Panel A shows the size distribution of 
microspheres injected into the arterial perfusion line. Venous effluent spheres 
were collected and counted in the absence (Panel B) and presence (Panel C) of 
5-HT (1 illv1) and expressed as a proportion of the total number of spheres 
injected into the arterial line. Values given are means ± SE for three perfusions. 
5-HT, serotonin. 
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Figure 7.6 	Effect of 5-HT on the washout of injected microspheres in 
perfused hindlimb H. 
Data obtained in Figure 7.6 are expressed as a percent of the total number of 
spheres counted for each treatment. Panel A shows the size distribution of 
microspheres injected into the arterial perfusion line. Venous effluent spheres 
were collected and counted in the absence (Panel B) and presence (Panel C) of 
5-HT (1 1.1.M). Values given are means ± SE for three perfusions. 5-HT, 
serotonin. 
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addition to the observed washout of a small number of erythrocytes, tends to suggest 
NE is in some way causing a small portion of the flow to reach previously unperfused 
vessels. 
The entrapment studies involved perfusion of both hindlimbs. In general, the 
effects of NE were consistent with those obtained when one hindlimb was perfined. 
NE increased V02, lactate and erythrocyte release in association with 
vasoconstriction. The results supported the dye washout studies in that NE-induced 
vasoconstriction was shown to recruit a space that was only perfused slowly in the 
absence of constriction. It has already been discussed that NE did not appear to 
increase flow to hypoxic regions (see Chapter 1). If smooth muscle work does not 
account for the large increases in metabolism during vasoconstriction, a form of 
agonist-mediated uncoupling or futile cycling must be postulated such that the 
responses were sustained, reproducible and independent of skeletal muscle 
contraction-mediated metabolism. Thus the increase in perfiised volume in the 
presence of NE may suggest heterogeneity of microvascular flow at the level of the 
capillaries, which did not compromise oxygenation of the surrounding skeletal muscle. 
Alternatively, the entrapped space may be in relatively metabolically inactive regions 
such as bone or connective tissue and changes in flow not related to changes in 
metabolism. This possibility could be explored by trapping and detecting either 
fluorescent or radioactive markers in firstly whole, then sectioned hindlimb tissue. 
For example, Bassingthwaighte and co-workers used the soluble, radioactively 
labelled flow marker 2-iododesmethylimipramine to determine regional flow in 
sectioned rabbit (Bassingthwaighte et aL, 1987) and sheep (Bassingthwaighte et al., 
1990) hearts. 
Because of the large pressures that would be involved, no experiments were 
performed to determine possible changes in flow induced by high doses of NE (2.5 
p.M, Chapter 2). 
In contrast to the effects of NE, 5-HT appeared to decrease the perfusion 
space of the hindlimb. The dye injection studies showed that 5-HT appeared to 
significantly alter the distribution of flow in the hindlimb, in a manner opposite to that 
of NE yet similar to that observed when the hindlimb was reversibly occluded below 
the knee. Maximum absorbance values in the venous effluent were significantly 
higher than those in the control condition indicating a proportion of dye had a shorter 
path length through the hindlimb. The extent of vasoconstriction was similar in both 
the NE and 5-HT experiments yet the effects on the absorbance profiles were quite 
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different. 
The FITC-dextran entrapment studies supported the dye efflux studies in that 
5-HT appeared to decrease the perfiised region. The volume of FITC-dextran 
entrapped by 5-HT appeared to decrease with time, and comprised less than 10% of 
the basal volume, again apparently less than the percent decrease in V0 2 . The results 
do not preclude the possibility of altered distribution of flow in the presence of 5-HT. 
5-HT may reduce, but not deny, flow to metabolically active regions. 
One consideration that must be made with the two indicator techniques is 
that heterogeneities in transit time and washout volumes are the composite of 
heterogeneities in both flow and volume. Thus if the hormones decreased the total 
vascular volume (by decreasing the radius of blood vessels) during vasoconstriction, 
the differences in transit time would be a combination of increased velocity (to 
maintain constant flow) and alterations in the number of blood vessels perfused. In 
addition, entrapped FITC-dextran volumes do not give an indication of the number of 
capillaries or the radius of the vessels the dextran was trapped in. Thus the small 
proportion of trapped volume observed with 5-HT could represent a large change in 
number of perfused capillaries or a small change in the number of large vessels 
perfused. However it must also be considered that a heterogeneity of flow may not 
underlie the observed metabolic effects during vasoconstriction. Possible mechanisms 
to increase V02 that are not dependent on changes in flow pattern include an 
endothelial cell shear-stress-mediated trigger of paranchymal metabolism (Chapter 1, 
Section 1.3.2.3) or vascular thermogenesis (Chapter 1, Section 1.3.2.4). 
The lack of marked difference in the washout pattern of injected 
microspheres in the presence of 5-HT compared to control suggests 5-HT was not 
opening direct anatomical arterio-venous (A-V) shunts (>15 wn) in skeletal muscle. 
The existence of such vascular bypasses in skeletal muscle has been debated, with 
functional evidence to support their presence (Lopez-Majano et aL, 1969) but in 
general refuted on morphological grounds (Rhodin, 1977), although A-V 
anastomoses are reported to be common in the surface fascia of feline tenuissimus 
muscle (Eriksson & Myrhage, 1972) and in the fascia covering the feline cremaster 
muscle (Grant & Wright, 1968) and within hindlimb skeletal muscle of rabbits 
(Warren & Ledingham, 1974). Indeed, Lindbom and Arfors (1984) noted that 
constriction of transverse arterioles may close their lumen, stopping flow to nutritive 
capillaries, but flow would continue through arcade arterioles into adjacent non-
nutritive connective tissue vessels. In rat spinotrapezius muscle, the size of these 
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arcade arterioles ranges between 20-50 p.m, and the root of the transverse arterioles 
between 8-30 pm (Zweifach etal., 1981, Figure 8.1). 
A recent study by Harrison et a/. (1990a) on local oxygen supply and blood 
flow regulation in contracting muscle in dogs and rabbits suggested the presence of 
high-flow capillaries (shunts or non-nutritive capillaries) that although only 13% of 
the capillary density (Potter & Groom, 1983) could carry approx. 70% of the flow 
under resting conditions and be adjusted by local regulatory mechanisms when oxygen 
demand was increased (i.e. in exercise). Using the data of Potter and Groom (1983) 
Harrison et al. (1990a) postulated the diameter of these putative shunts would be 7-8 
pm compared to the nutritive capillaries of 4-6 p.m diameter. Thus alterations in the 
proportion of flow between the two types would not be detectable with the commonly 
used 15 p.m spheres (Laughlin et al., 1982; Piiper et al., 1985; Gorski et al., 1986; 
Iversen & Nicolaysen, 1990; Bassingthwaighte etal., 1990) or the majority of spheres 
used in this study. Thus in this study, the lack of marked increases in effluent 
microspheres in the presence of 5-HT suggests that either the A-V shunt vessels had 
small luminal diameters or that most of the perffisate flow still passed through 
capillaries that were less nutritive. 
/ 
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CHAPTER 8 
Thesis discussion. 
8.1 	Summary of findings. 
The main aim of this thesis was to characterize the vascular and associated 
metabolic effects of norepinephrine (NE) and serotonin (5-HT) in the constant-flow 
perfused rat hindlimb. In the course of this work, three important findings have 
emerged: 
(1) Separate aradrenoceptors (ARs) control NE-mediated vasoconstriction-
associated increases and decreases in hindlimb metabolism; 
(2) The fuel and extracellular Ca2±-dependency of smooth muscle constriction is 
related to the control of oxygen, substrate and hormone delivery to resting 
and active tisssue; and 
(3) Vascular site-selective receptor gene expression may have a physiological 
role. 
The hormones NE and 5-HT proved to be interesting vasomodulators that 
had heterogeneous effects on hindlimb metabolism, apparently due to effects at 
different levels of the vascular tree. The vasoconstriction-associated effects on 
metabolism were observed in perfused, but not incubated, preparations thereby 
underlining the importance of a functional vascular system in the control of 
metabolism. 
Vasoconstriction mediated by low doses of NE occurs through a subgroup of 
a 1 -ARs and is associated with large increases in hindlimb metabolism. These effects 
are selectively opposed by D-AR and "5-HT I -like" agonists (Chapter 2), which is 
consistent with an action at sites within the tnicrocirculation, perhaps at A3 or A4 
arterioles (Figure 8.1). Further support for these sites being involved comes from the 
susceptibility of low-dose NE-mediated constriction to inhibition by hypoxic 
conditions and by removal of extracellular Ca2+. Both these events are usually 
associated with constriction of small arterioles (Chapters 3 & 4). There is an overall 
increase in a-AR density with decreasing vessel size, and perhaps an increased 
number/affinity of ARs in fast-twitch glycolytic fibre types (introduced in Chapter 1). 
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The large increase in hindlimb metabolism observed upon infusion of low-
dose NE may be due to the work done during constriction of the relatively large 
number of small arterioles as reviewed by Colquhoun and Clark (1991). The 
possibility that NE-mediated constriction altered the microcirculatory flow pattern 
was addressed (Chapter 7), and the results could also support the alternative concept 
of a flow redistribution to capillaries feeding tissues which are triggered to increase 
their metabolism by an as yet undetermined mechanism. Both these alternatives are 
receiving ongoing study, and are not necessarily mutually exclusive. 
The possibility that skeletal muscle has the potential to increase its 
metabolism, and this increase is controlled by circulating hormones and neuronally-
released factors is an important observation and may improve our understanding of 
thermoregulation. However, thermoregulation may not be as simple as an on-off 
positive thermogenic mechanism. In situations such as long-term overeating 
(obesity), positive thermogenic mechanisms may need to be overridden to prevent 
overheating and to maintain vital functions. The main finding from this work may be 
related to this latter situation and demonstrates how control of blood flow by 
vasoconstrictors can also decrease metabolism in skeletal muscle. This finding adds 
functional significance to the existence of receptor subtypes in discrete vascular 
locations. 
As outlined in Chapter 1, sympathetic nervous system (SNS) efferent activity 
increases to skeletal muscle postprandially, when the body is exposed to cold or 
hypoxia, and during intense muscular exercise. Depending on the intensity of each 
situation, there may be a necessity for reduced flow to the energetically-expensive 
skeletal muscle bed. Thus it is proposed that the locus of flow control shifts to larger 
vessels, probably at discrete sites, and the delivery of nutrients to either resting or 
contracting muscle can be markedly reduced, thereby temporarily compromising 
tissue metabolism. In this study it was found that these sites probably express 5- 
HT2A-receptors and a 1 B-ARs. Results from Chapters 3 and 4 showed both 5-HT-
and high-dose NE-mediated vasoconstriction could be supported anaerobically and in 
the absence of extracellular Ca2+, thus providing a method of dissociating positive 
and negative thermogenic vasoconstrictors. These latter findings are consistent with 
constriction of larger vessels. 
As reviewed in Chapter 2, literature reports generally support a 5-HT-
mediated constriction of larger vessels. In a skeletal muscle preparation, Alsip and 
Harris (1991) reported that 5-HT caused a 5-HT 2-receptor-mediated constriction of 
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large (Al) arterioles and a orphan 5-HT-receptor dilation of small (A3 or A4) 
arterioles (consistent with results in Chapter 2). The result of constriction at these 
sites was an overall decrease in resting (Chapters 2-7) and contracting (Chapter 6) 
hindlimb metabolism despite constant-flow. Thus it is possible that vigorous 
constriction of arteries or larger arterioles (Al, Figure 8.1) by 5-HT may divert flow 
through functional, but not anatomically-typical arterio-venous, vascular shunts in the 
hindlimb (Chapter 8). This may occur as a result of an alteration in the distribution of 
flow to different muscle groups (possibly away from slow-oxidative and more to fast-
glycolytic) and/or by selective reduction or denial of flow to the microvasculature 
within a muscle (Figure 8.1). In either case, oxygen and substrate availability is 
reduced to active smooth and skeletal muscle cells. 
A similar proposal is also put forward for high-dose NE. The a l -AR 
subgroup (presumably a m, Chapter 4) stimulated may be located on vessels upstream 
from the a1-ARs stimulated by low doses of NE, probably at the transverse arteriole 
roots. These vessels are reported to have the highest tone in vivo (Schmid-Schonbein 
et al., 1987), have dense sympathetic innervation (Saltzman et aL, 1992) and can 
readily close their lumen (Schmid-Schonbein & Murakami, 1985). Constriction at 
these sites could be the principal control mechanism for modulating the capillary 
perfusion (Saltzman etal., 1992). 
8.2 	Implications of findings. 
In the light of these findings it is proposed that resting skeletal muscle 
contributes to whole body thermogenesis and that it is controlled by total, and well as 
zonal (within muscle), nutrient delivery. The fine balance that must exist between 
delivery and usage of nutrients in skeletal muscle and without compromizing function 
in other parts of the body is controlled, at least in part, by the release of vasoactive 
agents from the sympathetic nerve endings. Interruptions to this balance could 
markedly alter skeletal muscle metabolism. Elevations in SNS activity observed in 
disorders such as hypertension and obesity may eventually lead to significant 
alterations in skeletal muscle blood flow and thereby metabolism. Reductions in the 
delivery of oxygen, fuels and hormones (including insulin) to muscle could contribute 
to the onset and presence (rather than be an effect) of the disorders, including obesity, 
non-insulin-dependent diabetes and atherosclerosis, often associated with 
hypertension (Figure 8.2). The clinical occurrence and importance of this possibility 
is currently receiving attention, and has recently been reviewed by Baron et al. (1993) 
and Julius et al. (1992). 
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Figure 8.1 	Schematic diagram of the branching sequence in the vascular 
network of skeletal muscle. 
Panel A shows the external sural artery feeding the soleus and plantaris muscles 
of the lower hindlimb. Panel B is an enlargement from within BOX I; and 
arterial branchings are numbered beginning with the sector that feeds the 
arteries: Al, feeding artery (60-120 gm); A2, arcade arteriole (20-50 gm); A3, 
transverse arteriole (8-30 tm); A4, precapillary arteriole (4-12 gm); and A5, 
capillary. Panel C is a transverse section of BOX II, and shows a typical 
arrangement of the slow-twitch oxidative (SO) fast-twitch oxidative/glycolytic 
(FOG) and fast-twitch glycolytic (FG) fibre types within the plantaris muscle. 
Modified from Eriksson and Myrhage (1972), Zweifach et al. (1981), Sullivan 
and Pittman (1982) and Saltzman et aL (1992). 
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Figure 8.2 	The link between hypertension and insulin-resistance in SKM: 
A model. 
This model depicts the possible causes and consequences of reduced skeletal 
muscle (SKM) blood flow. It should be considered in conjunction with the 
modified Landsberg hypothesis presented in Chapter 1 (Figure 1.1). In 
situations where the sympathetic nervous system (SNS) is over-stimulated, for 
example in obese patients, the plasma levels of norepinephrine (NE) and 
serotonin (5-HT) are increased, causing vasoconstriction of large, feeding or 
root arterioles through am-adrenoceptors and 5-HT2A-receptors, respectively. 
This constriction reduces SKM nutritive microcirculation blood flow, impairing 
nutrient (eg. 02, fatty acid and glucose) and hormone (eg. insulin) delivery. 
Long-term increases in blood pressure (hypertension) are often associated with 
peripheral vascular disease (PVD) and atherosclerosis, which also contribute to 
the reduction in nutrient access. This results in a decrease in vascular 
thermogenesis and causes a state of insulin resistance, which may, in turn, 
stimulate SNS activity thereby completing the cycle. 
Modified from Vanhoutte and Cohen (1983); Landsberg (1986); Clark et al. 
(1991); and Barradas and Mikhailidis (1992). MAO, monoatnine oxidase. 
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8.3 	Future considerations. 
The location of agonist-mediated responses warrants future investigation. 
The most direct approach would be to use cDNA clones of the various c4-ARs and 
5-HT2-receptors. Once the presence of the mRNAs was confirmed, in situ 
hybridization with cDNA probes or with fluorescent of radiolabelled antibodies to the 
receptor subtypes should localize receptor populations. 
Another important set of experiments would be to determine whether the 
effects observed in vitro are relevant to in vivo situations. Constant-pressure 
perfusions at more physiological levels using medium containing erythrocytes would 
allow an assessment of changes in flow and associated changes in metabolism upon 
infusion of agents. 
These problems could be partially addressed by visualizing the effects of 
vasomodulators in situ by use of intravital microscopy. This procedure has 
drawbacks in that access is limited to surface, predominantly fast-twitch glycolytic 
fibre-type muscle groups and only their surface microcirculatory networks. The 
microcirculation of two hindlimb muscle groups, the extensor digitorum longus (Tyml 
& Budreau, 1991) and tibialis (Lund et al., 1987), have been successfully 
characterized in situ. However, to compare metabolism to blood flow distribution, a 
constant-flow erythrocyte-perfused preparation would appear more relevant to these 
studies. 
The above experiments could also be repeated in various animal models. 
Both spontaneously hypertensive (Finch et al., 1990) and fructose-fed (Hwang et al., 
1987) rats display insulin resistance. The altered responsiveness to vasoactive agents 
in these disorders (reviewed by Struyker-Boudier et al., 1990) may demonstrate the 
importance of blood flow control in determining tissue metabolism. 
In conclusion, manipulation of microvascular haemodynamics in obesity, 
diabetes and hypertension may provide a means of treating and protecting against the 
complications of these conditions. Drugs such as ketanserin may lower blood glucose 
by opposing both 5-HT- and NE-mediated vasoconstriction, thereby improving insulin 
and glucose access to skeletal muscle (Figure 8.2). Agents that selectively oppose 
stimulation of 5-HT2A-receptors and especially ccuradrenoceptors may provide 
improved treatments for obese or non-obese patients with Type II diabetes and 
hypertension. 
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